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Chapter 1 
 
Background 
Conventional two-dimensional echocardiography (2DE) has been established as the most widely 
diagnostic tool in clinical cardiology practice. Its application helps in morphological and functional assessment 
of cardiac chambers and valves. The advancement in technology of echo machines and its software analysis 
minimized many difficulties and limitations. However, 2DE application still carries many limitations. It requires 
mental conceptualization of a series of multiple orthogonal planer or tomographic images into an imaginary 
multidimensional reconstruction for better understanding of complex intracardiac structures and their spatial 
relation with surroundings (1). Many of 2DE formula used for volume quantification and ejection fraction 
calculation especially for left ventricle are based on geometric assumption that may not true providing varied 
results in the setting of chamber dilatation or distortion and in the presence of regional wall motion abnormalities 
(2). Interobserver variability for 2DE images interpretation is still due to different ways of data interpolation 
especially for measurement of mitral and aortic valve orifice area (3,4). These limitations encourage numerous 
investigators to obviate it by the attempt to obtain three-dimensional images. Three-dimensional 
echocardiography was developed since more than 15 years provide more accurate assessment of ventricular 
volume, mass and function and provide a more complete view of the valves. Despite these advantages, it 
remained a research tool due to many limitations like electrocardiographic and respiratory gating, motion 
artifacts, time consuming offline analysis and reconstruction. Over the last few years, the advances in transducer 
and computer software technology led to enhancement of real-time three-dimensional echocardiography 
(RT3DE) to be applied for clinical utility. The recently developed matrix array transducer consists of 
approximately 3,000 firing elements improved the contrast resolution and penetration. By this transducer, the 
entire heart image could be obtained by a pyramidal full-volume acquisition of four cardiac cycles. The 
development in software made the data off-line analysis faster and easier.  
 
Clinical Application 
Numerous application of RT3DE have been proposed and well studied. It allows accurate assessment of 
ventricular volume and ejection fraction comparable to angiography, CT and MRI (5-7). It was also applied for 
accurate and feasible evaluation of left ventricular mass among patients with a broad range of cardiac diseases 
(8,9). Many studies showed feasibility of RT3DE for assessment of right ventricular volume and function (10,11). 
The other major area in which RT3DE has been used for anatomical assessment is in congenital heart disease 
with considerable evidence of the superiority of it over 2DE (12,13). Through RT3DE imaging planes and 
projections of the interatrial septum, accurate assessment of atrial septal defect including localization, number, 
size and rims could be obtained (14). This assessment helps in selection of therapeutic strategy either surgical or 
transcatheter closure (15). RT3DE application for assessment of ventricular septal defect is encouraging (16,17). 
RT3DE application in valvular heart disease became standard due to its more feasibility and accuracy than 2DE 
especially for mitral valve assessment. By its enface views, full anatomical description of the mitral valve 
annulus, subvlvular apparatus, leaflet surface, tethering distances and tenting volumes could be obtained (18-20). It 
helps in accurate calculation of mitral valve area comparable to catheterization with low interobserver and 
intraobserver variability (21,22). The qualitative and quantitative assessment of RT3DE expands its use before and 
after mitral valvuloplasty and before surgical treatment (23).  
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Outline of this thesis 
The aim of this thesis was to expand the use of RT3DE for anatomical and functional assessment of 
other important cardiac structures little or not studied before. It also discussed the feasibility and clinical 
applicability of RT3DE assessment of these structures.   
 
Chapter 2. The study provided the actual description of the tricuspid valve annulus morphology as seen by 
RT3DE. Its shape was evident as an oval-shaped and not completely circular. Measurement of tricuspid annular 
diameter by 2DE was nearly matched with the minor diameter by RT3DE and significantly smaller than the 
major diameter. Through the ability to study the cyclic changes of the annulus area and diameter during systole 
and diastole, the annular function could be evaluated by fractional area change and fractional shortening.  
 
Chapter 3. The study compared the measurement of tricuspid annulus area and diameter by RT3DE and MRI. 
Both techniques were well correlated and comparable. It was concluded that 2DE measurement of tricuspid 
annuls diameter could not be relied on due to underestimation compared to MRI and RT3DE. Annular function 
was correlated with the right ventricular systolic function, and thus it can be used as a marker of right ventricular 
function.  
 
Chapter 4. The study described the use of RT3DE for evaluation of rheumatic tricuspid valve stenosis and 
assessment of its severity. Through RT3DE enface view, a detailed morphological assessment of mobility, 
thickness and calcification of all tricuspid valve leaflets. The unique RT3DE functional assessment of the valve 
could also be obtained through measurement of valve orifice area, and the three commissural widths. 
 
Chapter 5. The study aimed to apply RT3DE for quantitative and qualitative assessment of the normal tricuspid 
valve and to standardize the normal values. The qualitative assessment included morphologic description of the 
three leaflets shape, position and their relation to each other and to the surrounding structures. The quantative 
assessment included measurements of tricuspid valve area, commissural width, tricuspid annular area and 
diameter. This paper described inconsistent findings in the echocardiographic textbooks on TV leaflet 
identification and set a new gold standard regarding the identification of each leaflet in each 2DE views. 
  
Chapter 6. The study explained the feasibility and reliability of RT3DE for assessment of the true mitral 
annulus area and diameter. Its shape was seen as D-shaped and not completely circular. MRI measurements of 
mitral annulus were used as a gold standard to compare between 2DE and RT3DE measurements. It showed 
underestimation of 2DE while RT3DE was superior to it and comparable to MRI. The accuracy of RT3DE 
measurements was obtained with good interobserver and intraobserver agreements   
 
Chapter 7. The morphological and functional changes of mitral annulus in both dilated and hypertrophic 
cardiomyopathy were described compared to normal subjects. The annulus increased in size and became flat due 
to over stretching in both types. Assessment of mitral annulus function by RT3DE calculation of fractional area 
changes and fractional shortening showed augmented function in hypertrophic cardiomyopathy and impaired in 
dilated cardiomyopathy. RT3DE measurements were comparable with MRI measurements with good 
interobserver agreement.  
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Chapter 8. The study was designed to apply a new RT3DE score for evaluation of mitral valve stenosis. By this 
score, each part of the two leaflets could be assessed separately regarding mobility, thickness, and calcification if 
any. Subvalvular apparatus affection was included in the score by assessment of chordal mobility, thickness nd 
separation at three levels. The study described the value of this score application for patients before percutaneous 
mitral valvuloplasty compared it with the standard 2DE Wilkins' score. The new RT3DE score is simple, less 
subjective with less interobserver variability. Its application added more valuable information needed before 
valvuloplasty and could predict the outcome (results and complications).   
 
Chapter 9. The study clarified the role of RT3DE for anatomic description of right ventricular outflow tract and 
pulmonary valve. The morphologic assessment of outflow tract, pulmonary valve annulus, pulmonary valve, and 
proximal pulmonary artery was achieved in a considerable number of patients. RT3DE measurements of the 
outflow tract and pulmonary valve annulus diameter were higher than that obtained by 2DE. Measurement of 
area of both right ventricular outflow tract and pulmonary annulus may aid in selection of therapeutic strategy. 
 
Chapter 10. The study described feasibility and reliability of RT3DE for assessment of left atrial volume and 
function. Functional assessment included both active and passive left atrial function through the volumetric 
changes during the cardiac cycle. RT3DE assessment of left atrial volume does not rely on assumption and thus 
depict the actual left atrial shape. RT3DE measurements were compared with 2DE measurements. It is so 
difficult by 2D planimetry to exclude left atrial appendage and pulmonary veins totally during volume 
calculation. This can explain the higher value of left atrial volume measurements by 2DE than that obtained by 
RT3DE.        
 
Chapter 11. Assessment of left atrial volume at three phases of cardiac cycle (maximum volume, minimum 
volume, and pre-atrial contraction volume) was obtained by RT3DE. RT3DE assessment of cyclic changes of 
left atrial volume and indices of passive and active function may help in understanding the left atrial physiology. 
The existence of left atrial Frank-Starling mechanism was described through RT3DE measurement and 
evidenced by an increase in left atrial contractility in response to an increase in preload up to a certain point, 
beyond which the left atrial contractility decreased.  
 
Chapter 12. The study assessed the calculation of left atrial ejection force in hypertrophic cardiomyopathy 
patients. This assessment depends on a standard formula used the mitral orifice (annulus or valve) area, 
transmitral velocity and blood viscosity. The calculation of ejection force by the formula used RT3DE 
measurement of mitral annulus diameter showed that hypertrophic cardiomyopathy is associated with higher 
ejection force than normal, and higher in obstructive HCM than non-obstructive indicating a higher atrial 
workload. The study concluded that ejection force should be determined in HCM patients by annulus area-
derived formula instead of valve area-derived formula due to annular dilatation. So, RT3DE measurement of 
atrial ejection force through annuls area is recommended as a better indicator for left atrial work in HCM 
because it is more accurate and logic than 2DE measurement 
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Chapter  2 
ABSTRACT 
Tricuspid annulus (TA) evaluation continues to be a major problem in the surgical decision-making process. 
Obviously, 2-dimensional transthoracic echocardiography (2D TTE) is limited in TA visualization due to its 
complex 3D shape. The study aimed to determine TA morphology, size and function with real-time three-
dimensional echocardiography (RT3DE) in 40 patients divided into two equal groups (I: normal TA and II: 
Dilated). 2D TTE measurements included TA diameter (TAD) at apical 4 chamber (AP4CH) and parasternal 
short axis (PSAX) views. RT3DE measurements included TA area (TAA), major TAD and minor TAD. TA 
fractional shortening (TAFS), and TA fractional area change (TAFAC) were calculated from End-systolic and 
end-diastolic measurements. RT3DE allowed visualization and measurement of the entire oval-shaped TA in all 
patients irrespective of its size (normal or dilated). 2D TTE measurement of TAD at both AP4CH and at PSAX 
views was significantly smaller than the major TAD measured by RT3DE (P <0.0001) and nearly matched with 
the minor TAD in all patients. Calculation of TAFS was comparable with both techniques. TAFAC was 
significantly higher than TAFS (P <0.0001). So, RT3DE could be relied on more accurately than 2D TTE in the 
assessment of TA size and function which may aid in decision-making and selection of proper surgical 
procedure when indicated. 
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INTRODUCTION 
The tricuspid valve (TV) is composed of three leaflets (anterior, posterior and septal) attached to a fibrous 
annulus1. The three-dimensional (3D) shape of this tricuspid annulus (TA) is complex and does not conform to a 
flat ring2. Tricuspid regurgitation (TR) is the most common pathology affecting the TV. An understanding of the 
pathological process underlying TR is necessary to determine the optimal management strategy. Usually, TR is 
secondary to left-sided valvular pathology (mostly mitral valve disease) with pulmonary hypertension and right 
ventricular dilatation 3,4.  Because the TA is a component of the right ventricle it will dilate also. However, since 
the septal leaflet is fixed between the fibrous trigones, the TA can only lengthen and dilate along the attachment 
of the anterior and posterior leaflets 5-7. Unfortunately, TV evaluation continues to be a major problem in the 
surgical decision-making process 8. Guidelines for TV repair include TA assessment (indexed TA size 
>2.1cm/m2 and TA fractional shortening <25%)3 . At the time of surgery the decision to repair the TV may be 
changed due to discrepant TA diameter (TAD) findings between pre-operative two-dimensional transthoracic (or 
transesophageal) echocardiography (2D TTE) and direct surgical visualization3. Obviously, 2D TTE is limited in 
visualizing the complete TA. Since real-time 3D echocardiography (RT3DE), has become available for clinical 
practice, it is now possible to examine the TV more completely 9. The present study aimed to determine actual 
TA morphology, size and function with RT3DE and to compare the results with standard 2D TTE findings. 
 
SUBJECTS AND METHODS 
 
The study included forty consecutive patients with good image 2D TTE quality in whom also RT3DE was 
performed. Indications for echocardiography included follow-up for adult congenital heart disease (n = 12), 
valvular heart disease (n = 10), cardiomyopathy (n = 8), and analysis of shortness of breath (n = 10). 
2D TTE Examination 
2D TTE was done with a Sonos 7500 ultrasound system attached to a S3 transducer (Philips, Best, The 
Netherlands). The TV was imaged from apical and parasternal views with the patient in the left lateral decubitus 
position. In each patient, the following variables were measured by two blinded observers: (1) TAD, obtained 
from the apical 4-chamber (AP4CH) and parasternal short axis (PSAX) views at an end-diastolic and end-
systolic still frame, and (2) TA fraction shortening (TAFS) defined as (end-diastolic TAD - end-systolic TAD) / 
end-diastolic TAD obtained from the AP4CH and PSAX. 
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RT3DE Examination 
RT3DE was done with the same ultrasound system attached to a X4 matrix array transducer capable of providing 
real-time B-mode images. A full volume 3D data set was collected within approximately 5-10 seconds of breath 
holding in full volume mode from an apical window. The 3D data set was transferred for off-line analysis with 
TomTec software (Unterschleissheim, Munich, Germany). Data were stored digitally and subsequently evaluated 
by two blinded observers (AMA, OIIS). Data analysis of 3D images was based on a 2D approach relying on 
images obtained initially from the apical view. The TA was sliced between two narrow lines to exclude other 
tissues on the 2D image leading to clarification of annulus by a 3D image. This image was viewed and traced 
from the ventricular aspect, in 6 patients (15%) the atrial aspect was used because of better quality. Manual 
tracing of the inner border of the tricuspid annulus was done from the atrial aspect and once this is completed the 
surface area was automatically calculated and could be visualized from different points of views. Manual 
modification was made to correct any inconsistence. 
The following RT3DE variables were obtained from both an end-diastolic and end-systolic still frame: (1) 
TA area (TAA3D), (2) major TAD3D defined as the widest TAD3D (see Figure 1), and (3) minor TAD3D defined 
as the smallest TAD3D (see Figure 1).  Subsequently, TAFS3D was calculated from major TAD3D data and TA 
fractional area change (TAFAC3D) was calculated from systolic and diastolic TAA3D. 
  
STATISTICAL ANALYSES  
All data obtained by 2D TTE and RT3DE are presented as mean  SD. A paired t-test was performed for 
comparing means of variables. The level of significance was set to P <0.05. A SPSS statistical package was used 
(SPSS, version 12.1, SPSS Inc, Chicago). Interobserver agreement for 2D TTE and RT3DE measurements was 
assessed according to the Bland and Altman principle 10. 
 
RESULTS 
In Table 1, the clinical and echocardiographic parameters of all patients are displayed. Patients were classified 
into two groups; group I included 20 patients with normal end-diastolic TAD2D-AP4CH (<35mm) and group II 
included 20 patients with dilated end-diastolic TAD2D-AP4CH (35mm). There were no significant differences in 
clinical variables (age, gender) between the two groups. All echocardiographic parameters were significantly 
higher in group II patients (all P <0.0001). 
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RT3DE acquisition 
Acquisition and post-processing of RT3DE data was performed successfully in all patients in a reasonable time 
(approximately 1 minute for acquisition and 5 minutes for data analysis). The TA was clearly delineated in all 
patients and, as seen in Figure 1, its shape was not circular but oval, both in normal sized and in dilated TA 
(Figure 2). 
 
 
Fig (1): (a) Tricuspid annulus with two lines inside, 
line 1 is TAD by 2DE in AP4CH and line 2 is 
major TAD by RT3DE, with large difference in 
measurements, (b) surgical view of tricuspid 
annulus and leaflets, (c) tricuspid annulus and 
leaflets as seen by RT3DE, and (d) simple diagram 
of tricuspid annulus and the three leaflets of the 
valve 
Fig (2): Real time 3D echo showed the morphology 
of the normal tricuspid annulus (A) and dilated 
annulus (B) as visualized from the ventricular 
aspect with delineation of its inner border. Both 
tricuspid annuli appeared as oval in shape. The 
horizontal line inside is the major tricuspid annular 
diameter (TAD) and vertical line is the minor TAD 
as measured by RT3DE. (C): Tricuspid annulus 
with the line measured at apical 4 chamber by 2DE 
inside it, which appeared away from the true 
diameter. (D): Tricuspid annulus with the line 
measured at parasternal short axis by 2DE inside it, 
which appeared away from the true diameter.
                   
 
 
 
                                                                                        
Comparison between 2D and 3D measurements 
Diastolic value  
There was a good correlation between end-diastolic TAD2D-AP4CH and TAD2D-PSAX (R = 0.79, P 
<0.0001). Major TAD3D was well correlated with end-diastolic TAD2D-AP4CH and TAD2D-PSAX (R = 0.74, P 
<0.0001 and R = 0.75, P <0.0001, respectively). As seen in Table 1 and Figure 2, major TAD3D measurements 
in both patients groups were significantly larger than end-diastolic TAD2D-AP4CH and TAD2D-PSAX. Also when the 
largest TAD2D was compared to TAD3D, 3D measurements were significantly larger (44.9  11.3 and 39.0  
10.3 mm, P <0.001). After reclassification of the patients according to major TAD3D findings only 10 patients 
could be classified as normal (major TAD3D <35mm). In these 10 patients actual TAD2D-AP4CH and TAD2D-PSAX 
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values were 30.6  6.0 and 29.1  6.4 mm, respectively. Importantly, in patients with normal TAD2D, 65% of 
them had grade 1-2 TR (see Table 1) whereas in normal TAD3D only 30% of patients had grade 1-2 TR. 
.0001). 
Systolic values  
There was an excellent correlation between end-systolic TAD2D-AP4CH and TAD2D-PSAX (R = 0.89, P 
<0.0001). Major systolic TAD3D measurements correlated well with end-systolic TAD2D-AP4CH and TAD2D-PSAX 
(R = 0.80, P <0.0001 and R = 0.66, P <0.05, respectively). As seen in Table 1, major systolic TAD3D 
measurements were in both patients groups significantly greater than end-systolic TAD2D-AP4CH and TAD2D-PSAX. 
Fractional shortening  
There were no significant differences between TAFS2D-AP4CH (14.2  7.1%), TAFS2D-PSAX (14.6  
9.2%), and TAFS3D (17.8  13.2%). TAFAC3D was significantly higher than the aforementioned TAFS2D or 
TAFS3D measurements (26.6  12.7 %; P <0
 Minor TAD 
No significant differences were detected between end-systolic and end-diastolic minor TAD3D versus 
TAD2D-AP4CH and TAD2D-PSAX in both groups (Table 1). 
Table 1. Clinical and echocardiographic data of all patients.  
 All patients (n = 40) 
Group I 
(n = 20) 
Group II 
(n = 20) 
Clinical characteristics    
  Age (yr) 29.8  11  26.3  9 33.1  14 
  Male gender (%) 17 (43%) 10 (50%) 7 (35%) 
Diastolic echo values     
  TAD2D-AP4CH (mm) 37.7  10.2  29.1  3.2* 45.4  7.9 ** 
  TAD2D-PSAX (mm) 35.7  9.1 29.6  6.1* 41.2  8.0* 
  Major TAD3D (mm) 45.0  11.3 38.6  9.3 50.7  10 
  Minor TAD3D (mm) 37.3  11.6 30.7  9.2 43.7  10.0 
  TAA3D (mm2) 159.7  84.3 105.8  67.5 208.3  81.7 
Systolic echo values    
  TAD2D-AP4CH (mm) 32.4  9.5 25.4  3.9 ** 38.3  7.1*** 
  TAD2D-PSAX (mm) 30.2  7.8 24.9  3.5* 34.4  6.7* 
  Major TAD3D (mm) 36.0  9.5 25.4  5.3 41.7  8.5 
  Minor TAD3D (mm) 30.5  8.5 25.4  5.3 35.6  8.1 
  TAA3D (mm2) 117.9  66.9 81.4  44.2 150.8  67.5 
Fractional shortening    
  TAFS2D-AP4CH  14.2  7.1 13.5  5.7 15.0  8.2 
  TAFS2D-PSAX 14.8  9.2 14.6  8.8 15.1  8.8 
  TAFS3D major TAD 17.8  13.2 18.5  14.3 16.6  10.4 
  TAFAC3D 26.2  12.9 23.7  13.4 27.9  12.2 
Tricuspid regurgitation      
  None 7 (17%) 7 (35%) 0 (0%) 
  Grade 1-2 23 (58%) 13 (65%) 10 (50%) 
  Grade 3-4 10 (25%) 0 (0%) 10 (50%) 
Group I included patients with normal tricuspid annulus diameter, Group II included patients with dilated (>35mm) tricuspid 
annulus diameter. AP4CH: apical 4-chamber view, FS: fractional shortening, PSSAX: parasternal short axis view, TAA: 
tricuspid annular area, TAD: tricuspid annular diameter, TAFAC: tricuspid annular fractional area change. * P <0.001 
compared to RT3DE; ** P <0.01 compared to RT3DE, *** P <0.05 compared to RT3DE 
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Interobserver agreement  
As seen in Figure 3, the limits of interobserver agreement for major TAD3D (mean difference -0.5  1.7 mm, 
agreement –3.9 to 2.9) were comparable to end-diastolic TAD2D-AP4CH (mean difference 0.1  2.0 mm, 
agreement –3.9 to 4.1). The limits of interobserver agreement for TAD2D-PSAX (mean difference 1.0  4.8 mm, 
agreement –3.8 to 5.8) were worse, in particular for lower TAD values. 
 
 
Fig (3): Interobserver correlation and agreement according to Bland and Altman principle for measuring 
tricuspid annular diameter (TAD), A): TAD in apical 4-chamber (P4CH) by two dimensional echocardiography 
(2DE), B): TAD in parasternal short axis (PSAX) by 2DE, C): Major TAD by real time three dimensional 
echocardiography (RT3DE). 
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DISCUSSION 
In the present study, the morphological and functional aspects of the TA were assessed by RT3DE. The main 
findings of our study are (1) TA shape was not circular but oval, both in normal sized and in dilated TA, (2) 
TAD is underestimated by 2D TTE, and (3) TAFS measurements are comparable for 2D TTE and RT3DE. 
TAD measurements are of critical importance in the TV surgical decision-making process 11-13. Absence 
of TR or the presence of only mild TR does not mean that the TV is free of any abnormality such as TA 
dilatation. At a given time, even considerable TA dilatation may not always result in significant TR (11,12). Not 
only the selection of patients undergoing surgery for TR is dependent on echocardiographic TAD assessment (11), 
but also the type of surgical technique (valve plication or ring placement) is influenced by measurements of TA 
function and TAD 3,14. 
Although 2D TTE is helpful to assess TV function and to detect TR severity it has important limitations 
in describing TV morphological details, such as TAD (13,14). It is well known that after mitral valve surgery 
patients may clinically deteriorate due to underestimated TV pathology and significant residual or developing 
TR 15-. RT3DE may yield more detailed anatomical information. In the present study, the TA was visualized well 
in all subjects allowing even measurements of its area, both at end-systole and end-diastole. This is in 
accordance with a 3D study by Schnabel et al. (9) in which TA visualization was well or at least sufficiently in 
over 90% of patients. When TAD2D measurements were compared with the TAD3D measurements, 2D 
measurements were significantly smaller than the major TAD3D measurements (diameter measured from the 
antero-septal to the antero-posterior commissure). In fact, TAD2D measurements corresponded more with the 
minor TAD3D measurements. In 2D TTE studies it was shown that the normal value for TAD is <35mm14. 
However, in our study half of the patients with a normal TAD2D had an actual TAD (measured with 3D) larger 
than 35mm. So, 2D TTE cannot be relied on defining TAD as normal. It seems necessary to re-establish normal 
TAD values with 3D imaging. Importantly, interobserver agreement for TAD3D measurements was comparable 
to TAD2D-AP4CH measurements and better than TAD2D-PSAX measurements. If 2D TTE is the only available 
assessment tool for TAD, the apical 4-chamber view seems preferred because of better interobserver agreement 
compared to TAD2D-PSAX and more alignment with TAD3D measurements. 
Like other cardiac structures, cyclic changes occur in TAD during systole and diastole (3,11,15). 
Calculation of TAFS from systolic and diastolic TAD showed no difference between 2D TTE and RT3DE. This 
is because end-systolic and end-diastolic TAD3D values are to an equal extent increased compared with 2D 
values. 
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Calculation of TA function by TAFAC3D was significantly higher than that measured by diameter 
changes either in 2D TTE or RT3DE. This could be explained by the accuracy of global function by area percent 
changes than single distance percent changes especially when more lengthening occur.  
In accordance with previous study (12) that reported no relation between presence and severity of TR and 
degree of TA dilatation when 2D TTE was relied on as 65% of normal TAD2D had grade 1-2 TR. but with 
normal major TAD3DE, the percentage decreased to 30%. 
 
STUDY LIMITATION  
The main limitation of this study is that RT3DE data were not compared with a “gold standard” such as magnetic 
resonance imaging or surgical findings. Nevertheless, our main findings (oval shape of the TA, larger TAD3D) 
were consistently found in the large majority of patients. Also, RT3DE images more critically depend on image 
quality than 2D TTE images and the value of RT3DE should be assessed in a more non-selected (image quality) 
population. 
CONCLUSION 
The TA is an oval structure with a major and a minor diameter. 2D TTE underestimates TAD, regardless 
whether it is measured from the apical 4-chamber or parasternal short axis view. This may have important 
implications in the TV surgical decision-making processes. 
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ABSTRACT 
Aim: To detect the accuracy of real-time three-dimensional echocardiography (RT3DE) and two-
dimensional echocardiography (2DE) for tricuspid annulus (TA) assessment compared with magenetic 
resonance imaging (MRI). 
Methods: Thirty patients (mean age 34 ± 13 years, 60% males) in sinus rhythm were examined by 
MRI, RT3DE, and 2DE for TA assessment. End-diastolic and end-systolic TA diameter (TAD) and TA 
fractional shortening (TAFS) were measured by RT3DE, 2DE, and MRI. c TA area (TAA) and TA 
fractional area changes (TAFAC) were measured by RT3DE and MRI. End-diastolic and end-systolic 
right ventricular (RV) volumes and ejection fraction (RV-EF) were measured by MRI. 
Results 
The TA was clearly delineated in all patients and visualized as an oval-shaped by RT3DE and MRI. 
There was a good correlation between TADMRI and TAD3D (r = 0.75, P = 0.001), while TAD2D was 
fairly correlated with TAD3D and TADMRI (r = 0.5, P = 0.01 for both). There were no significant 
differences between RT3DE and MRI in TAD, TAA, TAFS, and TAFAC measurements, while 
TAD2D and TAFS2D were significantly underestimated (P < 0.001). TAFS2D was not correlated with 
RV-EF, while TAFS3D and TAFAC3D were fairly correlated with RV-EF (r = 0.49, P = 0.01, and r = 
0.47, P = 0.02 respectively). 
Conclusion 
RT3DE helps in accurate assessment of TA comparable to MRI and may have an important implication 
in the TV surgical decision making processes. RT3DE analysis of TA function could be used as a 
marker of RV function. 
Value of TA assessment by RT3DE and MRI 
INTRODUCTION 
Evaluation of tricuspid annulus (TA) continues to be a major problem in the surgical decision-making 
process due to its complex three-dimensional shape1-3. Accurate assessment of TA has many values in 
clinical application. For example, the decision of tricuspid valve repair may change due to discrepancy 
between pre-operative measurement of TA diameter (TAD) by two-dimensional transthoracic (or 
transesophageal) echocardiography (2DE) and direct surgical visualization4. Several studies described  
a strong correlation between TA motion and right ventricular (RV) function 5-8. Analysis of TA 
velocity by tissue Doppler imaging has been found useful for RV functional assessment9,10. In these 
studies, the assessment of TA motion was relied on 2DE, M-mode and tissue Doppler recording. Since 
RT3DE has become available for clinical practice, it is now possible to examine the TV more 
completely11. This study aimed to use RT3DE in evaluation of TA morphology, size and cyclic changes 
during cardiac cycle. It also aimed to correlate TA function with RV function that was assessed by 
magnetic resonance imaging (MRI). 
 
SUBJECTS and METHODS 
The study included 30 patients (mean age 34 ± 13 years, 60% were males) who were scheduled for 
routine MRI examination for evaluation of right ventricular function (10 patients with congenital heart 
disease, five with chronic pulmonary disease, five with multivalvular affection, and 10 normals). 2DE 
and RT3DE were performed at the same day of MRI examination after their informal consent for 
assessment of TA. The inclusion criteria for selection were good 2D image quality, sinus rhythm and 
mild to moderate tricuspid regurgitation. 
 
MRI Examination 
MRI studies were performed with a 1.5 T MRI (General Electric, Milwaukee WI; Signa 1.5 T MRI) 
equipped with a four-element torso coil. A cardiac-triggered, steady-state, free-precession sequence 
(FIESTA; temporal resolution and time of echo of 3.5 and 1.3 ms, respectively, flip angle of 45 
degrees) was used for quantitative analysis. 10 cine short axis slices were acquired (slice thickness 10 
mm, gap 0 mm). Additional imaging parameters were a field of view of 320 to 380 mm and a matrix of 
160 X 128. These series of high quality images encompassing the right ventricle (RV) produced a 
three-dimensional data set with sharp edge between the blood pool and myocardium.  Quantitative 
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analysis was performed using standardized software (MassPlus, Medis Inc., Leiden, NL). By this 
software, manual tracing was done for TA and right ventricular (RV) endocardial border on all images 
(end-diastolic and end-systolic). The following measures were obtained at end-diastolic and end-
systolic: (1) TA area (TAAMRI), (2) TADMRI, (3) RV volume, (4) RV ejection fraction (RV-EF) was 
calculated as (RV end-diastolic volume- RV end-systolic volume/RV end-diastolic volume) · 100%, (5) 
TAfractional shortening (TAFSMRI) defined as (enddiastolic TADMRI–end-systolic 
TADMRI)/enddiastolic 
TADMRI · 100% and (6) TA fractional area changes (TAFACMRI) defined as (end-diastolic 
TAAMRI–end-systolic TAAMRI)/end-diastolic TAAMRI · 100%. 
Transthoracic 2DE 
2DE was done with a Sonos 7500 ultrasound system attached to a S3 transducer (Philips, Best, The 
Netherlands). The TV was imaged from apical 4-chamber view with the patient in the left lateral 
decubitus position. The following measures were obtained: (1) TAD2D was defined as the distance 
between the insertion sites of septal and anterior TV leaflets and obtained at an end-diastolic and end-
systolic still frame and (2) TA fraction shortening (TAFS2D) defined as (end-diastolic TAD2D–end-
systolic TAD2D)/enddiastolic TAD2D · 100% 
Transthoracic RT3DE  
RT3DE was done with the same ultrasound system attached to a X4 matrix array transducer capable of 
providing real-time B-mode images. A full volume 3D data set was collected within approximately 5-
10 seconds of breath holding in full volume mode from an apical window. The 3D data set was 
transferred for off-line analysis with TomTec software (Unterschleissheim, Munich, Germany). Data 
were stored digitally and subsequently evaluated by two blinded observers (AMA, OIIS). Data analysis 
of 3D images was based on a 2D approach relying on images obtained initially from the apical view. 
The TA was sliced between two narrow lines to exclude other tissues on the 2D image leading to 
clarification of annulus by a 3D image. TA was viewed and traced manually from the atrial aspect and 
once this is completed the surface area was automatically calculated and could be visualized from 
different points of views. Manual modification was made to correct any inconsistence. The following 
RT3DE variables were obtained from both an end-diastolic and end-systolic still frame: (1) TA area 
(TAA3D), and (2) TAD3D defined as the widest TAD (see Figure 1), Subsequently, TAFS3D and TA 
fractional area changes (TAFAC3D) (%) were calculated by the same formula used in 2DE. 
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STATISTICAL ANALYSES  
All data obtained by MRI, 2DE and RT3DE are presented as mean  SD. A paired t-test and was 
performed for comparing means of variables. The level of significance was set to P <0.05. A SPSS 
statistical package was used (SPSS, version 12.1, SPSS Inc, Chicago). Pearson’s coefficient was used 
for correlation between RT3DE and MRI data. Interobserver agreement for RT3DE measurements was 
assessed according to the Bland and Altman principle12. 
 
RESULTS 
Acquisition of RT3DE data was performed in all patients in a reasonable time (approximately 1 minute 
for acquisition and 5 minutes for data analysis). The TA was clearly delineated in all patients. An oval 
shaped TA (not circular) was visualized by RT3DE and MRI (Figure 1). TAD3D was obtained with 
very good interobserver agreement (mean difference – 0.4 ± 1.5 mm, agreement –3.4–2.6). There was a 
good correlation between TADMRI and TAD3D (R = 0.75, P = 0.001), while TAD2D was fairly 
correlated with TAD3D and TADMRI (R = 0.5, P = 0.01 for both). There were no significant 
differences between RT3DE and MRI in TAD, TAA, TAFS, and TAFAC measurements, while 
TAD2D and TAFS2D were significantly underestimated (P < 0.001) (Table 1). TAFS2D was not 
correlated with RV-EF, while TAFS3D and TAFAC3D were fairly correlated with RV-EF (r = 0.49, P 
= 0.01, and r = 0.47, P = 0.02 respectively). 
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DISCUSSION 
In the present study, the morphological and functional aspects of TA were assessed by MRI and 
RT3DE. The main findings of our study are (1) TA shape was not circular but oval, (2) TAD 
measurement by RT3DE is more accurate than by 2DE, and (3) TA function was fairly correlated with 
RV function. 
TAD measurements have an important role in the TV surgical decision-making process not 
only for the selection of patients undergoing surgery, but also the type of surgical technique (valve 
plication or ring placement)13-15. Although 2DE is helpful to assess TV function and to detect TR 
severity it has important limitations in describing TV morphological details, such as TAD14,15. RT3DE 
may yield more detailed anatomical description of TA morphology and function 16, 17. In the present 
study, the TA was visualized well in all subjects allowing even measurements of its area. This is in 
accordance with Schnabel et al. 11 who reported well or at least sufficient TA visualization in over 90% 
of patients. The measurements of TAD by RT3DE and MRI showed good correlation without 
significant difference between both techniques. When TAD2D measurements were compared with the 
TAD3D and TADMRI measurements, 2D measurements were significantly underestimated. Analysis 
of TA motion by M-mode, 2DE and tissue Doppler imaging has been studied as a feasible marker for 
RV function reflecting the longitudinal RV shortening and lengthening. All these analyses described 
the physiological behavior of TA plane systolic motion towards the apex along the RV long axis 5–10. 
The TA plane systolic displacement is not influenced by its complex structure and asymmetrical shape 
18. In the present study TA circumferential and horizontal motion along the RV short axis was assessed 
by RT3DE. TA motion along the RV short axis, which was fairly correlated with RV function that was 
assessed by MRI as a standard method for assessing RV ejection fraction. Fair and not good correlation 
may be explained by the meridional motion of the muscles and other structures of the RV inflow 
region. Furthermore, the myocytes are disposed longitudinally in the inflow region and more sensitive 
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to meridional stress 19. Despite this fair correlation, the summation of TA motion along both RV long 
and short axes increases the accuracy and correlation values for estimation of RV function 20.  
Study Limitations  
The main limitation of this study is that RT3DE images more critically depend on image quality than 
2DE images and the value of RT3DE should be assessed in a more non-selected (image quality). Due 
to the high cost of MRI, a small number of patients were included. 
 
CONCLUSION 
RT3DE helps in accurate assessment of TA comparable to MRI, while 2DE could not be relied on due 
to underestimation. This may have important implications in the TV surgical decision-making 
processes. RT3DE analysis of TA function could be used as a marker of RV function. 
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INTRODUCTION 
Rheumatic heart disease causes tricuspid valve (TV) stenosis in up to 8% of patients 1. Unfortunately, 
TV stenosis is easily missed at clinical examination except in advanced cases when a high degree of 
clinical suspicion exists 2. Undetected and thus uncorrected TV stenosis may lead to postoperative low 
cardiac output despite successful relief of left sided valve disease and carries a high mortality and 
morbidity 3. Two-dimensional echocardiography (2DE) can detect thickened TV leaflets and a reduced 
TV orifice diameter, and continuous-wave Doppler allows estimation of the tricuspid transvalvular 
pressure gradient 4. However, in most patients it is not possible to visualize all three TV leaflets 
simultaneously with 2DE 5.  Transthoracic real-time three-dimensional echocardiography (RT3DE) 
may be a valuable imaging modality for the examination of stenotic TV valves because all leaflets can 
be seen simultaneously and studied from both atrial and ventricular aspects. This study aimed to apply 
RT3DE for TV assessment in patients with rheumatic TV heart disease. 
 
PATIENTS AND METHODS 
 
Five patients (mean (SD) age 33 (7) years, four men) with an established diagnosis of rheumatic TV 
disease were examined by 2DE (Philips Sonos 7500 with S3 probe, Best, The Netherlands) and RT3DE 
(same system with X4 probe). These patients were compared to eight patients (mean (SD) age 35 (4) 
years, five men) with rheumatic heart disease without relevant TV involvement and 13 controls (mean 
(SD) age 31 (6) years, eight men) without rheumatic heart disease. With 2DE, the TV was assessed 
from the apical 4-chamber and parasternal short axis views. 2DE data obtained were: (1) TV leaflet 
separation (TV-LS2D) defined as the distance between the TV tips at maximal opening obtained from 
an apical 4-chamber (TV-LS2D-AP4CH) and parasternal short-axis window (TV-LS2D-PSAX), (2) tricuspid 
annular diameter (TAD2D) obtained from an apical 4-chamber (TAD2D-AP4CH) and parasternal short-axis 
(TAD2D-PSAX) view at an end-diastolic still-frame, and (3) descriptive morphology of the TV leaflets 
including thickness, mobility and calcification. Each descriptor was graded as mild when less than one 
whole TV leaflet was involved, moderate when a one or two whole TV leaflets were involved and 
severe when all three TV leaflets were involved. 
The apical recorded full volume three-dimensional data set was analysed with TomTec 
software (Unterschleissheim, Munich, Germany). RT3DE data obtained were: (1) TAD3D defined as 
the widest TAD that could be measured from an end-diastolic still frame, (2) maximal tricuspid annulus 
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area (TAA3D) obtained from an end-diastolic still frame and measured by manual planimetry, (3) TV 
area (TVA3D) defined as the narrowest part of the TV at the time of maximal TV opening and 
measured by manual planimetry, (4) descriptive TV morphology as described before in the 2DE section 
but now separately scored for each TV leaflet, and (5) commissural width for each TV commissure 
(antero-septal, antero-posterior, and postero-septal), obtained from an end-diastolic still frame. 
 
RESULTS 
TV-LS2D-AP4CH and TV-LS2D-PSAX were well correlated (r = 0.89, P <0.05) with comparable mean  (SD) 
values for TV-LS2D-AP4CH and TV-LS2D-PSAX (11.8 (2.6) vs. 11.8 (3.4) mm, respectively). As Table 1 
shows mean TV-LS2D values were not significantly different in the three studied groups. 
Acquisition and post-processing of RT3DE data was successfully performed in all patients. 
TAD3D was larger than TAD2D in all TV stenosis patients, regardless of the 2DE view used (mean 
values were 46 mm for TAD3D, 38 mm for TAD2D-AP4CH, and 35 mm for TAD2D-PSAX). Mean (SD) 
TVA3D in the patients with significant TV stenosis was 216 (61) mm2, correlated well with mean TV-
LS2D (r = 0.95, P <0.01). Due to the small number of patients, TVA3D was not significantly related to 
the transtricuspid mean pressure gradient (r = -0.76). 
RT3DE and morphological description (including thickness, mobility, calcification, and 
position) was possible for each separate TV leaflet. The grade of TV leaflet affection scored with 2DE 
and RT3DE were similar in terms of thickness, mobility, and calcification. However, RT3DE could 
also assess individual TV leaflet position (relative to other TV leaflets) and the extent of TV affection. 
In addition, all three commissures could be adequately evaluated with RT3DE including assessment of 
commissural width during maximal TV opening. As seen in the Table, patients with TV stenosis had 
significantly smaller commissural width. 
Table 1. Comparison of patients with rheumatic heart disease with tricuspid valve stenosis, without 
significant tricuspid valve stenosis, and controls. 
 
 
 
Rheumatic HD 
TV with stenosis 
(n = 5) 
 
Rheumatic HD 
TV without stenosis 
(n = 8) 
Controls 
(n = 13) 
Male sex, n  (%) 4 (80) 5 (63) 8 (62)  
Age (years) 33 (7) 35 (4) 31 (6) 
TV-LS2D (mm) 11.8 (2.9) 12.0 (4.8) 15.0 (3.3) 
TVA3D (mm2) 216 (61)* 381 (92) 518 (207) 
3D commissural width (mm) 2.6 (0.2)* 4.1 (0.5) 5.9 (1.6) 
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2D, two-dimensional; 3D, three dimensional; HD, heart disease; LS, leaflet separation; TV, tricuspid 
valve; TVA, tricuspid valve area.  
Values are represented as mean (SD) unless otherwise specified. 
*P <0.005 versus patients with rheumatic HD without significant TV involvement and P < 0.0001 
versus controls. 
 
DISCUSSION 
Rheumatic TV inflammation causes scarring and fibrosis of TV leaflets with fusion of its commissures 
resulting in TV stenosis. Estimation of the transtricuspid pressure gradient is usually only performed 
when a morphologically abnormal TV is seen. Therefore, good morphological imaging and description 
of the TV is essential to identify TV stenosis. With RT3DE, each separate TV leaflet can be assessed 
with regard to thickness, mobility, calcification, and its relation to other TV leaflets. In addition, 
RT3DE provides unique TV measurements such as TVA3D and commissural width at the time of 
maximal TV opening. This distance between the TV commissures during diastole may be a new 
indicator of TV stenosis severity. Although the TV leaflets can sometimes be visualised simultaneously 
by 2DE from an angulated subcostal view, measurement of TVA is only rarely possible because even 
when all leaflets are visualised simultaneously the image cross section will not be at the correct TVA 
level. Unfortunately, from all other 2DE views, including the atypical parasternal projection 5, only two 
TV leaflets can be visualized simultaneously. In our study, TVA3D had better discriminative value than 
TV-LS2D for the separation of rheumatic heart disease patients with TV involvement versus rheumatic 
heart disease patients without TV involvement or normal control subjects (see Table). Importantly, in 
rheumatic TV involvement TVA3D best correlated to the mean transtricuspid pressure gradient than 
mean TV-LS2D. Obviously, our findings should be confirmed in larger studies and some of our findings 
should be validated using a gold standard such as magnetic resonance imaging. By combining all 
information obtained by RT3DE the diagnostic and therapeutic decision-making process regarding the 
TV may be facilitated. 
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ABSTRACT 
Background: The tricuspid valve (TV) is a complex structure. Unlike the aortic and mitral valve it is not 
possible to visualize all TV leaflets simultaneously in one cross-sectional view by standard two-dimensional 
echocardiography (2DE) either transthoracic or transesophageal due to the position of TV in the far field. 
Aim: Quantitative and qualitative assessment of the normal TV using real-time 3-dimensional echocardiography 
(RT3DE). 
Methods: RT3DE was performed for 100 normal adults (mean age 30 ± 9 years, 65% males). RT3DE 
visualization was evaluated by 4-point score (1: not visualized, 2: inadequate, 3: sufficient, and 4: excellent). 
Measurements included TV annulus diameters (TAD), TV area (TVA), and commissural width. 
Results: In 90% of patients with good 2DE image quality, it was possible to analyse TV anatomy by RT3DE. A 
detailed anatomical structure including unique description and measurement of tricuspid annulus shape and size, 
TV leaflets shape, and mobility, and TV commissural width were obtained in majority of patients. Identification 
of each TV leaflet as seen in the routine 2DE views was obtained.  
Conclusion: RT3DE of the TV is feasible in a large number of patients. RT3DE may add to functional 2DE data 
in description of TV anatomy and providing highly reproducible and actual reality (anatomical and functional) 
measurements 
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INTRODUCTION 
The tricuspid valve (TV) is a multi-component complex structure 1. In classic anatomic studies the anterior, 
septal and posterior TV cusps were described 2,3. Unlike the aortic and mitral valve it is not possible to visualize 
all TV cusps simultaneously in one cross-sectional view by standard two-dimensional transthoracic 
echocardiography (2DE)4. During transesophageal two-dimensional echocardiography small changes in 
transducer angle, probe position and rotation may bring to light some additional TV details 5,6. However, because 
of the position of the TV in the far field, transesophageal echocardiography can still only provide limited 
information and can also not visualize all TV cusps simultaneously. In three-dimensional (3D) transesophageal 
image reconstruction and intracardiac echocardiography studies this goal could be achieved but at the cost of 
some procedural risks and an increase in procedural duration 7,8. Real-time three-dimensional echocardiography 
(RT3DE) can visualize the atrio-ventricular valves from both the ventricular and atrial side in detail without 
these limitations 9. This study aimed to apply RT3DE for quantitative and qualitative assessment of normal TV 
anatomy. 
 
SUBJECTS AND METHODS 
 
In one hundred patients (mean age 30  9 years, 65% males) the TV was examined by transthoracic RT3DE after 
an informed consent. All patients had sinus rhythm and normal right-sided heart (normal right ventricular 
dimensions and function, normal right atrial dimension, trivial or absent tricuspid regurgitation and normal 
tricuspid valve function). Patients with good 2DE image quality only were included.  
Transthoracic RT3DE 
RT3DE was done with a commercially available ultrasound system (Philips Sonos 7500, Best, The Netherlands) 
attached to a X4 matrix array transducer capable of providing real-time B-mode images. The 3D data set was 
collected within approximately 5-10 seconds of breath holding in full volume mode from an apical window and 
transferred for off-line analysis with TomTec software (Unterschleissheim, Munich, Germany). Data analysis of 
3D images was based on a two-dimensional approach relying on images obtained initially from the apical 4-
chamber view. The images were adjusted to put the TV in the center of interest. To exclude non-relevant tissue, 
the TV was sliced between the two narrowest lines by which all parts of the TV leaflets were still in between. 
The TomTec software allows in this way visualization of the short-axis TV view in a 3D display (see Figure 1). 
RT3DE gain and brightness were adjusted to improve delineation of anatomic structures. The following points 
were checked for visualization: 1) tricuspid annulus diameter and area, 2) TV leaflets (number, mobility, 
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thickness and relation to each other), 3) TV area, and 4) TV commissures (antero-septal, antero-posterior, and 
postero-septal) including the position of their closure lines. All these structures were classified according to a 
subjective 4-point scale for image quality (1 = not visualized, 2 = inadequate, 3 = sufficient and 4 = good). 
For quantitative assessment of TV the following RT3DE data were obtained: 1) TV annulus diameter 
defined as the widest diameter that could be measured from an end-diastolic still frame, 2) maximal TV annulus 
area obtained from an end-diastolic still frame and measured by manual planimetry, 3) TV area defined as the 
narrowest part of the TV at the time of maximal opening and measured by manual planimetry, and 4) TV 
commissural width obtained from a late-diastolic still frame using zoom function to avoid underestimation. The 
images were optimized for each commissure along its plane to measure the maximal width of the angle formed 
by the to adjacent TV leaflets. 
To identify the TV leaflets visualized by the standard 2DE images the TomTec quad screen display was 
used. As seen in Figure 1, this screen contains four images; the upper two images are two-dimensional 
echocardiographic images perpendicular to each other, the lower two images are a short-axis two-dimensional 
echocardiographic image and a RT3DE image. From the properly chosen two-dimensional image a mid-diastolic 
frame was selected to visualize the TV leaflets just separated from each other. Each leaflet was defined by a 
marker, after which this marker position was compared with the RT3DE image to detect which leaflet was 
shown in the 2DE images. Analysis of images was done by two experienced echocardiographers (AMA, JSM) 
independently. Each one dealt with the full volume image as acquired from echo machine and the selection of 
cut plane, angulation and gain setting adjustment were dependable on his experience. 
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 STATISTICAL ANALYSES  
All data obtained by RT3DE were presented as mean  SD. Interobserver agreement for the visualization score 
was estimated using kappa values for each morphologic feature and classified as poor (kappa <0.4), moderate 
(kappa 0.4 to 0.7), or good (kappa >0.7). Interobserver variability for RT3DE measurements was assessed 
according to the Bland and Altman method in a randomly selected group of 50 patients 10. 
 
RESULTS 
Acquisition and analysis of the RT3DE data was performed in approximately 10 minutes per patient. The TV 
could be visualized in 90% of patients enface from both ventricular and atrial aspects in relation to adjacent 
cardiac structures. In these 90 patients detailed analysis of the TV was performed including tricuspid annulus 
shape and size, TV leaflets shape, size, and mobility, and commissural width. 
Tricuspid annulus  
Tricuspid annulus visualization was good in 54 patients (60%), sufficient in 27 patients (30%), and inadequate in 
9 patients (10%). As seen in Figure 2, tricuspid annulus shape appeared as oval rather than circular. Tricuspid 
annulus diameter and area could be measured in 63 patients (70%), normal values were 4.0  0.7 cm and 10.0  
2.9 cm2, respectively. 
 
Tricuspid valve leaflets 
Visualization of the three TV leaflets (in motion) was good visualized in 72 patients (80%), sufficient in 9 
patients (10%), and inadequate in another 9 patients (10%). The anterior leaflet was the largest and most mobile 
of the three leaflets and had a nearly semicircular shape. The septal leaflet was the least mobile and had a semi-
oval shape. Its position was parallel to the interventricular septum. The posterior leaflet was the smallest one 
with variable shape. It was clearly separated from the septal leaflet in all patients but in 10% of patients it was 
hard to discriminate the posterior leaflet from the anterior leaflet even during maximal TV opening.  
 45
Chapter 5 
From the RT3DE data set all standard two-dimensional TV cross-sections (apical 4-chamber, 
parasternal short-axis and parasternal long-axis right ventricular inflow) were simulated. As seen in Figure 3, in 
the apical 4-chamber view in all patients the septal leaflet was seen adjacent to the septum and the anterior leaflet 
was seen adjacent to the right ventricular free wall. In the parasternal short-axis view, the posterior leaflet was 
seen adjacent to the right ventricular free wall in 92% of patients and in the remaining 8% no leaflet could be 
obtained although modification of the cut plane downward could identify this leaflet. In this view the leaflet 
adjacent to the aorta was the anterior in 52% and the septal leaflet in 48%. In the parasternal right ventricular 
inflow view the leaflets seen were identical to the apical 4-chamber view with in all patients the septal leaflet 
seen adjacent to the septum and the anterior leaflet seen adjacent to the right ventricular free wall. 
 
Tricuspid valve area 
Visualization of the triangular shaped TV area was visualized good in 50 patients (55%), sufficient in 27 patients 
(30%), and inadequate in 13 patients (15%). As seen in Figure 4, the anterior and septal leaflets formed the TV 
area’s angle and the small posterior leaflet formed its base. TV area could be measured in 77 patients (86%) and 
mean TV area in these patients was 4.8  1.6 cm2.  
Tricuspid valve commissures  
As seen in Figure 4, the three TV leaflets were separated from each other by three commissures. The 
commissures and the direction of closure lines were good visualized in 45 patients (50%), sufficient in 18 
patients (20%), inadequate in 18 patients (20%), and not visualized in 9 patients (10%). TV commissural width 
could be obtained in 63 patients (70%), mean commissural width in these patients was 5.4  1.5 mm for the 
antero-septal commissure, 5.2  1.5 mm for the postero-septal commissure, and 5.1  1.1 mm for the antero-
posterior commissure, respectively. Visualization and measurement of commissures was relatively easy for the 
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antero-septal commissure and most difficult for the antero-posterior commissure. All measurements are listed in 
Table 2 as absolute value and indexed to body surface area. 
 
 
 
Table 1: Scores for real-time three-dimensional echocardiography visualization of TV structures.  
Score  TV  Annulus 
TV 
 Leaflets 
TV  
area 
TV  
commissures 
     
Good (4) 60% 80% 55% 50% 
Sufficient (3) 30% 10% 30% 20% 
Inadequate (2) 10% 10% 15% 20% 
Not visualized (1) 0% 0% 0% 10% 
Mean score 3.5 ± 0.7 3.7 ± 0.6 3.4 ± 0.7 3.1 ± 1.0 
Median score 3.0 3.0 3.0 2.5 
 Abbreviations: TV = tricuspid valve 
 
Table 2: Normal (absolute and index) values of TV annulus (diameter and area), TV area, and the width of the 3 
TV commissures.  
Parameter Absolute value Index Value 
   
Tricuspid annulus diameter 4.0 ± 0.7 (cm) 2.2 ± 0.4 (cm/m2) 
Tricuspid annulus area 10.0 ± 2.9 (cm2) 5.5 ± 1.6 (cm2/m2) 
Tricuspid valve area 4.8 ± 1.6 (cm2) 2.7 ± 0.9 (cm2/m2) 
Antero-septal commissure 5.4 ± 1.5 (mm) 2.9 ± 0.8 (mm/m2) 
Postero-septal commissure 5.2 ± 1.5 (mm) 2.9 ± 0.7 (mm/m2) 
Antero-posterior commissure 5.1 ± 1.1 (mm) 2.9 ± 0.6 (mm/m2) 
 
Interobserver variability  
The visualization score between two observers was good for the TV annulus (kappa value 0.91) and TV leaflets 
(kappa value 0.71) and moderate for the TV commissures (kappa value 0.59). As seen in Figure 5, good 
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interobserver correlations were found for measurement of TV annulus (r = 0.98, P <0.0001) and TV area (r = 
0.95, P <0.0001) and fair correlation was found for TV commissural width (r = 0.51, P <0.001). In the same 
Figure, the interobserver agreement for TV annulus diameter (mean difference - 0.28  1.20 mm, agreement: 
2.12, - 2.68), for TV area (mean difference:  0.17  0.52 cm2, agreement: 1.21, - 0.87), and for TV commissural 
width (mean difference: 0.01  0.62 mm, agreement:  1.25, - 1.24) is displayed. 
 
 
DISCUSSION 
Two-dimensional echocardiography is a valuable imaging modality for the functional assessment of TV 11-13. 
However, with 2DE it is not possible to visualize all TV cusps simultaneously in one cross-sectional view nor 
can detailed anatomical information of the TV annulus, leaflets, and commissures be provided. Previous studies 
and case reports described visualization of TV by RT3DE 9,14 in abnormal states, while this study applied 
RT3DE for the morphological assessment of the normal TV anatomy. RT3DE allowed analysis of TV annulus, 
leaflets and commissures in the majority of patients. Beside this morphologic description, quantitative 
assessment could be obtained. However, it should be noticed that only patients with good 2DE image quality 
underwent RT3DE. In our experience these patients represent over 50% of the total number of patients referred 
to our echocardiographic laboratory. Nevertheless, RT3DE allowed TV analysis to a level quite comparable to 
that recently reported by others for the mitral valve leaflets 15. 
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One of the salient findings in our study was the identification of the TV leaflets as seen in the routine 
2DE views. It is still a matter of controversy in echocardiographic textbooks. In one well known 
echocardiographic textbook 16, the leaflet seen in the apical 4-chamber view adjacent to the right ventricular free 
wall was described as being the anterior or posterior leaflet depending on the exact rotation and angulation of the 
image plane. However, in our study this leaflet was consistently found to be the anterior leaflet (see Figure 6 for 
explanation), as described in another textbook 17. Also, in both these echocardiographic textbooks 16,17 in the 
parasternal short-axis view the leaflet adjacent to the right ventricular free wall was described as being the 
anterior. However, as shown in Figure 3 and explained in Figure 6, in all patients in whom a leaflet could be 
identified in our study it was the posterior one. 
In our study tricuspid annulus diameter (and area) could be reliably obtained with RT3DE. Tricuspid 
annulus measurement is of critical importance in the TV surgical decision-making process if a patient is operated 
for mitral valve disease and has concomitant TV regurgitation 18,19. In addition, TV area could be reliably 
obtained and this may have important implications for the diagnosis of tricuspid stenosis 20,21. Visualization of 
commissures and measurement of its width were obtained with difficulty, in particular for the antero-posterior 
commissure. Commissural width also showed weak interobserver correlation. This may be due to differences in 
the commissural levels and tissue dropout. For proper assessment of the three commissures, more cut planes with 
different angles are needed. However, assessment of commissural width may also be a valuable tool for the 
diagnosis, follow up, and selection of therapeutic strategy of tricuspid stenosis. All our RT3DE measurements 
were consistent with the measurements described in anatomical studies 2,3. Our data may potentially take RT3DE 
a step further into clinical routine (providing accurate TV measurements) and may enhance the understanding of 
TV valve morphology. 
Limitation of Study 
The main limitation of this study is that RT3DE data were not compared with a “gold standard” such as magnetic 
resonance imaging, autopsy or surgical findings. Also, RT3DE images more critically depend on 2DE image 
quality. 
CONCLUSION 
Three-dimensional imaging of the TV is feasible in a large number of patients. RT3DE may add to functional 
2DE data in description of TV anatomy and providing highly reproducible and actual reality (anatomic and 
functional) measurements.  
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ABSTRACT 
Background: Mitral annulus assessment is of great importance for the diagnosis and treatment of 
mitral valve disease. The present study sought to assess the value of real-time three-dimensional 
echocardiography for the assessment of true mitral annulus diameter (MAD). 
Methods: One hundred and fifty patients (mean age 38 ± 18 years) with adequate two-dimensional 
(2D) echocardiographic image quality underwent assessment of MAD2D and MAD3D (with real-time 
three-dimensional echocardiography). In a subgroup of 30 patients true MAD was validated with 
magnetic resonance imaging (MRI). 
Results: There was a good interobserver agreement for MAD2D (mean difference = - 0.25 ± 2.90 mm, 
agreement: - 3.16, 2.66) and MAD3D (mean difference = 0.29 ± 2.03, agreement = - 1.74, 2.32). 
Measurements of MAD2D and MAD3D were well correlated (R = 0.81; p <0.0001). However, MAD3D 
was significantly larger than MAD2D (3.7 ± 0.9 vs. 3.3 ± 0.8 cm, p <0.0001). In the subgroup of 30 
patients with MRI validation, MAD3D and MADMRI were significantly larger than MAD2D (3.3 ± 0.5 
and 3.4 ± 0.5 cm vs. 2.9 ± 0.4 cm, both p <0.001). There was no significant difference between 
MADMRI and MAD3D. 
Conclusion: MAD3D can be reliably measured and is superior to MAD2D in the assessment of true 
mitral annular size. 
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INTRODUCTION 
The mitral annulus (MA) is a vital component of the mitral valve apparatus and plays a crucial role in 
left ventricular and left atrial function 1. The MA marking the hinge line of the mitral valve leaflets is 
more D-shaped than circular as portrayed by prosthetic rings. The straight border accommodates the 
aortic valve allowing this valve to be wedged between the interventricular septum and the mitral valve. 
Although the term annulus implies a solid ring-like fibrous cord to which the leaflets are attached, this 
is not the case 2. Therefore, some authors used the term “aortoventricular membrane” instead of MA, to 
emphasize that there is an extension of this fibrous cord into the subvalvular region 3. MA assessment 
is of great importance for the diagnosis and treatment of mitral valve disease. MA dilatation is one of 
the main mechanisms for development of mitral regurgitation and selection of the optimal individual 
therapy for mitral regurgitation depends on MA size and function 4,5. This has been studied in both 
animals and humans using echocardiography, sonomicrometry and magnetic resonance imaging (MRI) 
6-11. The present study aimed to assess true MA diameter (MAD) by comparing two-dimensional 
echocardiography (2DE), real-time three-dimensional echocardiography (RT3DE), and MRI as gold 
standard. 
 
METHODS 
 
The study included 150 patients (Table 1) randomly selected from our 3D database that included 
relatively young patients (mean age 38 ± 18 years) with adequate 2DE image quality. Age, gender, 
weight and height of all patients were recorded and body surface area was calculated by the standard 
formula (weight 0.425 in kilograms x height 0.725 in centimeters x 0.007184). In all patients, 2DE and 
RT3DE were performed. 
Table1: Clinical categorization of patients (n = 150) 
Category N (%) 
Normal 52 (34%) 
Congenital Heart Disease 48 (32%) 
Ischemic Heart Disease 20 (14%) 
Valvular Disease 20 (14%) 
Cardiomyopathy 10 (6%) 
 
Transthoracic 2DE 
2DE was undertaken with the patient lying in the left lateral decubitus position using both apical and 
parasternal views. 2DE studies were performed using a 3.5 MHZ probe and a commercially available 
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ultrasound system (Philips Sonos 7500, Best, The Netherlands). The following measures were 
obtained: (1) MA diameter (MAD2D) obtained from an apical 4-chamber view at end-diastole (Just 
before mitral valve closure), and (2) MAD index (MADI2D) calculated as MAD2D / body surface area. 
Transthoracic RT3DE 
RT3DE was done with the same ultrasound system attached to a X4 matrix array transducer capable of 
providing real-time B-mode images. A full volume 3D data set was collected within approximately 5-
10 seconds of breath holding in full volume mode from an apical window. The 3D data set was stored 
digitally and transferred for off-line analysis with TomTec software (Unterschleissheim, Munich, 
Germany). Two blinded observers (AMA, OIIS) subsequently evaluated all data. Data analysis of 3D 
images was based on a 2D approach relying on images obtained initially from the apical view. The MA 
was sliced between two narrow lines to exclude other tissue on the 2D image leading to clarification of 
the MA in the 3D image. The 3D image of the MA was viewed and traced from the ventricular aspect. 
Manual tracing of the inner border of the MA was done and once this was completed the surface area 
was automatically delineated and could be visualized from different points of views. The following 
RT3DE data were obtained: (1) end-diastolic MAD3D defined as the perpendicular line drawn from the 
top of the MA curvature to the middle of the straight MA border (see Figure 1), (2) end-diastolic MA 
area (MAA3D), (3) MAD3D index (MADI3D) calculated as MAD3D / body surface area, and (4) MAA3D 
index (MAAI3D) calculated as MAA3D / body surface area. 
Normal values for MAD2D, MAD3D, MADI3D, MAA3D, and MAAI3D were established in 25 
patients without apparent left-sided heart disease (defined as normal left atrial and ventricular 
dimension and function with normal mitral valve function). 
 
Magnetic resonance imaging 
In a non-selected group of 30 patients, MRI was performed with a 1.5 T MRI (General Electric, Signa 
1.5 T MRI, Milwaukee WI) equipped with a for-element cardio coil. An ECG-triggered, steady state, 
free-precession sequence (FIESTA; repetition time and time of echo of 3.5 and 1.4 ms, respectively, 12 
shots, temporal resolution of 42 ms, flip angle of 45 degrees) was used for quantitative analysis. Ten 
cine short axis slices were acquired (slice thickness 8 mm, gap 2 mm) covering the heart from the base 
to the apex. Additional imaging parameters were a field of view of 320 to 380 mm and a matrix of 160 
X 128. Quantitative measurements were performed using standardized Dicom viewing software on the 
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basal slice demonstrating the mitral valve annulus in end-diastole. MADMRI was defined as described 
before in the RT3DE section (see Figure 1). 
 
STATISTICAL ANALYSES  
All data obtained by 2DE, RT3DE, and MRI were presented as mean ± SD. Data analyses were 
performed using statistical software (SPSS, version 12.1, SPSS Inc, Chicago). A paired sample t-test 
was performed to compare between means of variables of techniques. The difference in values was 
considered statistically significant with the level of P < 0.05. Pearson’s coefficient was used for 
correlation between variables. Interobserver and intraobserver agreements were assessed for MAD2D 
and MAD3D in the first 100 patients and expressed according to the Bland and Altman method 12. 
 
RESULTS 
Acquisition and post-processing of RT3DE data were performed successfully in all patients within a 
reasonable time (approximately 1 minute for acquisition and 5 minutes for data analysis). The MA was 
clearly delineated in all patients and, as seen in Figure 1, its shape was not circular but D-shaped, both 
in normal sized and in dilated MA. As seen in Figure 2, in the total group of 150 patients, 
measurements of MAD2D and MAD3D were well correlated (R = 0.81; p <0.0001). However, MAD3D 
was significantly larger than MAD2D (3.7 ± 0.9 vs. 3.3 ± 0.8 cm, P < 0.0001). 
Surgical validation: In three patients referred for mitral valve repair, MAD3D matched with MAD 
measured by surgeon (blinded with MAD3D measurement) while MAD2D by preoperative transthoracic 
2DE and intraoperative transesophageal echo was smaller than the surgical measurement.     
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MRI validation: In the subgroup of 30 patients who underwent 2DE, RT3DE, and MRI, the D-shaped 
MA was confirmed by the MRI images (Figure 1d). As seen in Figure 3, MAD2D, MAD3D, and 
MADMRI were well correlated. MAD3D and MADMRI were significantly larger than MAD2D (3.3 ± 0.5
and 3.4 ± 0.5 cm vs. 2.9 ± 0.4 cm, both P < 0.001). There was no significant difference between 
MAD
 
 MRI and MAD3D. Also, there was no significant difference between MAA3D and MAAMRI (Table
2). 
Table 2: Comparison between RT3DE and MRI measurements 
 RT3DE MRI 
Diastolic MAA (cm2) 8.7  2.9 9.0  2.3 
Diastolic MAAI (cm2/m2) 4.7  1.8 4.8  2.0 
Diastolic MAD (cm) 3.3  0.5 3.4  0.5 
Diastolic MADI (cm/m2) 1.8  0.5 1.8  0.7 
 
Abbreviation: MAA: mitral annulus area, MAAI: mitral annulus area index, MAD: mitral annulus 
diameter, MADI: mitral annulus diameter index 
 
Normal RT3DE values: Normal values assessed in patients without apparent left-sided heart 
disease were 2.5 ± 0.5 cm for MAD2D, 2.8 ± 0.6 cm for MAD3D , 1.5 ± 0.3 cm/m2 for MADI3D, 8.1 ± 
2.4 cm2 for MAA3D, and 4.3 ± 0.8 cm2/m2 for MAAI3D. 
Interobserver and intraobserver agreements: As seen in Fig. 3, there was a good interobserver 
agreement for MAD2D (mean difference = - 0.25 ± 2.90 mm, agreement: - 3.16, 2.66) and MAD3D 
(mean difference = 0.29 ± 2.03mm, agreement = - 1.74, 2.32). Likewise, there was a good intraobserver 
agreement for MAD2D (mean difference = - 0.23 ± 2.28mm, agreement = -2.51, 2.05) and MAD3D 
(mean difference = - 0.10 ± 3.00mm, agreement = - 3.10, 2.92). 
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DISCUSSION 
Assessment of MA size is an important issue in patients with mitral valve disease. An increase in 
MAD results in reduced mitral valve leaflet coaptation and thus an increase in the incidence and 
severity of mitral regurgitation 13,14. Reduction in MAD is an essential element in mitral valve repair 
and prevention of regurgitation not only in organic mitral valve disease, but also in ischemic mitral 
regurgitation 15,16. Accurate assessment of MAD is crucial for the selection of a proper sized prosthetic 
ring, percutaneous annuloplasty device or stented valve implantation 17-19. The current study showed 
that in patients with adequate 2DE image quality, the MA could be well visualized from the ventricular 
(and atrial) aspect with RT3DE. MAD3D could be reliably measured with excellent inter- and 
intraobserver agreements.  
The main finding in our study was a significant underestimation of true MAD by MAD2D as 
evidenced by MAD3D and MADMRI measurements. Because of the relatively fixed MA trigone, 
changes in MAD size (regardless whether these are due to cyclic changes in the heart cycle or to a 
pathological process such as left ventricular dilatation) 7 occur mainly along the axis represented by the 
perpendicular line drawn from the top of the MA curvature to the middle of the straight MA. As seen in 
Figure 4, it is this MAD that we measure with RT3DE, whereas with 2DE an underestimated MAD is 
measured. MAD3D and MADMRI were well correlated with no significant difference in between these 
measurements. The underestimation of true MAD may explain the frequently encountered discrepancy 
between pre-operative MAD2D assessment and implanted ring-prosthesis size 20.  
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Because of the limited information available in the literature we assessed normal MAD and 
MAA in patients without apparent left-sided heart disease. With variable methods available for MAA 
measurements, the definition of normal MAA is quite variable, probably caused by the complex 
geometry of the MA. MAA2D measurements in other studies 9,21 ranged from 6.9 ± 0.8 to 12.2 ± 3.8 
cm2. In two recent very small studies (with 10 and 7 subjects, respectively) 7,22, normal transesophageal 
assessed MAA3D values were 11.8 ± 2.5 cm2 and normal MAAMRI values were 9.5 ± 1.4 cm2. MAA 
values in fresh human autopsy specimens23 ranged from 6.4 to 8.2 cm2. In our study, MAA3D in normal 
subjects was 8.1 ± 2.4 cm2 or (4.3 ± 0.8 cm2/m2) when corrected for body surface area. 
 
Study Limitations  
The study excluded patients with bad image quality and/ or in non-sinus rhythm because RT3DE is 
totally dependent on 2D images and the analysis of full volume mode will not be achieved with 
variable heart rate. The another limitation was that the surgical measurements of MAD were obtained 
only in three cases  
 
CONCLUSION 
MAD3D can be reliably measured in patients with adequate image quality and is superior to MAD2D in 
the assessment of true MA size. Normal values for MAD3D are 2.8 ± 0.6 cm (or indexed for body 
surface area 1.5 ± 0.3 cm/m2) and for MAA3D 8.1 ± 2.4 cm2 (or indexed for body surface area 4.3 ± 0.8 
cm2/m2). 
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ABSTRACT 
Objective: We sought to assess mitral annular (MA) size and function in hypertrophic (HCM) and 
dilated cardiomyopathy (DCM) using real-time 3-dimensional echocardiography (RT3DE). 
Methods: The study included 30 patients with HCM, 20 patients with DCM, and 30 control subjects. 
RT3DE measurements included end-systolic and end-diastolic MA area (MAA3D), MA diameter 
(MAD3D), MA fractional area change (MAFAC), and MA fractional shortening. In subgroup of 50 
patients, magnetic resonance imaging (MRI) was used for MAAMRI and MADMRI measurement  
Results: End-diastolic MAA3D was larger in HCM than in control group (P <0.0001). Higher MAFAC 
and MAFS were present in HCM than in control group (P = 0.001 and P = 0.006 respectively). End-
systolic and end-diastolic MAA3D in DCM were higher than in HCM and control groups (P <0.0001). 
Lower MAFAC and MA fractional shortening were present in DCM than in HCM and control groups 
(P <0.0001). MAFAC correlated well with left ventricular function in control subjects (r = 0.94, P < 
0.0001), whereas correlation was less in DCM (r = 0.53, P = 0.02) and HCM (r = 0.42, P < 0.01). 
RT3DE and MRI measurements were comparable.  
Conclusion: RT3DE assessment of MA size and function in control subjects and patients with 
cardiomyopathy is accurate and well correlated with MRI. 
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INTRODUCTION 
The mitral annulus (MA) is a vital component of the mitral valve apparatus and plays a crucial role in 
left ventricular (LV) and left atrial function 1. The MA changes its shape from a saddle shape to a more 
flat structure and this leads to pronounced variations not only from heart to heart but also within the 
same heart 2. The MA opposite the area of valvular fibrous continuity tends to be weaker because of 
lack of a well-formed fibrous cord. This area is susceptible to expand under hemodynamic stress, and 
therefore often involved in annulus dilatation. During systole, contraction of the surrounding LV 
muscle causes the annulus to contract. MA physiology assessment is important for diagnosis and 
treatment of mitral valve disease3,4. Several anatomic alterations of mitral valve apparatus are 
frequently presented in hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) 5-
8.Three-dimensional echocardiography (3DE) has the ability to analyse the shape and dynamics of 
normal and abnormal MA 9. It can also assess the MA area (MAA) in short axis paraplanes 10,11. The 
current study aimed to use real-time 3DE (RT3DE) in the assessment of MA size and function in 
patients with HCM and DCM compared with control subjects. To detect the accuracy of RT3DE 
measurement, the RT3DE data were compared to that obtained from magnetic resonance imaging 
(MRI). 
METHODS 
The study included 30 patients (mean age of 38  15 years, 80% males) with established diagnosis of 
HCM12,  20 patients (mean age 39  12 years, 50% males) with established diagnosis of DCM13 and 30 
control subjects (mean age 40  20, 66% males) with normal 2-dimensional echocardiography (2DE) 
study results. Depending on resting LV outflow tract (LVOT) gradient detected by continuous wave 
Doppler, the patients with HCM were classified into two subgroups: A) included 20 patients with non-
obstructive HCM (LVOT gradient <50 mmHg) and B) included 10 patients with obstructive HCM 
(LVOT gradient >50 mmHg). All patients and control subjects were examined by 2DE and RT3DE. In 
a non-selected group of 50 patients (20 normal, 15 HCM patients, and 15 DCM patients), MRI studies 
were performed as gold standard technique for validation of RT3DE measurements.    
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2DE examination 
The 2DE studies were performed using a 3.5 MHZ probe and a commercially available ultrasound 
system (Philips Sonos 7500, Best, The Netherlands). The 2DE examination was undertaken with the 
patient in the left lateral decubitus position using both apical and parasternal views The following data 
measures were obtained: (1) LV fractional Shortening (LVFS2D) was defined as (end-diastolic 
dimension – end-systolic dimension) / end-diastolic dimension x 100% by M-mode, (2) LV ejection 
fraction (LVEF2D) defined as (end-diastolic volume – end-systolic volume) / end-diastolic volume x 
100 % using 2D biplane modified Simpson method, (3) Mitral regurgitation was defined by color 
Doppler and graded according to the maximum regurgitant jet area as mild (jet area< 4 cm2), moderate 
(jet area 4-8 cm2), and severe (jet area> 8 cm2)14  
RT3DE examination 
RT3DE was performed using the same ultrasound system with (X 4 matrix) transducer capable of 
providing real-time B-mode and colour-Doppler. The 3D images were collected within 5 to 7 seconds 
of breath holding in full volume mode. The 3D data were transferred to an offline analysis system 
(Tom Tec, Munich, Germany). Data were stored digitally and subsequently evaluated by two expert 
echocardiographers. Data analysis of 3DE imaging had been based on a 2D approach relying on the 
echocardiographic images obtained from the apical views and on manual tracing of inner border of the 
mitral annulus. Once this is completed the surface area was automatically delineated and could be 
visualized from different points of view. Manual modification was done to correct any image if 
necessary. The following measures were obtained: (1) MAA3D measured from atrial aspect at end-
diastole (just before mitral valve closure) and at end-systole (just before mitral valve opening), (2) MA 
diameter (MAD3D) defined as the perpendicular line drawn from the peak of annular area curvature to 
the middle of its straight annular border (aortic trigone) at the same frames selected for area 
measurement, and (3) MA fractional area changes (MAFAC3D) (%) and MAFS3D (%): calculated by 
the formula used for LVFS2D. 
MRI examination 
In a non-selected group of 50 patients (20 control subjects, 15 patients with HCM, and 15 patients with 
DCM), MRI studies were performed with a 1.5-T whole-body scanner (Sigma, General Electric, 
Milwaukee, Wis) and using a 4-channel phased-array body coil. A retro-triggered, steady state, free-
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precession gradient echo-sequence was used for cine imaging. Image parameters were: repetition time 
of 3,5 milliseconds (ms), echo time 1.4 ms, temporal resolution of 42 ms, flip angle of 45 degrees, slice 
thickness of 8 mm with a slice gap of 2 mm, and an image resolution of 2.0 x 3.0 mm). First, cines with 
a 4-, 3-, and 2-chamber view were obtained. Then, a stack of 10 short axis slices was used for full 
coverage of the LV, planned on the 4-chamber view starting at the level of the mitral valve annulus, 
using the 2-chamber view as second localizer. Quantitative measurement was performed using 
standardized digital imaging and communication in medicine viewing software on the basal short axis 
slice, on which the mitral valve annulus was visualized in end-diastole. MAAMRI and MADMRI were 
defined as described before in the RT3DE section (see Figure 1).  
  
Figure 1: Morphology of mitral annulus in control subject (left), patient with hypertrophic 
cardiomyopathy (middle), and patients with dilated cardiomyopathy (right) as visualized by RT3DE 
(top) and MRI (bottom). Horizontal lines indicate the annulus diameter (MAD). 
 
STATISTICAL ANALYSES  
All data obtained by 2DE and RT3DE were presented as mean  SD. Data analyses were performed 
using statistical software (SPSS, version 12.1, SPSS Inc, Chicago). Independent sample t-test and 
analysis of variance (ANOVA) test were used for comparison between the 3 groups for analysis of 
variance within each group and in-between. The level of significance was set to P <0.05. Interobserver 
agreements for RT3DE measurements were expressed according to the method of Bland and Altman15.    
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RESULTS 
Echocardiographic data of all groups are shown in Table 1. There were no significant differences in age 
distribution. The highest LVFS2D and LVEF2D were present in patients with HCM (38.4  9.6 and 71.1 
 17.7% respectively), whereas the lowest LVFS2D and LVEF2D were present in patients with DCM 
(10.0  2.2 and 18.4  4.1 % respectively). The prevalence and severity of mitral regurgitation were 
comparable in HCM and DCM patient groups and higher than in control group (P <0.0001). 
Acquisition of RT3DE data set was performed successfully in all patients and control subjects (Figure 
1).  
MA in HCM    
End-diastolic MAA3D was significantly larger in HCM group than in control group (11.7 ± 2.8 vs. 8.7 
± 2.9 cm2, P <0.0001), whereas end-systolic MAA3D showed no significant difference. End-diastolic 
MAD3D tended to be higher in patients with HCM than in control subjects but this was not statistically 
significant (P = 0.05). MAFAC3D and MAFS3D were larger in patients with HCM than in control 
subjects (51.2 ± 21.8% vs. 33.8 ± 13.8 %, P = 0.001 and 31.0 ± 17.6% vs. 20.1 ± 10.2%, P = 0.006 
respectively). Age and sex were equally distributed within both HCM subgroups (IA and IB). LV end-
diastolic diameter was comparable in both groups, whereas LV end-systolic diameter was lower in 
subgroup IB (3.1  0.7 vs. 2.3  0.7 cm, P = 0.01). Thus, a higher LVFS2D was present in IB than in IA 
(48.0  6 vs. 34.3  8%, P = 0.001). The prevalence and severity of mitral regurgitation were 
comparable in both subgroups. All MA measurements by RT3DE showed no significant difference 
between the HCM subgroups.  
MA in DCM   
MAA3D and MAD3D were significantly larger in patients with DCM than in control subjects both at 
end-diastole and end-systole (all P < 0.0001) (Table 1). Compared with control subjects, patients with 
DCM had significantly lower MAFAC3D (23.2 ± 15.1 vs. 33.8 ± 13.8 %, P = 0.01) and MAFS3D (4.2 ± 
7.9 vs. 20.1 ± 10.2%, P = 0.03). 
DCM versus HCM  
MAA3D was significantly larger in DCM than in HCM both at end-diastole (15.5 ± 6.6 vs. 11.7 ± 2.8 
cm2, P = 0.01), and at end-systole (11.6 ± 5.4 vs. 5.6 ± 2.5 cm2, P < 0.0001). End-systolic MAD3D was 
significantly larger in DCM than in HCM (3.6 ± 0.8 vs. 2.7 ± 1.0 cm, P = 0.001), whereas no 
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significant differences in end-diastolic MAD3D were found. MAFAC3D and MAFS3D were 
significantly lower in DCM than in HCM (all P < 0.0001) (Table 1). 
Table 1: Clinical and echocardiographic data of all studied patient groups 
 HCM  (n = 30) 
DCM  
(n = 20) 
           Control 
(n = 30) 
Age (yr) 38  15  39  12  40  20  
Male gender (%) 24 (80%) 8 (40%) 18 (60%) 
LVFS2D (%) 38.4  9.6 10.0  2.2 28.3  5.4 
LVEF2D (%) 71.1  17.7 18.4  4.1 52.4  1.0 
Mitral regurgitation 
       No 
Mild 
Moderate-severe 
 
8 (27%) 
15 (50%) 
7 (23%) 
 
4 (20%) 
12 (60%) 
4 (20%) 
 
24 (80 %) 
6 (20%) 
0 (0%) 
Diastolic values    
        MAA3D  (cm2) 11.7  2.8 15.5  6.6 8.7  2.9 
        MAD3D  (cm) 4.0  1.6 4.3  1.0 3.4  0.5 
Systolic values    
        MAA3D (cm2) 5.6  2.5 11.6  5.4 5.6  1.7 
        MAD3D (cm) 2.7  1.0 3.6  0.8 2.7  0.5 
Systolic function    
        MAFAC3D (%) 51.2  21.8 23.2  15.1 33.8  13.8 
        MAFS3D (%) 31.0  17.6 14.2  7.9 20.1  10.2 
 
DCM, Dilated cardiomyopathy; EF, ejection fraction; FAC, fractional area change; FS, fractional 
shortening; HCM, hypertrophic cardiomyopathy; LV, left ventricular; MA, mitral annulus; MAA, MA 
area; MAD, MA diameter  
 
MA function & LV function 
MAFS3D did not correlate with LVFS2D and LVEF2D in all patients. MAFAC3D was strongly 
correlated with LVEF2D in control subjects (r = 0.94, P < 0.0001). However, this correlation decreased 
in DCM and HCM, (r = 0.53, P = 0.01 and r = 0.42, P = 0.02 respectively) (Figure 2). 
MRI and RT3DE 
In the subgroup of 50 patients who were investigated with both MRI and RT3DE, there was an 
excellent agreement between both imaging modalities in measurements of MAA (r = 0.92, P < 0.0001) 
and MAD (r = 0.85, P < 0.0001) (Figure 3). No significant differences were found between both 
imaging modalities for measurements of MAA and MAD (Table 2). 
Table 2: Comparison between RT3DE and MRI measurements 
 RT3DE MRI 
Diastolic MAA (cm2)   
HCM patients 11.7  2.8 11.3  2.3 
DCM patients 15.5  6.6 16.4  5.5 
Normal control 8.7  2.9 9.0  2.3 
Diastolic MAD (cm)   
HCM patients 4.0  1.6 3.8  0.7 
DCM patients 4.3  1.0 4.5  0.9 
Normal control 3.4  0.5 3.3  0.5 
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Interobsever agreement  
As shown in Figure 4, in the control group, interobserver agreement was good for MAA3D (mean 
difference = - 0.1  1.7, agreement = - 3.5, 3.3) and for MAD3D (mean difference = - 0.1  1.9, 
agreement = - 3.90, 3.70). In patients with HCM, agreement was also good for MAA3D (mean 
difference = - 0.2  1.3, agreement = - 2.8, 2.4), and for MAD3D (mean difference = -0.1  2.1, 
agreement = - 4.3, 4.1). In patients with DCM, agreement was also good for MAA3D (mean difference 
= - 0.5  2.3, agreement = - 5.1, 4.1), and for MAD3D (mean difference = - 0.3  2.2, agreement = - 4.7, 
4.1).  
 
Figure 4: Interobsever agreement of mitral annuls (MA) area (MAA) and MA diameter (MAD) 
measurements by RT3DE in control group, and in patients with HCM and DCM. 
 
DISCUSSION 
In this study the morphological and functional aspects of the MA in HCM and DCM were assessed by 
RT3DE. MA shape was not completely circular but D-shaped in control subjects and in patients with 
cardiomyopathy. MAA3D and MAD3D correlated well with MAAMRI and MADMRI in control subjects 
and in patients with cardiomyopathy. Despite MA dilatation in patients with HCM and DCM, MA 
function is augmented in patients with HCM and impaired in patients with DCM as assessed by 
MAFAC3D and MAFS3D.  
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The importance of studying MA size and function in cardiomyopathy is to expand the 
understanding of the underlying patho-physiology of the occurrence of mitral regurgitation in several 
cardiomyopathies. Subsequently, it may also affect therapeutic decision-making in patients with 
significant functional mitral regurgitation, because accurate assessment of the MA is crucial for 
selection of prosthetic mitral valve rings, percutaneous annuloplasty devices and stented valve 
implantation 16-18  
In the current study, the MA could be well visualized with RT3DE from different points of 
view in both patients and control subjects. Tracings of the MA and calculation of its surface areas in 
systole and diastole were reproducible and discriminated normal from dilated MA. Larger end-diastolic 
MAA3D in HCM and DCM were found (11.7  2.8 and 15.5  6.6 cm2, respectively), which is in 
concordance with measurements from Flachskampf et al (10.2  4.2 cm2 in HCM and15.2  4.2 cm2in 
DCM)19.  
The MA acts as a sphincter facilitating ventricular filling by expansion and aids to competent 
mitral valve closure by contraction. In accordance with the previous studies, MA function was 
augmented in HCM and impaired in DCM19,20. This may be a result of stretching of MA that occurs 
along the left ventricular axis. The functional activity of the muscular part of MA along the left 
ventricular axis may play a role. Both types of HCM (obstructive and non-obstructive) showed no 
significant differences in parameters of MA size and function. This may be explained by the fact that 
MA stretching of MA occurs mainly along the muscular part and very little on the fibrous part. In 
HCM, MA dilatation occurs to a certain limit beyond which, more stretch will be prevented by the 
hyperactive muscular part even with significant mitral regurgitation. In both HCM types, the muscular 
part is hyperactive. In this study MAFAC3D in control subjects showed good correlation with LVEF3D, 
but this correlation was less in both HCM and DCM groups. This discrepancy may be explained by the 
higher incidence of electromechanical dys-synchrony in HCM and DCM 21-23.  
When MA dilates, the geometry changes due to flattening and stretching with loss of normal 
saddle shape, which may contribute to functional mitral regurgitation 24,25. This may explains the direct 
correlation between mitral regurgitation severity and MA dilatation 26. In addition, MA dilatation may 
underlie the high incidence of mitral regurgitation in patients with HCM irrespective to LVOT gradient 
27. The MA dilatation may also explain why significant mitral regurgitation persists after successful 
surgical myomectomy in obstructive HCM and disappears when the myomectomy is combined with 
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mitral valve repair 28,29. It also partially explains why annuloplasty is preferred to mitral valve 
replacement with improvement of outcome after mitral annuloplasty in severe LV dysfunction 30,31. 
 
CONCLUSION 
RT3DE can be reliably used for accurate assessment of MA size and function in control subjects, 
patients with HCM, or patients with DCM and can be used to facilitate clinical decision making when 
surgical mitral valve repair is indicated. In addition, it may be used in the follow up studies of patients 
with cardiomyopathy. 
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ABSTRACT 
Objectives: Assessment of mitral valve (MV) morphology in mitral stenosis (MS) patients by a new real-time 
three-dimensional echocardiography (RT3DE) scoring system. 
Methods: We conducted a two-staged study. The first stage was to study the feasibility, and reliability of the 
RT3DE score in 17 patients with MS. The second stage was a validation of the RT3DE score in 74 consecutive 
patients (mean age 33.4  8.6 years, 65% females) who were candidate for percutaneous mitral valvuloplasty 
(PTMV). MV morphology was assessed by Wilkins’ score and compared to the RT3DE score. RT3DE score 
was constructed by dividing each MV leaflet into 3 scallops and composed of 31 points (with increasing 
abnormality) including 6 points for thickness, 6 for mobility, 10 for calcification and 9 for subvalvular apparatus 
involvement. The total RT3DE score was assumed and defined for low (<8), mild (8-14) and high (≥15)..  
Results: In the first stage, RT3DE score was easily applied to all patients with good interobserver and 
intraobserver agreements. In the second stage, RT3DE improved the MV morphological assessment for detection 
of extent and distribution of calcification, and commissural splitting. Both scores were correlated well for 
assessment of thickness and calcification (r= 0.63, p<0.0001 and r= 0.44, p<0.0001 respectively). Pre-PTMV 
predictors of optimal success were the low calcification and subvalvular apparatus Wilkins score and low 
mobility and subvalvular apparatus RT3DE score. Incidence and severity of mitral regurgitation were associated 
with high calcification RT3DE score. 
Conclusions: The new RT3DE score is feasible and highly reproducible for the assessment of MV morphology 
in MS patients. In comparison with Wilkins score, RT3DE score added more valuable information before PTMV 
that may help in selection of patients and could predict the outcome. 
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INTRODUCTION 
Rheumatic mitral valve (MV) disease still remains an important public health concern particularly in developing 
countries. In selection of the proper therapeutic strategy for mitral stenosis (MS), two-dimensional 
echocardiography (2DE) is of crucial importance 1. Apart from estimation of the transmitral pressure gradient, 
2DE can calculate MV area by planimetry and pressure half-time 2. 2DE is essential in the selection of patients 
for percutaneous mitral valvuloplasty (PTMV) 3. Of all available MV scoring systems, the Wilkins’ score is the 
most commonly used 4-6.  This score evaluates MV thickness, mobility, leaflet calcification, and the degree of 
subvalvular apparatus thickening 6. A favourable Wilkins’ score (<8 points) is highly predictable of good 
outcome after PTMV 7. More recently, it has been shown that other factors such as commissural fusion and 
calcification are also strong predictors of outcome after PTMV 8-10. 
The introduction of real-time three-dimensional echocardiography (RT3DE) and advances in analysis 
software has improved MV orientation and evaluation11. Several studies have reported improved accuracy and 
superiority of RT3DE over 2DE for MV area (MVA) estimation 12-14. RT3DE allows a unique “en-face” view 
and morphologic analysis of the entire MV apparatus including the MV annulus and subvalvular apparatus, also 
in relation to other nearby structures. We proposed a new RT3DE score for the quantitative and qualitative 
assessment of the MV in patients with mitral stenosis (MS) and compared it with Wilkins score in the prediction 
of PTMV outcome.  
 
METHODS 
 
The study was designed as two-stages. The first stage was for derivation of the RT3DE score and assessment of 
its applicability in 17 patients (mean age 30.6  7.8 year, 70% females) with an established diagnosis of MS and 
good 2DE image quality. All 17 patients were in sinus rhythm.  Once the score was developed, the second stage 
of the study was started for validation of this score in a prospective new sample of 74 consecutive patients (mean 
age 34.4  5.9 year, 62% females). 67 patients (74 %) were in sinus rhythm, while 24 patients (26 %) were in 
atrial fibrillation. Finally, the RT3DE score was applied for the entire 91 patients (first and second stages) to 
assess its value. All patients were examined by 2DE and RT3DE. All data were analyzed by two independent 
expert echocardiographers (A. M. A & O, I. S in the first stage, A. M. A & W. M. A in the second stage). The 
analysis was done also by each one at two different days to assess the interobserver and intraobserver 
variabilities.     
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The study was designed as two-stages. The first stage was for derivation of the RT3DE score and assessment of 
its applicability in 17 patients (mean age 30.6  7.8 year, 70% females) with an established diagnosis of MS and 
good 2DE image quality. All 17 patients were in sinus rhythm.  Once the score was developed, the second stage 
of the study was started for validation of this score in a prospective new sample of 74 consecutive patients (mean 
age 34.4  5.9 year, 62% females). 67 patients (74 %) were in sinus rhythm, while 24 patients (26 %) were in 
atrial fibrillation. Finally, the RT3DE score was applied for the entire 91 patients (first and second stages) to 
assess its value. All patients were examined by 2DE and RT3DE. All data were analyzed by two independent 
expert echocardiographers (A. M. A & O, I. S in the first stage, A. M. A & W. M. A in the second stage). The 
analysis was done also by each one at two different days to assess the interobserver and intraobserver 
variabilities.     
Transthoracic 2DE examination  
A complete 2DE study was performed 24 hours prior to PTMV using a 3.5 MHz (S3) probe and a commercially 
available ultrasound system (Philips Sonos 7500, Best, Netherlands). The morphology score according to 
Wilkins’ score system was applied for evaluation of four factors: leaflet thickness, mobility, calcification and the 
degree of subvalvular thickening (Table 1). Each factor is given a score of 0 for normal, 1 for mild MV 
involvement, 2 for moderate and 3-4 for severe, yielding a summed score of 16 points. The higher the score, the 
greater the morphological abnormality of the MV Thus a score of less than 5 points defines mild MV 
involvement, 5-8 moderate involvement, and >8 severe MV involvement severity 6. The following 
measurements were obtained: 1) MVA was defined as the narrowest orifice at the time of maximal mitral valve 
opening and measured by 2D planimetry in short axis view, 2) mean transmitral pressure gradient was calculated 
by continuous wave Doppler, 3) mitral regurgitation was graded according to vena contracta using color Doppler 
and graded as mild , moderate and  severe 15, 4) left atrial diameter was measured in M-mode from parasternal 
long axis view at the level of aortic valve, 5) commissural splitting was defined as the terminal distance between 
the two MV leaflets and measured from parasternal short axis view at the mitral valve level at an end-diastolic 
still frame for each commissure (anterior and posterior). The splitting was scored as 0 for no splitting, 0.5 for 
partial splitting, and 1 for complete splitting 16. If PTMV was planned, the previous data were obtained pre-
PTMV and within 48 hours post-PTMV. One-year clinical and 2DE examination follow up was completed for 
74 patients who underwent PTMV. The following measurements were obtained: 1) MVA, 2) mean transmitral 
pressure gradient and 3) mitral regurgitation. The end-points were: recurrent symptoms, restenosis, need re-
intervention either PTMV or MV surgery.  
 78
New MV scoring system by RT3DE 
Table 1: Wilkins’ score 
 
 
Mobility Subvalvular thickening Thickening Calcification 
     
1 Highly mobile valve with only leaflet tips restricted 
Minimal thickening just 
below the mitral leaflets 
Leaflets near normal in 
thickness (4-5 mm) 
A single area of 
increased echo 
brightness 
     
2 
Leaflet mid and base 
portions have normal 
mobility 
Thickening of chordal 
structures extending up to 
one-third of the chordal 
length 
Midleaflets normal, 
considerable thickening 
of margins (5-8 mm). 
 
Scattered areas of 
brightness confined 
to leaflet margins 
     
3 
Valve continues to move 
forward in diastole mainly 
from the base 
Thickening extending to 
the distal third of the 
chords 
Thickening extending 
through the entire 
leaflet (5-8 mm). 
Brightness extending 
into the midportion of 
the leaflets 
     
4 
No or minimal forward 
movement of the leaflets 
in diastole 
Extensive thickening and 
shortening of all chordal 
structures extending down 
to the papillary muscle 
Considerable 
thickening of all leaflet 
tissue (>8-10 mm) 
Extensive brightness 
throughout much of 
leaflet tissue 
     
 
Transesophageal 2DE  
Transesophageal 2DE was performed 24 hours pre-PTMV for assessment of MV morphology evidence of left 
atrial and /or left atrial appendage thrombi and for measurement of interatrial septum thickness. 
Transthoracic RT3DE examination 
Image acquisition  
RT3DE was performed immediately after the 2DE study by the same machine using an X4 matrix transducer 
capable of providing real-time B-mode and colour-Doppler. Full volume images of three cardiac cycles were 
collected within 5-7 seconds of breath holding in patients with sinus rhythm. Due to variability of cardiac cycle 
duration in atrial fibrillation patients, the 3D images of one cardiac cycle were collected. . The 3D data were 
transferred to an offline analysis system (Tom Tec, Munich, Germany) in the first stage of the study and  (Q-lab 
version 6. Philips) in the second stage. Data were stored digitally and subsequently evaluated by two 
independent physicians. Data analysis of 3D echo imaging was based on a 2D approach relying on the echo 
images obtained from the apical 4-chamber and parasternal long axis views in patients with sinus rhythm. 
Additional two views (apical long axis and parasternal short axis) were needed in atrial fibrillation patients. By 
using the crop function for images formatting, parallel sections through scanned volume in three perpendicular 
planes were done. The narrowest slice to enable visualization of MV (leaflets and subvalvular) was selected.  
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Score Derivation 
The new RT3DE morphology score (Table 2) was derived to include both MV leaflets and subvalvular apparatus 
guided by the well known 2DE Wilkins’ score. As seen in Figure 1, each leaflet could be seen clearly by RT3DE 
divided into three scallops (antero-lateral A1 - P1, middle A2 - P2 and postero-medial A3 - P3) that were scored 
separately. For the scoring of the subvalvular apparatus, three cut sections of the anterior and posterior chordae 
were obtained from the full-volume images acquired at parasternal long axis position at three levels: proximal 
(valve level), middle and distal (papillary muscle level). Each cut section and each chorda were scored 
separately. 
1). Scoring of valve leaflets included thickness, mobility and calcification for each scallop as follow: Normal 
thickness and mobility was scored as 0 and abnormal thickness or restricted mobility was scored as 1. Absence 
of calcification was scored as 0, calcification in middle scallop (A2 or P2) was scored as 1, and calcification of 
commissural scallops of both leaflets (A1, A3 - P1, P3) was scored as 2. 
2). Scoring of the subvalvular apparatus included chordal thickness and distance of splitting in-between the 
chordae as follow: Normal thickness was scored as 0, and abnormal thickness was scored as 1, normal chordal 
splitting (distance in-between >5 mm)16 was scored as 0, partial splitting (distance in-between <5 mm) as 1, and 
absence of splitting as 2.  
3). The total points of leaflets and subvalvular apparatus RT3DE score were summed to calculate the total 
RT3DE score, ranging from 0 to 31 points. The degree of leaflet and subvalvular apparatus involvement were 
defined as follows:  
1. For leaflet thickness and mobility, it was 0 for normal, 1-2 for mild MV involvement, 3-4 for 
moderate and  5 for severe  
2. For calcification and subvalvular apparatus involvement it was 0 for normal, 1-2 for mild, 3-5 for 
moderate and  6 for severe.  
3. Total score of mild MV involvement was defined as <8 points, Moderate MV involvement 8 -14, 
and severe MV involvement  15 for high 
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Figure 1: RT3DE en face view of mitral valve as 
seen from   ventricular aspect with the three 
scallops of each leaflet (A1, A2, A3 – P1, P2, P3).  
 
Table 2: RT3DE score of mitral valve 
 Anterior leaflet Posterior leaflet 
 A1 A2 A3 P1 P2 P3 
Thickness (0-6) 
0 = normal    1 = thickened 0 – 1 0 - 1 0 – 1 0 – 1 0 - 1 0 – 1 
Mobility (0-6) 
0 = normal    1 = limited 0 – 1 0 - 1 0 – 1 0 – 1 0 - 1 0 – 1 
Calcification (0-10) 
0 = no         1,2 = calcified 0 – 2 0 - 1 0 – 2 0 – 2 0 - 1 0 – 2 
 Subvalvular Apparatus 
 Proximal 1/3 Middle 1/3 Distal 1/3 
Thickness (0-3) 
0 = normal    1 = thickened 0 – 1 0 – 1 0 – 1 
Splitting (0-6) 
0 = normal      1 = partial    
 2 = no  
0, 1, 2 0, 1, 2 0, 1, 2 
Abbreviations: A1- P1: anterolateral parts, A2 - P2: middle parts, A3 – P3: postero-medial 
 
Percutaneous Mitral Valvuloplasty (PTMV):  
Seventy four patients of ninety one (mean age 30.4  8.6 years, 70% females) were class I candidate for PTMV 
according to AHA/ACC guidelines 17. All of them had <9 MV Wilkins score.  PTMV was performed by two 
experienced operators who were unaware with the RT3DE assessment.  After patient consent, one femoral 
arterial and venous sheaths were introduced after local anaesthesia. A pigtail catheter was advanced just at the 
aortic valve level. Trans-septal puncture was performed with a Brockenbrough needle. PTMV was performed 
using the Inoue balloon technique as previously described 18. The definition of optimal success was achievement 
of 50% increase in MVA as compared to pre PTMV or an achieved MVA 1.5 cm2 which is larger with mitral 
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regurgitation moderate or less 15. Suboptimal success was defined as the achieved MVA <1.5 cm2 with 
regurgitation moderate or less and severe regurgitation irrespective of the achieved MVA. 
  
STATISTICAL ANALYSES  
All statistics were performed using SPSS version 12.0.1 (SPSS inc., Chicago, Illinois). Each component of both 
scores was assessed separately, and then total score of 2DE and RT3DE were calculated for every patient. Both 
scores were investigated for correlation using Pearson’s correlation analysis to demonstrate the basic differences. 
Comparisons were considered significant in presence of a p value < 0.05. Interobserver agreement was evaluated 
with the Kappa index, classified as poor with value 0.01-0.20, slight 0.21- 0.40, fair 0.41- 0.60, good 0.61- 0.80, 
very good 0.81- 0.92, and excellent 0.93-1.00 19. To obtain independent predictors of success and development 
of significant mitral regurgitation (> grade 2), multiple Cox regression analysis was performed. The 95% 
confidence interval was derived from the natural algorithm of the coefficient  1.96 times the standard error. 
 
RESULTS 
First Stage Study Results 
Acquisition of RT3DE data was performed successfully in all 17 patients within a reasonable time (3 minutes for 
acquisition and 10 minutes for data analysis). The MV was clearly visualized in all patients and its morphology 
could be assessed by both the 2DE and RT3DE scores. Optimal assessment of MV leaflets and commissures by 
RT3DE was obtained from the parasternal window more than the apical window, while assessment of 
subvalvular apparatus was optimally assessed from the apical window. The RT3DE score was applied easily by 
the investigators in all patients. The echocardiographic reports by the investigators were identical for the score 
points.  
Total Results 
Data acquisition and analysis were obtained in all patients in the two stages (91 patients). In patients with sinus 
rhythm (67 patients), the data analysis and score calculation were easily obtained through cropping of a full 
volume images whitin 10 minutes. In patients with atrial fibrillation (24 patients), the data analysis and score 
calculation were depend on multiple live 3D images obtained from parasternal and apical views within 13 
minutes. 
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Score Qualification (Table 3) 
The study of each part of both MV leaflets by RT3DE helped in more concise description than global evaluation 
by 2DE. RT3DE assessment of leaflet mobility was clearly and easily obtained. Leaflet calcification was fairly 
detected by 2DE while RT3DE added more information regarding distribution of calcification on leaflet’s parts 
and its extent (Figure 2 A,B). Annular calcification (site and extent) was clearly defined by RT3DE while not 
depicted well by 2DE. For subvalvular apparatus, RT3DE helped in detailed quantitative assessment of chordal 
thickening and separation at three levels while by Wilkins score, chordal separation was not obtained (Figure 2 
D). Width of anterior and posterior commissures post-PTMV could be assessed well by RT3DE while by 2DE 
was inadequate.  
 
 
 
 
Figure 2: A). Stenotic MV with 
calcification involved middle part of 
anterior leaflet (A2), B).  Stenotic MV 
with calcification involved both 
commissures (arrows) with closed mitral 
valve, C). Marked thickening of both 
leaflets of MV, D) thickening of chordae 
tendinae. 
 
 
Table 3: Qualitative value of RT3DE compared with 2DE in assessment of MV morphology 
 Wilkins score RT3DE score 
Site of calcification + ++ 
Extent of calcification + ++ 
Chordal thickening + ++ 
Chordal separation - + 
Commissures + ++ 
Mitral Annulus + ++ 
++: clearly defined, +: defined, -: ill-defined 
Score Quantification 
Thickness score: 2DE detected mild thickening in 40%, moderate in 55%, and severe in 5%, while RT3DE 
detected 24% as mild, 62% as moderate, and 14% as severe. Both scores correlated well (r = 0.63, p <0.0001).  
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Mobility score: 2DE detected freely mobile leaflets in 3%, mildly restricted leaflet mobility in 48%, moderate in 
39% and severe in 10%, while by RT3DE, 16% were defined as normal, 34% as mild, and 51% as moderate. No 
correlation between both scores was detected. 
Calcification score: 2DE score detected no calcification in 40%, mild calcification in 38%, moderate in 19% and 
severe in 3%, while RT3DE score detected no calcification in 25%, mild calcification in 38%, moderate in 31% 
and severe in 6%. Both scores were fairly correlated (r= 0.44, p<0.0001)   
Subvalvular apparatus score:  2DE detected mild degree of subvalvular affection in 39%, moderate in 45% and 
severe in 16%, while RT3DE defined 2% as normal, 25% as mild affection, 55% as moderate and 18% as severe.  
No correlation between both scores was detected. 
Total Scores Quantification 
The distribution of all included patients within both scores is shown in Table 4. High score was detected in 10% 
by 2DE and in 25% by RT3DE. Low score was detected in 35% by 2DE and in 16 % by RT3DE. Both scores 
were comparable for the definition of intermediate severity (r = 0.6, p = 0.007), while for low and high were not.  
 
 Table 4: Distribution of patients within Wilkins’ score and RT3DE score  
  Normal Mild Moderate Severe 
      
2DE 0 (0%) 36 (40%) 50 (55%) 5 (5%) 
Thickness 
RT3DE 0 (0%) 22 (24%) 56 (62%) 13 (14%) 
      
2DE 3 (3%) 44 (48%) 35 (39%) 9 (10%) 
Mobility 
RT3DE 14 (16%) 31 (34%) 46 (51%) 0 (0%) 
      
2DE 36 (40%) 35 (38%) 17 (19%) 3 (3%) 
Calcification 
RT3DE 23 (25%) 35 (38%) 28 (31%) 5 (6%) 
      
2DE 0 (0%) 35 (39%) 41 (45%) 15 (16%) Subvalvular 
apparatus RT3DE 2 (2%) 23 (25%) 50 (55%) 16 (18%) 
      
2DE 0 (0%) 32 (35%) 50 (55%) 9 (10%) 
Total score 
RT3DE 0 (0%) 14 (16%) 54 (59%) 23 (25%) 
      
 
Interobserver variability: 
Wilkins score showed fair agreement for the assessment of leaflet thickness and mobility (Kappa index: 0.55 and 
0.56 respectively), while it was poor for calcification and subvalvular apparatus (Kappa index: 0.03 and 0.01 
respectively). For RT3DE, the agreements were good for the assessment of leaflet thickness and mobility (Kappa 
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index: 0.66 and 0.63 respectively), and fair for the assessment of calcification (Kappa index: 0.42). Assessment 
of subvalvular apparatus showed slight agreement (Kappa index: 0.21) for chordal thickening, while for splitting 
it was excellent (Kappa index: 0.95).    
Immediate results of PTMV  
Depending upon the previous definition of success, optimal successful dilatation was achieved in 57 patients 
(77%) and suboptimal success in 17 patients (23%). The immediate echocardiographic and hemodynamic 
outcome is shown in Table 5. Serious complications including cardiac tamponade, or need for surgical 
interference were not present. 
Table 5: Hemodynamic and echocardiographic results of PTMV 
Variable Pre-PTMV Post-PTMV P value 
    
MVA2DE (cm2) 0.91  0.13 1.9  0.30 <0.0001 
MVART3DE (cm2) 0.92  0.14 2.1  0.30 <0.0001 
Mean pressure gradient (mmHg) 20.0  5.8 7.0  2.5 <0.0001 
LA diameter (cm) 5.1  0.95 4.7  7.7 <0.001 
LV fractional shortening (%) 31.7  6.8 35.1  5.2 0.002 
Mitral regurgitation 
No 
Grade 1 
Grade 2 
Grade 3-4 
 
37 (50%) 
32 (43.3%) 
5 (6.7%) 
0 (0%) 
 
5 (6.6%) 
37 (50%) 
15 (20%) 
17 (23.3%) 
0.001 
 
By 2DE: MVA was increased from 0.91  0.13 to 1.9  0.30 cm2, p < 0.0001. Significant reduction in the mean 
transmitral PG was reduced from 20.0  5.8 to 7.0  2.5 mmHg; p< 0.0001. 17 patients (23 %) developed mitral 
regurgitation > grade 2 and in the remaining percentage of patients (77%) mitral regurgitation was ≤ grade 2. 
Complete splitting of anterior commissure was achieved in 48 patients (65%) and partial splitting in 18 patients 
(25%). Complete splitting of posterior commissure was achieved in 37 patients (50%) and partial splitting in 22 
patients (30%). Bilateral complete commissural splitting was obtained in 37 patients (50%).  
By RT3DE: MVA was increased from 0.92  0.14 to 2.1  0.30 cm2, p < 0.0001. Splitting of both commissures 
could be assessed clearly (Figure 3). Complete splitting of anterior commissure was achieved in 46 patients 
(62%) and partial splitting in 22 patients (30%). Complete splitting of posterior commissure was achieved in 37 
patients (50%) and partial splitting in 18 patients (25%).  
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Figure 3: A) RT3DE en face view of a widely 
splitted antero-lateral and postero-medial 
commissures post-PTMV, B) side view of partially 
splitted anterior commissure. 
 
PTMV results and Wilkins score 
Using multiple stepwise Cox regression analysis for Wilkins score components, calcification and subvalvular 
apparatus involvement were the only two independent predictors of successful PTMV (p= 0.025 and 0.028 
respectively). Thus the lower the score points of calcification and subvalvular apparatus involvement, the larger 
the achieved MVA. No independent predictors could be identified for the development of >grade 2 mitral 
regurgitation.  
PTMV results and RT3DE score 
Analysis of RT3DE score components showed that leaflet mobility and subvalvular thickening were independent 
predictors of successful PTMV (p= 0.0045 and 0.04 respectively). High mean transmitral gradient was detected 
in 12 patients (16.6%) despite successful PTMV. In those patients, subvalvular apparatus score was mild 
according to Wilkins score while by RT3DE score it was moderate in 5 of them and severe in 7 of them. For the 
development of >grade 2 mitral regurgitation, calcification was the only independent predictor. In 4 out of 17 
patients who developed >grade 2 mitral regurgitation, RT3DE calcification score was severe while by Wilkins 
score it was mild. In the remaining 13 patients, calcification score was moderate by both Wilkins and RT3DE 
scores. The calcification was detected in the commissural segments of MV leaflets in 10 patients by RT3DE.  
One-year follow up 
Clinical and 2DE follow up were completed for all patients underwent PTMV. In patients with optimal 
successful PTMV (57 patients), 7 patients developed recurrence of dyspnea (grade II-III), while the remaining 50 
patients were asymptomatic. 2DE of those 7 patients showed insignificant reduction of MVA from 1.7  0.25 
cm2 to 1.5  0.21 cm2 but the mean transmitral gradient increased from 10.0  2.1 mmHg to 14.2  1.9 mmHg; 
p< 0.01. In those patients, the subvalvular apparatus score before PTMV was severe by RT3DE and mild by 
2DE. In patients with suboptimal PTMV (17 patients), 5 of them became severely symptomatic. 3 patients were 
referred for surgery due to increased MR grade (grade 3/4) and 2 patient underwent repeat PTMV due to 
restenosis (MVA was reduced from 1.4  0.34 to 1.0  0.11 cm2). The 3 patients whom referred to surgery had 
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severe calcification score by RT3DE before PTMV while in the 2 patients referred to repeat PTMV, the 
calcification score was moderate. The 2DE calcification score in those 5 patients was mild.  
 
DISCUSSION 
For a proper selection of therapeutic strategy in patients with MS, clinical evaluation and assessment of MV 
anatomy are essential 20-22. Transthoracic 2DE allows classification of patients into anatomic groups to predict 
immediate and long-term outcome23,24. Although, most cardiologists use the Wilkins’ score, several 
echocardiographic scoring systems have been suggested for evaluation of MV anatomy4,5,7,15. None of the 
available scores has been shown to be superior to any of the others25.  
With RT3DE, the MV can be evaluated en face. Additionally, rotation and orientation of the MV to the 
desired plane are easy and independent of the orientation of the acoustic window where image acquisition is 
done14,26. Many studies demonstrated the superior value of RT3DE for the qualitative morphological description 
of MV27-29. RT3DE may become the standard echo technique in the future for the assessment of MS patients due 
to its unique orientation of MV leaflets, commissures and MVA that could be obtained in a high population 
percentage11. RT3DE could be relied on for evaluation of success of valvuloplasty through accurate 
measurement of the achieved MVA, verification of commissural splitting and differentiation between splitting 
and stretch 14.Thus the need to construct a new RT3DE score for quantitative MV assessment paving the way for 
RT3DE to be totally dependable pre and post-PTMV.  
The current study described the feasibility of RT3DE for evaluation of patients with MS after PTMV. It 
helped in the measurement of the achieved MVA and width of commissures. For the first time, the study used a 
new easily applicable quantitative RT3DE score for assessment of MV morphology pre-PTMV and compared it 
with Wilkins score as a predictor of the PTMV immediate outcome. The RT3DE score has several potential 
benefits and include the following:  
1) RT3DE could detect the thickness of each leaflet part, so a higher percentage of moderate to severe 
degree of thickening was found (76% by RT3DE vs. 60% by 2DE).  
2) The whole leaflet length could not be evaluated by a single 2DE image especially for the posterior 
leaflet, which is short and naturally less mobile than the anterior one (Table 6) (Figure 4). By RT3DE, 
visualization and assessment of the whole length of both leaflets is possible through single image plane 
especially in sinus rhythm. Leaflet mobility could be well assessed and scored by RT3DE and its score 
was a good independent predictor for successful PTMV. 
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Table 6: Observed scallop in each 2D echocardiographic views 
View A1 A2 A3 P1 P2 P3 
PLAX - + - - + - 
AP 4-CH - + + + - - 
AP 2-CH + + - - + - 
AP LAX - + - - + - 
PSAX  +  + + + 
Abbreviations: PLAX: parasternal long axis, AP4-CH: apical 4-chamber, AP2-CH: apical 2-chamber, AP LAX: 
apical long axis, PSAX: parsternal short axis, + = Visualized, - = Not visualized,  = May be visualized 
 
Figure 4: Diagram showing the 
direction of 2D echocardiographic cut 
planes with each MV scallop could be 
visualized through each plane 
 
3) The assessment of leaflet calcification and in particular the distribution of calcification along the leaflet 
parts plays an important role in the outcome of patients after PTMV as the percentage of success 
decreases and incidence of complication increase30-32. 2DE Wilkins score depends on the bright areas 
and the extension of calcification along the leaflet length8,9. Multiple cut planes are needed for detection 
of calcification in all scallops of both MV leaflets (Figure 3), while RT3DE could predict the extent and 
distribution of calcification in each scallop from single short axis cut plain. Calcification of 
commissures is one of the strong predictors of outcome after PTMV because it affects the degree of 
commissural splitting8-10. That is why in the new RT3DE score, calcification at the commissural parts of 
leaflet was described by a higher score than the middle leaflets calcification. In our study, calcification 
by RT3DE score was the only predictor for the development of >grade 2 mitral regurgitation post 
PTMV not only due to calcification extent but also the calcification site. In 13 out of 17 patients who 
developed >grade 2 mitral regurgitation, the calcification score was moderate by both Wilkins and 
RT3DE scores, however it was detected at the commissural segments of MV leaflets in 10 patients by 
RT3DE. The presence of annular calcification is an important information in patients with atrio-
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ventricular conduction defect, cerebral stroke and for surgical decision32-36. RT3DE could clearly detect 
the site and extent of calcification, as the whole annular circumference was clearly defined. 
4) Rheumatic involvement of subvalvular apparatus includes fusion, thickening, retraction, shortening and 
calcification. As a consequence, the free interchordal space diminishes and the opened “leaflet – 
chordae tendineae tunnel” available for diastolic flow is limited37. Currently, assessment of MVA 
morphology and functional anatomy in relation to other valvular components remains a clinical 
challenge. Qualitative assessment of subvalvular apparatus by 2DE underestimates severity38. 
Assessment of the subvalvular apparatus by transesophageal 2DE is still controversial. Although, 
Stewart et al39 considered transesophageal 2DE the method of choice for evaluation of subvalvular 
apparatus, Levin et al40 reported limited ability of it to accurately identify and evaluate specific 
subvalvular features that influence valvuloplasty outcome. RT3DE score assessed the chordal thickness 
and separation at three levels by dividing their length into three parts (proximal, middle and distal). For 
each third, chordal thickness and distance in-between were scored. This detailed information especially 
for chordal separation was not obtained by Wilkins score which may explain absence of correlation 
between both scores for assessment of subvalvular apparatus. Chordal calcification was not included in 
our RT3DE score because in patients with chordal calcification, the MV leaflets are always heavily 
calcified and thus unfavorable for PTMV. Chordal thickening and fusion is a good independent 
predictor for successful PTMV. This may explain the residual higher transmitral gradient despite 
successful PTMV in 12 patients (16.6%). with subvalvular affection that was considered low by 
Wilkins score, while by RT3DE score, it was moderate to severe. Chordal separation can be used as a 
marker of successful PTMV16. 
5) Retrospective analysis of MV morphology score before PTMV by both RT3DE and 2DE showed that 
the severe subvalvular RT3DE score was associated with poor outcome after 1 year (expressed by 
recurrent symptoms and increased transmitral gradient). Also, moderate and severe calcification 
RT3DE score was associated with the need for repeat PTMV and MV surgery. In both conditions, 2DE 
underestimated the severityof calcification and subvalvular scores.   
6) The detailed morphological assessment of MV will help in proper selection of therapeutic strategy for 
significant MS. Prediction of PTMV success and complications could be detected more accurately by 
RT3DE score than by Wilkins score. 
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7) The RT3DE score is simple and more helpful particularly for less experienced operators as it provides a 
simple number for each leaflet scallop and subvalvular apparatus segment separately. This was evident 
by good interobserver variability for most of the score components. 
The new RT3DE score may not superior to the standard Wilkins’ score and it will not replace it at the current 
time but at least the study paved the way to standardize RT3DE in future and to achieve both quantitative and 
qualitative assessment of the MV. The time spent for analysis of RT3DE images is slightly longer than with 2D 
images, however the benefits of its application compensate this time   
 
Study Limitation: 
The number of RT3DE score points is high due to the detailed information given for each MV leaflet scallop and 
chordal segment however, its simplicity and clear definition of grades of severity overcame the increased score 
points. Application of RT3DE is easy in patients with sinus rhythm because its analysis depends on a full 
volume images. Due to variability of R-R interval in atrial fibrillation, full volume could not be obtained well 
and application of RT3DE score needs 3D images from multiple views. Although arrhythmias such as atrial 
fibrillation was considered in the past as a limitation for RT3DE image acquisition, the current ultrasound 
systems which allow for 7 subvolumes per beat and late experience found that this is not a limitation anymore.  
The study included patients with good 2DE image quality, however RT3DE assessment of MV could be 
obtained in 80% of general population irrespective of image quality11. With the advance in software and 
transducers, it is expected that the number of good analyzable studies will increase in the future. The new 
transesophageal RT3DE was not used because it was not available during the study accomplishment. However, 
no standard score by the transesophageal 2DE to compare with the transesophageal RT3DE. PTMV procedure 
was done using Inoue balloon and other devices (double balloon and metallic valvulotome) were not used. 
However, the comparison between these devices is beyond the study aim      
 
Conclusions 
The new proposed RT3DE score for morphological assessment of MV was applied for the assessment of MS 
patients and compared to 2DE Wilkins score. It shows more valuable information to the morphological 
assessment of the MV and should be the preferred score for proper selection and outcome prediction of PTMV. 
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ABSTRACT 
Aim: Assessment of pulmonary valve (PV) and right ventricular outflow tract (RVOT) using real-time 
3-dimensional echocardiography (RT3DE). 
Methods: Two-dimensional echocardiography (2DE) and RT3DE were performed in 50 patients with 
congenital heart disease (mean age 32  9.5 years, 60% female). Measurements were obtained at 
parasternal views: short axis (PSAX) at aortic valve level and long axis (PLAX) with superior tilting. 
RT3DE visualization was evaluated by 4-point score (1: not visualized, 2:  inadequate, 3: sufficient, 
and 4: excellent). Diameters of PV annulus (PVAD), and RVOT (RVOTD) were measured by both 
2DE and RT3DE, while areas (PVAA) and (RVOTA) by RT3DE only. 
Results: By RT3DE, PV was visualized sufficiently in 68% and RVOT excellently in 40%. PVAD and 
PVAA were measured in 88%. RVOTD and PVAD by 2DE at PLAX were significantly higher than 
PSAX (P <0.0001) and lower than that by RT3DE (P <0.001).  
Conclusion: RT3DE helps in RVOT and PV assessment adding more details supplemental to 2DE. 
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INTRODUCTION 
The right ventricular outflow tract (RVOT) extends from the antero-superior aspect of the right 
ventricle to the pulmonary artery (PA), and includes the pulmonary valve (PV). It is best imaged by 2-
dimensional echocardiography (2DE) from the parasternal long axis view angulated superiorly and the 
parasternal short axis at the base of the heart. It can also be imaged from the subcostal long and 
transverse windows and the apical window 1. Visualization of the PV leaflets by 2DE in long axis is 
limited especially in adults because 2DE images only one or two leaflets well and a short axis view 
often is not obtainable 2. The level of RVOT obstruction can be determined using pulsed Doppler and 
color flow to identify the anatomic site at which the flow velocity increases and the post-stenotic flow 
disturbance appears. The obstruction itself may be depicted on 2DE as a muscular subpulmonic ridge, 
as deformed doming PV valve leaflet or as narrowing in the PA 2. Transesophageal echocardiography 
helps in imaging RVOT from a high esophageal position at 0o rotation with a long axis view of the PA 
from the valve plane to its bifurcation. The PV also may be visualized in the 90o long axis plane. The 
PV is seen in its perpendicular relationship to the aortic valve in the far field of the image, so it remains 
virtually impossible to assess the precise morphology of valve cusps or its commissures 3. Magnetic 
resonance imaging may add to the assessment of the obstruction level, PA size and may detect other 
associated lesions such as PA stenosis and coexisting pulmonary regurgitation 4. Until now, it has not 
been possible to visualize all three leaflets of the PV simultaneously by non-invasive diagnostic tools 
except in rare cases in which the valve pushed interiorly 5. The introduction of 3-dimensional 
echocardiography (3DE) helps in displaying the intracardiac anatomy in views that are similar to the 
ones encountered during operation 6. With more advances in the techniques, probe and software, it is 
now possible to assess intracardiac structure and function accurately within a reasonable time with the 
real-time 3DE (RT3DE). We hypothesize that RT3DE will clarify the knowledge of PV anatomy and 
RVOT by direct visualization from all aspects. The study aimed to use RT3DE in assessment of the 
morphology of pulmonary valve (PV) and right ventricular outflow tract (RVOT) and comparing its 
measurements with that obtained by 2DE.  
 
SUBJECTS and METHODS 
 
Fifty patients (mean age 32  9.5 years, 60% female) (Table 1) referred for echocardiography lab for 
evaluation of adult congenital heart disease. All patients were in sinus rhythm. In all 2DE was done 
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with the patient in the left lateral decubitus position using both apical and parasternal views with a 
commercially available ultrasound system (Philips Sonos 7500 with 3.5 MHz probe, Best, The 
Netherlands). RVOT and PV were examined at parasternal short axis (PSAX) view at aortic valve level 
and parasternal long axis (PLAX) with moving transducer towards the base angulating superiorly. The 
subtotal short axis view at aortic valve level was used instead of parasternal one in 10 cases. Zooming 
was used to clarify images and minimize artefacts. The following variables were measured in each 
patient 7: (1) RVOT diameter (RVOTD) measured just proximal to the PV at both views at its maximal 
width (end-diastole), (2) PV annulus diameter (PVAD) at same frame, (3) proximal PA diameters 
(PPAD), and (4) distal PA diameters (DPAD) just before its bifurcation. Measurements were obtained 
only from good image quality without echo dropout. 
Table 1: Distribution of congenital heart defects in studied patients 
 
Type of congenital defect Number of patients (%) 
  
Atrio-ventricular septal defect (AVSD) 13 (26%) 
Valvular Pulmonary stenosis (PS) 7 (14%) 
Post defect closure 7 (14%) 
Atrial septal defect (ASD) 5 (10%) 
Atrial septal defect + Ventricular septal defect 4 (8%) 
Transposed great arteries (TGA) 4 (8%) 
Ventricular septal defect (VSD) 3 (6%) 
Ebstein’s anomaly 2 (4%) 
Coronary AV fistula 2 (4%) 
Normal 2 (4%) 
Fallot’s tetralogy 1 (2%) 
 
Transthoracic RT3DE 
RT3DE was done by the same ultrasound system attached to a X4 matrix array transducer, 
capable of providing real-time B-mode images. 3D images were collected approximately within 5-7 
seconds of breath holding in full volume mode. The 3D data set was transferred to an offline analysis 
software package (TomTec, Munich, Germany). Data were stored digitally and subsequently evaluated 
by two blinded observers (AMA, JMcG). Data analysis of 3D echo imaging had been based on a 2D 
approach relying on the echo images obtained from both views (PSAX and PLAX). By using the crop 
function for image formatting, multiple sections through the scanned volume were done. We selected 
the narrowest slice to enable visualization of RVOT and PV from both aspects (proximal ventricular 
and distal pulmonic). RT3DE gain and brightness were adjusted to improve delineation of anatomic 
structures. The relevant features of RVOT, PV, PPA and DPA were checked and classified according 
to a subjective 4-point scale for image quality (1= not visualized, 2 = inadequate, 3 = sufficient and 4 = 
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excellent). By manual tracing of the inner border of RVOT and the PVA, the surface area was 
automatically delineated and could be visualized from different points of view. The following measures 
were obtained: (1) RVOTD included maximum RVOTD (max RVOTD) defined as the widest diameter 
of the RVOT, and minimum RVOTD (min RVOTD) defined as the shortest diameter of the RVOT, (2) 
RVOT area (RVOTA): measured at its maximal width (end-diastole), (3) PVAD: included two 
diameters: included maximum PVAD (max PVAD) defined as the widest diameter of the PVA, and 
minimum PVAD (min PVAD) defined as the shortest diameter of the PVA, (4) PVA area (PVAA): 
measured at its maximal width (end-diastole), and (5) PPAD, DPAD. 
 
STATISTICAL ANALYSES  
All data obtained by 2D TTE and RT3DE were presented as mean  SD to determine whether the 
difference in values between both techniques was statistically significant or not. A paired sample t-test 
was performed for comparing between means of variables. The level of significance was set to P <0.05. 
Interobsever agreement for visualization score was estimated using kappa values for each morphologic 
feature and classified as excellent with value of 0.93-1.0, very good 0.81-0.92, good 0.41-0.60 8. For 
2DE measurements, a random sample consisted of 20 patients was selected and t-test was applied for 
interobserver variability. Interobserver variability for RT3DE measurements in all patients was 
estimated according to the Bland and Altman method 9. 
 
RESULTS 
RVOT and PV by 2DE 
Higher percentage of clear visualization and measurements of RVOT and PVA could be obtained from 
the PLAX view than from the PSAX view. RVOTD could be measured from the PLAX view in 28 
patients (56%) and in 26 patients (52%) from the PSAX view. PVAD was measured in 48 patients 
(96%) from the PLAX view and in 46 patients (92%) from the PSAX view. PPAD and DPAD were 
recorded from both views in equal percentage (78% for PPA and 42% for DPA). Measurements of 
RVOTD and PVAD from both views correlated well (Figure 2A,D). However, RVOTD and PVAD 
were significantly higher as measured from the PLAX view than from the PSAX (P <0.0001).  
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RVOT and PV by RT3DE 
Acquisition and analysis of RT3DE data were performed successfully within 5-7 minutes per patient. 
RVOT was visualized excellently in 20 patients (40%) and not visualized in 24 patients (48%). Its 
shape appeared as an oval shape and not completely circular (Figure 1A). Calculated RVOTA, max 
RVOTD and min RVOTD were obtained in 26 patients (52%). The mean RVOTA was 41.5  33.4 
mm. PVA was visualized excellently in 44 patients (88%) and was not visualized in two patients (4%). 
The mean PVAA was 33.5  30.1 mm. PV was visualized sufficiently in 34 patients (68%) and 
excellently in 12 patients (24%). The number, thickness and mobility of cusps could be studied in 35 
patients (70%). Bicuspid pulmonary valve was seen in 3 patients. The diagnosis of the three patients 
was transposed great arteries, Fallot’s tetralogy, and pulmonary stenosis. Pulmonary valve 
commissures and lines of closure were seen in 35 patients (70%) (Figure 1C,D). Pulmonary valve area 
could not be obtained well in a considerable number of patients with high interobserver variability.  
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Comparison of 2DE and RT3DE 
The RT3DE quadscreen showed that RVOTD obtained by 2DE from PSAX view was perpendicular on 
the max RVOTD and parallel to the min RVOTD, while RVOTD obtained from PLAX was parallel to 
the max RVOTD but was not extended to the annular ends. The same findings were found for PVAD 
(Figure 1A,B). Measurements of RVOTD with 2DE and RT3DE were significantly correlated with each 
other (Figure 2B,C), and also for PVAD (Figure 2E,F). The max RVOTD was significantly larger than 
RVOTD measured by 2DE from both views (P <0.0001), while the min RVOTD was comparable to 
RVOT measured from PSAX view (P = 0.8). PVAD measurement by RT3DE was significantly larger 
than that measured by 2DE from both views (P <0.0001). The value for RT3DE application in 
comparison with 2DE is shown in Table 4. 
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PPA and DPA by 2DE and RT3DE 
Measurements of PPAD and DPAD were equal in both 2DE views (PSAX and PLAX). By RT3DE, 
PPA was excellently visualized in 29 patients (58%) and sufficiently in 10 patients (20%). DPA was 
excellently visualized in 15 patients (30%) and not visualized in 27 patients (54%) (see Table 3). 
Measurements of PPAD and DPAD by 2DE and RT3DE were comparable (see Table 2). 
Table 2: Measurements of 2DE and RT3DE 
 2DE (PLAX) 2DE (PSAX) RT3DE P value * P value ** 
      
 
RVOTD (mm) 
 
19.7  7.7 
 
16.4  6.8 
22.2  10.0 (max) 
15.7  6.2 (min) 0.0001 0.001 
PVAD (mm) 16.4  7.3 13.5  6.1 19.4  9.1 0.0001 0.0001 
PPAD (mm) 18.3  7.1 18.1  7.1 17.4  5.3 NS NS 
DPAD (mm) 19.3  9.1 19.1  8.0 18.6  6.4 NS NS 
2DE: 2 dimensional echocardiography, PLAX: parasternal long axis, PSAX: parasternal short axis, 
RT3DE: real-time 3-dimensional echocardiography, DPAD: distal pulmonary artery diameters, PPAD: 
proximal pulmonary artery diameter, PVAD: pulmonary valve annulus diameter, and right ventricular 
outflow tract (RVOT). 
* P value between 2DE measurements at both views (PLAX and PSAX) 
** P value between measurements of RT3DE and 2DE at PLAX 
 
 
Table 3: Scores for RT3DE visualization of RVOT, PVA, PV, PPA and DPA 
  
Score RVOT PVA PV PPA DPA 
      
Excellent (4) 20 (40%) 44 (88%) 12 (24%) 29 (58%) 15 (30%) 
Sufficient (3) 6 (12%) 4 (8%) 34 (68%) 10 (20%) 8 (16%) 
Inadequate (2) 0 (0%) 0 (0%) 4 (8%) 0 (0%) 0 (0%) 
Missed (1) 24 (48%) 2 (4%) 0 (0%) 11 (22%) 27 (54%) 
Median score 2.4 3.8 3.1 3.1 2.2 
Mean score 2.4  1.4 3.8  0.6 3.2  0.6 3.2 0.5 2.2  1.4 
  
Abbreviations: DPAD: Distal pulmonary artery, PPAD: proximal pulmonary artery, PV: Pulmonary 
valve, PVA: pulmonary valve annulus and RVOT: right ventricular outflow tract. 
  
Interobsever correlation and agreement  
The agreement for visualization score by RT3DE was fair for the assessment of PV (Kappa value: 
0.59), good for RVOT (Kappa value: 0.71) and very good for PVA, PPA and DPA (Kappa value: 
0.91). Excellent interobserver correlation was found for RT3DE measurements (r = 0.94, P <0.0001) 
for RVOTD, and PVAD. Excellent interobserver correlation also was found for 2DE (r = 0.98, P 
<0.0001) for RVOTD and PVAD. According to the Bland - Altman analysis of agreement, the mean 
differences were (mean difference: - 0.15  1.4, agreement: 2.65 - 2.95; p = 0.7) (mean difference: - 
0.57  1.90, agreement: 3.33 - 4.37; p = 0.09) (mean difference: 0.08  1.5, agreement:  3.08 - 2.92; P 
 100
Pulmonary valve and right ventricular outflow tract 
= 0.7) (mean difference: - 0.40  1.90, agreement:  3.40 - 4.20; P = 0.1) for RVOT by 2DE, PVAD by 
2DE, RVOT by RT3DE, and PVAD by RT3DE, respectively (Figure 3, 4). 
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DISCUSSION 
The study applied RT3DE for the assessment of PV and RVOT morphology and compared its 
measurements to those obtained with 2DE. This assessment could be obtained excellently or at least 
sufficiently in a higher percentage of patients. The main findings of our study are (1) RVOT shape was 
not circular but oval, (2) RVOTA and PVAA could be measured by RT3DE, and (3) RT3DE 
measurements of RVOTD and PVAD were higher than 2DE measurements. Assessment of PV and 
RVOT is of clinical importance because the understanding of normal morphology and function helps in 
detection of anomalies and selection of therapeutic strategies. For example, in pulmonary stenosis, 
therapeutic strategy is totally dependent on RVOT and PV morphology and function. The incidence of 
anomalies included within the term of pulmonary stenosis varies between 10.7% and 30% of all 
congenital heart defects 10,11. Despite this incidence, the pulmonary valve is the least studied valve. Its 
assessment is totally dependent on 2DE, but images often less satisfactory in adolescents and adults 7. 
The use of pulsed and continuous wave Doppler helps in accurate estimation of subvalvular and 
transvalvular pressure gradients for detection of pulmonary stenosis and selection for balloon 
valvuloplasty 12. Several methods have attempted to accurately characterize PV morphology and 
detailed anatomy 13. Kinelitze et al used bright blood cine magnetic resonance to visualize leaflets of 
the valve in 14 patients following Ross operation and he achieved good visualization with signal to 
noise ratio 7.5  2.2 in patient group versus 9.8  3.0 in normal control group 14. Berdajs et al 
constructed a geometric model of the pulmonary root in 20 normals. By morphometric measurements 
of the distances between commissures and between intervalvular triangles, they described the 
asymmetrical structure of pulmonary root 15. The current study shows that measurement of PVAD and 
RVOTD by 2DE according to the standard echocardiographic views leads to significant 
underestimation in comparison with RT3DE measurements. This could be explained by the fact that 
2DE measures the distance from the basal attachment of one leaflet to the basal attachment of adjacent 
leaflet and these lines do not necessarily span the full diameter of RVOT but provide a tangential 
profile of the outlet 16. Lines of RVOTD and PVAD measurements from PSAX view are perpendicular 
on the max RVOTD and PVAD by RT3DE. Thus, if 2DE is the only available method for PV and 
RVOT assessment, PLAX view should be used due to better visualization, and more alignment with 
RT3DE measurements of RVOTD and PVAD than PSAX. The study showed that RT3DE achieved 
excellent visualization of PVAA and calculation of its diameters in 88% of patients. In contrast, RVOT 
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visualization and diameter measurement was not optimal and this may be due to tissue dropout and 
gain adjustment during acquisition. The PV visualization was sufficiently achieved in 92% of patients. 
The number, thickness and mobility of leaflets could be clearly visualized in 70% of patients. 
Commissures and direction of closure lines also could be visualized. Since calculation of PV area was 
not obtained well in considerable number of studied group and had wide interobserver variability, it 
was excluded from further analysis. This may be due to multiple levels at which area could be 
calculated as well as time points; no standardized method is available. Providing these data potentially 
constitute future application of RT3DE in a wider clinical routine and may enhance understanding 
valve morphology by providing accurate measurements necessary for selection of proper management 
(balloon valvuloplasty, surgical valvotomy, stented pulmonary valve or valve replacement). Another 
advantage of RT3DE application was visualization of PPA in 78% of patients and DPA in 46% of 
patients, which may help in visualization of supravalvular stenosis (by measuring luminal reduction 
and level(s) of stenosis), post-stenotic dilatation (by measuring % of luminal dilatation) or evaluation 
prior to surgery (shunts or correction). 
Limitation of study 
 
The study was conducted in a small number of patients characterized by heterogeneous congenital heart 
defects. The age of patients 32  9.5 years affected the image quality of 2DE and RT3DE leading to 
significant difficulties in visualization of the RVOT. The data of the studied patients were not 
correlated with direct surgical visualization because a considerable number of patients were studied 
after corrective surgery or surgery was not the selected therapeutic strategy.  
Perspective 
 
The clinical value of RT3DE has to be validated in future studies by including selected group of 
patients with pulmonary stenosis with reference to intraoperative findings or MRI. For example a 
comparison of PV area by RT3DE at various levels to surgical findings could be helpful to develop a 
standardized approach to PV assessment. 
CONCLUSION 
RT3DE could help in clarification of detailed anatomy of RVOT and PV beyond the scope of 
established 2DE. A detailed assessment may provide a basis for proper selection of therapeutic 
strategy.  
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ABSTRACT 
Background: Determination of left atrial (LA) size and function is important in clinical decision-
making. Calculation of LA volume (LAV) is the most accurate index of LA size.   
Aim: To compare real-time 3-dimensional echocardiography (RT3DE) and 2-dimensional 
echocardiography (2DE) for calculation of LAV and function. 
Methods: Fifty patients were studied using 2DE and RT3DE for calculating LAV including: 
Maximum (Vmax), minimum (Vmin) and pre atrial contraction (VpreA) volumes. For 2DE, the 
formula: LAV = 8 (A1) (A2)/3  (L) was used, while for RT3DE, offline analysis was performed using 
commercially available software. LA function indices including total atrial stroke volume (TASV), 
active ASV (AASV), total atrial emptying fraction (TAEF), active AEF (AAEF), passive AEF (PAEF), 
and atrial expansion index (AEI) were calculated. 
Results: Patients were classified into 2 equal groups: group I with normal Vmax (<50ml) and group II 
with Vmax (50ml). Good correlation was obtained between RT3DE and 2DE for LAV (r = 0.64, P = 
0.001) in group I and (r = 0.83, P <0.0001) in group II. In group I, LAV and functions showed no 
significant difference by both techniques, while in group II, the Vmin and VpreA were significantly 
lower by RT3DE than 2DE (P = 0.009, 0.006). TAEF, AEI, and PAEF indices were significantly 
higher by RT3DE than 2DE in group II. 
Conclusion: RT3DE provides a reproducible assessment of active and passive LA function by 
volumetric cyclic changes. It is comparable and may be superior to 2DE due to its higher sensitivity to 
volume changes. 
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INTRODUCTION 
The left atrium (LA) serves as a reservoir, a conduit and a booster pump for blood returning from the 
lungs to the heart. Changes in LA size and function are associated with cardiovascular disease and are 
risk factors for atrial fibrillation, stroke and death (1-3). Echocardiography is the most commonly used 
non-invasive imaging technique for estimation of LA size. The M-mode measurement of the LA 
antero-posterior dimension as indicator for size has several limitations due to geometric assumption 
made about LA shape and due to slightly diverging position and orientation of imaging planes (4). It has 
been suggested that LA volume (LAV) may be a superior index for LA size (5). Two-dimensional 
echocardiographic (2DE) derived LAV has been shown to provide a more accurate assessment of LA 
size than M-mode but the problem of geometric assumption still remains (6,7). Three-dimensional 
echocardiography (3DE) has demonstrated superior accuracy for measuring left ventricular volume 
comparable to conventional 2DE and the 3DE reconstruction has been validated for LAV 
quantification (8-10). Real-time 3DE (RT3DE) allows fast acquisition from a single acoustic window of 
dynamic pyramidal data structure that encompasses the entire heart (11). The purpose of the present 
study was to compare between 2DE and RT3DE for calculation of LAV and assessment of LA function 
in normal-sized and dilated LA. 
 
METHODS 
 
The study retrospectively comprised randomly selected fifty patients in sinus rhythm with good 2DE 
image quality. A standard 2DE and RT3DE examinations were performed for all patients.  
Transthoracic 2DE 
2DE was undertaken with the patient lying in the left lateral decubitus with quite respiration using 
both apical and parasternal views. 2DE studies were performed using a 3.5 MHZ probe and a 
commercially available ultrasound system (Philips Sonos 7500, Best, The Netherlands). The following 
measures were taken: LA area at apical 4-chamber view (A1) by manual tracing of LA endocardial 
border. The superior border of atrial outline was a straight line connecting both sides of the mitral 
leaflet base attachment points. Both the atrial appendage and the pulmonary veins were excluded when 
visualized, LA area at apical 2-chamber (A2) with same tracing, and LA long axis (L): defined as the 
distance of the perpendicular line measured from the middle of the plane of mitral annulus to the 
superior aspect of LA in both 4 and 2-chamber views and the shortest of both lines was used (Figure 1). 
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LAV was calculated according to the formula(12): Volume = 8(A1) (A2) / 3 (L) at 3 phases of 
ventricular cardiac cycle: 1) maximum volume (V max): at end-systole, the time at which atrial volume 
was largest just before mitral valve opening, 2) minimum volume (V min): at end-diastole, the time at 
which atrial volume at its nadir before mitral valve closure, and 3) volume before atrial contraction (V 
pre A): the last frame before mitral valve reopening or at time of P wave on ECG. From the three 
volumes, the following measurements were selected as indices of LA function and calculated according 
to previous studies (13, 14): 
 1) Total Atrial Stroke Volume (TASV):  V max – V min. 
 2) Total Atrial Emptying Fraction (TAEF): TA SV/ V max x 100 
 3) Active Atrial Stroke Volume (AASV): V pre A – V min. 
 4) Active Atrial Emptying Fraction (AAEF): AA SV/ V pre A x 100 
 5) Atrial Expansion Index (AEI): TASV / V min x 100. 
 6) Passive Atrial Emptying Fraction (PAEF): (V max – V pre A) / V max x 100 
 
Fig 1: Calculation of LAV using 2DE by manual tracing of LA endocardial border at apical 4 
chambers (A1) and apical 2 chamber views (A2), L is the long axis, then apply the formula. 
 
Transthoracic RT3DE 
RT3DE was performed also with the patient lying in the left lateral decubitus using 4 MHZ 
transducer capable of providing real-time B-mode and colour-Doppler using same ultrasound system. 
The system scans a 60 o x 30 o 3D pyramid of data. 3D images were collected in full volume mode 
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approximately within 5-7 seconds of seconds of breath holding in expiration. The 3D data were 
transferred to an offline Q-lab system for analysis. Data were stored digitally and subsequently 
analysed. Analysis of 3D echo imaging had been based on a 2D approach relying on the echo images 
obtained from the apical views and on a semi automated tracing of endocardial border. This is 
performed by mark 5 points in the atrial surfaces of mitral annulus: at anterior, inferior, lateral and 
septal annuli and the 5th point at apex of LA. Once this is completed, the endocardial surface was 
automatically delineated and a mathematical model of the LA could be visualized from different points 
of views and the LAV calculation was obtained (Figure 2). Manual modification was made to correct 
the automatic tracings if needed. LAV was measured at the same phases as measured by 2DE and the 
same measurements calculated. All the recorded images were analysed at different times by two 
independent echocardiographers. The same images were also analyzed on a different day by one of 
these same observers. 
 
Fig 2: Calculation of LAV using RT3DE by automatic tracing using Q lab software. Upper 2 images is 
apical 4 chamber and 2 chamber views, by marking 5 points, the whole LA cast was obtained. 
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STATISTICAL ANALYSES  
All values of LAV and its functions were expressed as mean  SD. Paired sample t-test was 
performed to determine whether the difference in the values between 2 methods was significant or not. 
The level of significance was set to p<0.05. Regression analysis for detection of correlation between 
both techniques for all values, the correlation considered being significant <0.05 level. The statistical 
package used was SPSS version 12.1. Pearson’s coefficient was used for inter and intraobserver 
correlation between all LAV by both techniques. Interobserver agreement was studied according to 
Bland and Altman method (15). 
 
RESULTS 
A total of 50 patients with mean age 43.6  9.3 years and male percentage 66% were included 
in this study. The baseline criteria of all patients are listed in (Table 1). Calculation of LAV was 
obtained by 2DE in all patients within 10 minutes as mean time for every patient. According to V max, 
patients were classified into 2 equal groups: group I included patients with V max <50 ml, and group II 
included patients with V max 50 ml. There were no significant differences between both groups in 
age and sex distribution. Mild mitral regurgitation was present in 11 patients: 3 patients (12%) in 
Group I, 8 patients (32%) in Group II. Cardiac abnormalities (hypertension, coronary artery disease, or 
cardiomyopathy) were detected in 20 patients (80%) in Group II, whereas in Group I only 5 patients 
(20%) had cardiac abnormalities.  
Table 1:  Baseline criteria for all patients in both groups 
 
Total patients  
n= 50 
Group I  (V max < 
50 ml) n= 25 
Group II (V max ≥ 
50 ml) n= 25 
Age (year) 43.6  9.3 42.2  7.5 44.8  8.5 
Male Gender (%) 33 (66%) 17 (68%) 16 (66%) 
Clinical Diagnosis       
  Normal 
  Hypertension 
  Coronary disease 
  Cardiomyopathy 
 
25 (50%) 
13 (26%) 
7 (14%) 
5 (10%) 
 
20 (80%) 
3 (12%) 
2 (8%) 
0 (0%) 
 
5 (20%) 
10 (40%) 
5 (20%) 
5 (20%) 
Mitral regurgitation 
  None 
  Mild (grade 1) 
 
39 (78%) 
11 (22%) 
 
22 (88%) 
3 (12%) 
 
17 (68%) 
8 (32%) 
Medications 
 None 
 B-Blockers 
 ACE/I 
 Ca channel blocker 
 Nitrates 
 
25 (50%) 
2 (4%) 
9 (18%) 
9 (18%) 
5 (10%) 
 
20 (80%) 
0 (0%) 
2 (8%) 
3 (12%) 
0 (0%) 
 
5 (20%) 
2 (8%) 
7 (28%) 
6 (24%) 
5 (20%) 
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Both groups were compared to each other with respect to cyclic changes of LAV during the 
cardiac cycle and indices of functions were calculated (see Table 2). The three LAV were increased in 
group II, and thus TASV was nearly twice as large in group II than group I. All indices of active LA 
functions including TAEF, AAEF, and AEI were lower for group II indicating an impaired LA 
function.  
Table 2: Values of LAV and parameters of LA function in both groups using RT3DE and 2DE 
 
Group I  (V max< 50 ml) n= 
25 
Group II (V max≥ 50 ml) n= 
25 P value P value 
 RT3DE 2DE RT3DE 2DE * ** 
       
V max  37.1  11.5 38.2  10.7 79.1  26.4 84.2  33.6 NS NS 
V min  15.6  6.1 17.7  8.1 39.7  17.8 46.8  21.4 0.05 0.009 
V pre A  23.5  8.1 25.0  7.6 52.0  17.3 61.0  23.5 NS 0.006 
TSV  21.5  10.2 20.4  7.0 39.3  15.7 38.4  18.1 NS NS 
TA EF  56.3  15.6 55  14% 50.5  13.4 46.1  13.2 NS 0.04 
AA SV  8.0  6. 7.3  4 12.2  6.1 15.0  7.3 NS NS 
AA EF 30.2  28.1 31.4  17.8 25.7  14.0 26.4  12 NS NS 
AEI  17.0  12 14.2  7.4 11.5  5.4 9.4    4.0 NS 0.04 
AP EF  34.1  10.1 34.0  10.1 33.6  10.3 26.8  12.1 NS 0.01 
 
RT3DE acquisition: 
All RT3DE examination was carried out successfully and automatic tracing was possible. The 
acquisition time for RT3DE dataset was 15 seconds. Calculation of LAV was obtained within 5-7 
minutes per patient depending on image quality. LAV in group II was twice as large as group I. Indices 
of active LA function including (AAEF, AEI) were significantly less than group I. 
Comparison of 2DE and RT3DE 
There was a good correlation between both techniques for the three LAV measurements (r = 
0.64, P = 0.001) in group I and (r = 0.83, P < 0.0001) in group II. The results of linear regression 
analysis for both techniques are shown in Figure 3. By comparing the absolute figures of LAV and 
indices of function by both techniques, the values of RT3DE were not significantly different from that 
measured by 2DE either for LAV or function in group I. In group II, however the V min and V pre A 
were significantly lower by RT3DE than by 2DE and this was reflected on TAEF, AEI and PAEF 
indices which became higher by RT3DE than by 2DE (see Table 2). 
Observer agreement 
There was excellent concordance for the three LAV analysed between two independent 
observers (r = 0.97, P <0.0001) for RT3DE and (r = 0.98, P < 0.0001) for 2DE (Figure 3). According 
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to the Bland and Altman principle, 2DE showed good agreement with V min (mean difference: - 0.26  
3.17, agreement = - 6.6, 6.08) but with V max and V Pre A, the agreement was less (mean difference: 
6.03  9.43, agreement = - 12.83, 24.89) and (mean difference: 1.71  4.31, agreement = - 6.91, 10.33) 
respectively. Interobserver agreement for RT3DE was good in the three LAV. For V max, mean 
difference: 1.34  4.34, agreement = - 7.34, 10.02, for V pre A, mean difference: - 0.26  3.36, 
agreement = - 6.98, 6.56, and for V min, mean difference: 0.19  3.29, agreement = - 3.10, 3.48) 
(Figure 4,5,6). Intraobserver correlation was (r = 0.90, p<0.0001) and (r = 0.88, p < 0.0001) for RT3DE 
and 2DE respectively for the three LAV.  
Fig 3: Correlation between RT3DE and 2DE in calculation of the three LAV: V max, V min and V pre 
A in both groups  
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Fig 4: Interobserver agreement and correlation for measuring V max by 2DE and RT3DE 
 
Fig 5: Interobserver agreement and correlation for measuring V min by 2DE and RT3DE. 
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Fig 6: Interobserver agreement and correlation for measuring V pre A by 2DE and RT3DE. 
 
DISCUSSION 
This study showed feasibility and reproducibility of RT3DE in detection of cyclic changes in 
LAV and calculation of its function either in normal or dilated LA. Good correlation was found 
between RT3DE and 2DE. Studying LAV by RT3DE seems more logical because LA is a slightly 
tapered pillow shaped 3D structure without a natural long or short axis. Its shape can be distorted by its 
dilatation or dilatation of neighbouring structures. Hence, LAV measurement may be a better indicator 
of true LA size (5). The M-mode echocardiography for estimation of LA size is commonly used and 
widely accepted because of its simplicity and historical assumption that LA is spherical in shape but 
studies showed that it seriously underestimates the LA size (9,10). Use of 2D view to calculate LAV by 
single plane planimetry has limited reproducibility with a mean interobserver variability of 21% (16). 2D 
calculation of LAV by biplane method has a close correlation with LAV measured by cinecomputed 
tomography (17) and magnetic resonance imaging (MRI) (10). Reports about use of 3D reconstruction for 
calculation of LAV recommended its clinical application due to time saving and low interobserver 
variability (9) and its values are comparable to MRI (10). In the present study, the patients were classified 
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into normal and dilated LAV groups depending on large population study included 2041 normals and 
1274 abnormals where normal LAV was (47.35  17.38ml) and abnormal LAV was (50.8  19.3ml) 
(18). LAV was estimated by 2DE using biplane apical images and compared to values that obtained by 
RT3DE. In accordance with previous studies (4,10,19), it was found that there is a linear correlation 
between both techniques in calculation of LAV and function in normal or dilated LA. However, 2DE 
measurement of V min and V pre A was overestimated in the dilated LA group. Due to this 
overestimation, lower values of AA EF, AEI and AP EF were calculated. This in discordance with the 
previous study by Khankirawantana et al (9) which concluded that 2D calculation of LAV has a close 
correlation with 3D with underestimation of LAV especially if the volume was greater than 35 ml. The 
discrepancy between both studies is that they included LA appendage as a part of LA chamber, which 
was excluded by our measures. The overestimation of 2DE to cyclic changes in LAV may be due to the 
gain dependent nature of boundary echoes, which leads to inclusion of pulmonary veins or portion of 
appendage despite efforts to exclude them. With V min, both techniques showed higher interobserver 
agreement but with the larger volumes (V max and V Pre A), RT3DE showed better agreement than 
2DE. This also could be explained by difficulty in total exclusion of LA appendage and pulmonary 
veins by 2DE especially when LA dilates. This explanation was confirmed by previous studies that 
reported less clear visualization of LA appendage by 2DE than by 3D (20,21). 
 
Study Limitations  
We did not include LA appendage for calculation of LAV and function. Its variability in shape, its 
difficulty to measure and the lack for standard figures for its normal volume seems reasonable to 
exclude it. Also, the previous studies do not discuss the role of it (22,23). Another limitation with using 
RT3DE is total dependency on 2DE image quality and image artefacts could be created by motion or 
ectopics. 
 
CONCLUSION 
RT3DE provides an accurate measurement of LAV and function and could be considered as feasible 
and reproducible method for its clinical application. The visualization of LA in 3D shape independent 
of geometric assumption favours its use.                        
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ABSTRACT 
Background: The Frank-Starling law describes the relation between left ventricular volume and 
function. However, only a few studies described the relation between left atrial volume (LAV) and 
function. 
 
Objective: To describe a LA Frank-Starling law by studying changes in LAV measured by real-time 
three-dimensional echocardiography (RT3DE). 
 
Methods: LAV was calculated by RT3DE in 70 patients at end-systole (LAVmax), end-diastole 
(LAVmin) and pre-atrial contraction (LAVpre-A). According to LAVmax, patients were classified into 
three groups: LAVmax <50 ml (group I), LAVmax 50 to 70 ml (group II), and LAVmax >70 ml (group 
III). Calculated indices of LA pump function were active atrial stroke volume (SV) defined as LAVpre-A 
– LAVmin and active atrial emptying fraction (EF), defined as active atrial SV / LAVpre-A x 100%
 
Results: Active atrial SV was significantly higher in group II than in group I (mean (SD) 19.0 (9.2) vs. 
8.2 (4.9) ml, P <0.0001), in group III it was non-significantly lower compared to group II (16.7 (12.5) 
vs. 19.0 (9.2) ml). Active atrial SV correlated well with LAVpre-A (r = 0.56, P <0.0001), but decreased 
with larger LAVpre-A. Active atrial EF tended to be higher in group II than in group I (43.1 (18.2) vs. 
33.2 (17.5), P < 0.10), in group III it was significantly lower than in group II (26.2 (18.5) vs. 43.1 
(18.2), P <0.01). 
 
Conclusion: A Frank-Starling mechanism in the LA could be described by RT3DE, shown by an 
increase in LA contractility in response to an increase in LA preload up to a point, beyond which LA 
contractility decreased. 
Left atrial Frank-Starling law assessment 
INTRODUCTION 
The Frank-Starling law, describing the relationship between increased length of myocardial fibres and 
its mechanical performance, is important for cardiac function 1. The relation between myocardial 
preload and mechanical performance is described by a curve in which an upward position on the curve 
means increased performance, while a downward position means decreased myocardial performance 2. 
Assessment of left atrial (LA) function has important therapeutic and prognostic value 3. The 
instantaneous LA pressure-volume relation provides an accurate index of LA contractility 4. However, 
measurement of this index is invasive and technically difficult and therefore not suitable for routine 
clinical application 3. Non-invasive assessment of LA contractility has been studied by two-
dimensional echocardiography, Doppler parameters, cine computed tomography, radionuclide methods, 
and magnetic resonance imaging 5-9. In previous studies it was suggested that a Frank-Starling 
mechanism also existed in the human LA 10-12.  The LA serves as a reservoir, conduit and booster pump 
for blood returning from the lungs to the heart. LA volume (LAV) is a superior index of LA size 13 and 
owing to complex LA anatomy it may echocardiographically be best assessed by three-dimensional 
echocardiography 14,15. This study aimed at describing  LA Frank-Starling law by studying changes in 
LAV measured by real-time three-dimensional echocardiography (RT3DE). 
 
METHODS 
The study comprised 70 clinically stable patients (mean age 45.6  9.3 years, 66% males) in sinus 
rhythm without atrio-ventricular or intra-ventricular conduction abnormalities on a resting 12-lead 
electrocardiogram. Nineteen patients (27%) were not known with cardiovascular disease, 20 patients 
(29%) had essential hypertension, 16 patients (23%) had coronary heart disease, and 15 patients (21%) 
had non-compaction cardiomyopathy. None of these patients had mitral stenosis or significant (more 
than grade 1) mitral regurgitation. The patients were selected on good two-dimensional image quality. 
Transthoracic RT3DE 
RT3DE was performed with a Sonos 7500 ultrasound system (Philips Sonos 7500, Best, The 
Netherlands) attached to an X4 matrix array transducer capable of providing real-time B-mode images. 
Full volume three-dimensionsl images were collected within about 5-7 seconds of breath holding. 
Zoom function and gain adjustment were used to clarify the endocardial border. The probe position was 
modified to include the whole left atrium in the centre of the RT3DE image sector. The three-
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dimensional dataset was transferred to a Q-LAB system for offline analysis. Analysis of three-
dimensional images was based on a two-dimensional approach relying on the images obtained from an 
apical four-chamber view and on semi-automated tracing of the LA endocardial border for calculation 
of LAV. Tracing was performed by marking five atrial points: the anterior, inferior, lateral and septal 
mitral annuli and the LA apex. Once this was completed, the endocardial surface was automatically 
delineated and the LA model could be visualized from different points of views and LAV was obtained 
(Figure 1). Manual modifications were made to correct automatic tracings in the majority of patients, 
and in particular in patients with dilated LA to exclude the LA appendage and the pulmonary veins 
entrance from LAV. Borders that manifested as lines were traced in the middle of the line. In addition, 
careful attention was given to neighbouring well-visualized pixels as guidance for the true LA wall. 
 
Figure 1. Quad screen display of the Q-LAB analysis software showing methodology 
for left atrial volume calculation by marking the five left atrial points. 
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LAV Calculation 
LAV was measured at three phases of the cardiac cycle: (a) maximum volume (LAVmax) 
obtained from an end-systolic frame just before mitral valve opening, (b) minimum volume (LAVmin) 
obtained from an end-diastolic frame just before mitral valve closure, and (c) volume before atrial 
contraction (LAVpre-A) obtained from the last frame just before mitral valve reopening. 
 In accordance to previous studies 12,16, the following indices of LA function were assessed: (a) 
total atrial stroke volume (SV), defined as LAVmax - LAVmin, (b) total atrial emptying fraction (EF), 
defined as total atrial  SV / LAVmax x 100%, (c) active atrial SV, defined as LAVpre-A – LAVmin, (d) 
active atrial EF, defined as active atrial SV / LAVpre-A x 100%, (e) passive atrial SV, defined as 
LAVmax - LAVpre-A, (f) passive atrial EF as an index for LA conduit function, defined as passive atri
SV / LAV
al 
d as 
unction. 
max x 100%, and (g) atrial expansion index as an index for LA reservoir function, define
(LAVmax - LAVmin) / LAVmin x 100%. To characterize the three phases of LA activity, passive atrial 
SV and EF were defined as indices for LA conduit function, active atrial SV and EF for LA pump 
function, and atrial expansion index for LA reservoir f
Depending on LAVmax values, the patients were arbitrary classified into three groups: group I 
included 29 patients with LAVmax <50 ml, group II included 15 patients with LAVmax 50 to 70 ml, and 
group III included 26 patients with LAVmax >70 ml. 
  
STATISTICAL ANALYSES 
The statistical package used was SPSS version 12.1. All LAV values and its functions were expressed 
as mean (SD). An independent sample t-test was performed to determine whether the difference in the 
values was significant with a level of significance set to P <0.05. Interobserver agreements for LAVs, 
were expressed according to Bland and Altman method17.  
 
RESULTS 
Table 1 lists the baseline criteria of the different LAV groups. There were no significant differences in 
age and sex distribution between the groups. Mild mitral regurgitation was present in 19 patients: 4 
patients (14%) in group I, 5 patients (33%) in group II, and 10 patients (38%) in group III. All patients 
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in group II and III had cardiac abnormalities (hypertension, coronary artery disease, or 
cardiomyopathy), whereas in group I only 10 patients (34%) had cardiac abnormalities.  
Table 1: Baseline criteria of the studied left atrial volume groups. 
 
 
 
G I: Vmax <50 ml 
(n = 29) 
 
G II: Vmax 50 -70 ml 
(n = 15) 
 
G III: Vmax >70 ml 
(n = 26) 
    
Age 40.2  7.5 44.8  8.5 46.2  9.5 
Male gender (%) 17 (59%) 10 (67%) 19 (73%) 
Clinical Diagnosis 
  Normal 
  Hypertension 
  Coronary disease 
  Non-compaction CM 
 
19 (66%) 
7 (24%) 
3 (10%) 
0 (0%) 
 
0 (0%) 
10 (67%) 
5 (33%) 
0 (0%) 
 
0 (0%) 
3 (12%) 
8 (31%) 
15 (57%) 
Mitral regurgitation 
  None 
  Mild (grade 1) 
 
25 (86%) 
4 (14%) 
 
10 (67%) 
5 (33%) 
 
16 (62%) 
10 (38%) 
 
Calculation of LAV was obtained within 5-7 minutes for each patient. Absolute interobserver 
agreement for RT3DE was (mean difference 1.3 (4.3) ml, agreement - 7.3, 10.0 ml) for LAVmax, (mean 
difference - 0.3 (3.4) ml, agreement - 7.0, 6.6 ml) for LAVpre-A, and (mean difference 0.2 (3.3) ml, 
agreement - 3.1, 3.5 ml) for LAVmin (Figure 2). 
 
Figure 2.  Interobserver agreement for RT3DE measurement of the different left atrial volumes (LAV): 
maximum, minimum, and pre-atrial contraction according to the Bland and Altman principle. 
 
LA volumes in the different patient groups 
Figure 3 shows significant differences (higher values for patients with larger LAV) were noted for 
LAVmax in group I compared with II (36.3 (10.7) vs. 55.2 (5.7) ml, P <0.0001) and in group II 
compared with III (55.2 (5.7) vs. 92.0 (19.9) ml, P <0.0001), for LAVmin in group I compared with II 
(15.4 (5.5) vs. 23.1 (7.0) ml, P <0.0001) and in group II compared with III (23.1 (7.0) vs. 45.7 (15.9) 
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ml, P <0.0001), and for LAVpre-A in group I compared with II (23.6 (7.7) vs. 42.1 (9.6) ml, P <0.0001) 
and in group II compared with III (42.1 (9.6) vs. 62.4 (16.5) ml, P <0.0001). 
LA pump function  
Active atrial SV was significantly higher in group II than in group I (19.0 (9.2) vs. 8.2 (4.9) ml, P 
<0.0001), in group III it was non-significantly lower than in group II (16.7 (12.5) vs.19.0 (9.2) ml). 
Figure 4A shows that active atrial SV correlated well with LAVpre-A (r = 0.56, P <0.0001), but 
decreased with larger LAVpre-A. Active atrial EF tended to be higher in group II than in group I (43.1 
(18.2) vs. 33.2 (17.5), P < 0.10), in group III it was significantly lower than in group II (26.2 (18.5) vs. 
43.1 (18.2), P <0.01). 
LA conduit function  
Passive atrial SV was comparable in group I and group II (12.8 (7.4) vs. 13.2 (8.5) ml), but more than 
two-fold greater in group III than in group II (29.6 (24.4) vs.13.2 (8.5) ml, P <0.005). Passive atrial EF 
tended to be lower in group II than in group I (23.8 (16.1) vs. 34.0 (14.7) %, P < 0.10), but tended to be 
higher in group III than in group II (30.0 (19.3) vs. 23.8 (16.1) %, P <0.10). 
LA reservoir function  
The atrial expansion index was nearly identical in group I and II (156.1 (97.7) % and 158.8 (78.7)%, 
respectively), and non-significantly lower in group III (128.2 (107.3)%). 
Total LA function  
Total atrial SV was significantly larger in group II than in group I patients (32.2 (5.5) vs. 20.9 (8.9) ml, 
P <0.0001), and the largest total atrial SV was in group III (46.5 (25.5) ml, P <0.001). Figure 3B shows 
that total atrial SV correlated well with LAVmax (r = 0.82, P <0.0001). Total atrial EF was comparable 
in group I, II and III (56.4 (13.3) %, 58.5 (10.5) %, and 49.9 (15.6) %, respectively). 
 
Figure 3. Left atrial volume (LAV) at three phases: (A) Maximum, (B) pre-atrial contraction, and (C) 
minimum in the different study groups. 
 125
Chapter 11 
 
 
Figure 4. (A) Relation between pre-atrial contraction left atrial volumes (LAV) and active atrial stroke 
volume; (B) maximum left atrial volumes and total atrial stroke volume (left). 
 
 
 DISCUSSION 
LA function significantly contributes to the maintenance of cardiac output and impairment of its 
function contributes to circulatory failure, mitral regurgitation, atrial fibrillation and stroke 18,19. 
Previous studies assessed LA function by invasive pressure-volume loop determination 4, or by LAV 
changes assessed by nuclear scintigraphy, computed tomography, or magnetic resonance imaging 7,9. 
RT3DE is an interestingly alternative for LAV assessment because of availability, rapid acquisition and 
analysis, low cost, no need for contrast or radiation, and relatively high temporal resolution. In this 
study LAV was assessed in the three atrial phases by RT3DE. 
To the best of our knowledge, this is the first RT3DE study to describe the existence of a 
Frank-Starling mechanism in the LA. The Frank-Starling mechanism was shown by an increase in LA 
contractility in response to an increase in LA preload up to a point, beyond which LA contractility 
decreased (Figure 4A). 
 Despite the correlation between an increase in LAVpre-A and active atrial SV in patients with 
normal to moderately enlarged LAV, active atrial SV reached a plateau and even decreased in patients 
with the largest LAV. These findings are in accordance with previous non-invasive and invasive 
studies 3,5,20. Active atrial SV increase in response to an increase in LAVpre-A may be related not only 
to a pressure increase but also to an enhanced inherent inotropic state of LA myocardium. This may 
explain the improvement of atrial pump function after digoxin administration in patients with heart 
failure 6.  The clinical implication of the described Frank-Starling law in the LA is its role in heart 
failure. In early stages of heart failure, the LA compensates well by mechanical adaptation to the 
increased hemodynamic load which may prevent or delay appearance of symptoms of heart failure 11. 
Thus, evaluation of LA function in heart failure patients will have therapeutic and prognostic value. 
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Another clinical implication is that LA functional assessment may help as a predictor for development 
of atrial fibrillation and maintenance of sinus rhythm after cardioversion 21. 
LA conduit function is mainly determined by the rate of left ventricular relaxation 22. This 
may explain the tendency for a reduction in passive atrial EF in group II patients, in whom LV diastolic 
function is impaired due to a high incidence of hypertension and ischemic heart disease. The increased 
LA conduit function in group III patients appears as a compensatory mechanism to counterbalance 
decreased LA pump function 19,23. These changes in LA conduit function due to impaired left 
ventricular relaxation are reflected in changes in mitral inflow E/A ratio. This may explain the 
improvement in LA function in patients with restrictive physiology after angiotensin converting 
enzyme inhibitor therapy 24. 
LA reservoir function is determined by LA myocardial contraction and relaxation, and mitral 
annulus displacement during left ventricular contraction 25,26. In this study there was only a non-
significant decrease in LA reservoir function in patients with the largest LAV. This may be due to the 
multi-factorial mechanisms responsible for LA reservoir dysfunction. 
Study limitations 
LA tracing can be problematic owing to (a) decreased resolution of three-dimensional imaging 
compared with two-dimensional imaging, (b) the LA is in the far-field, and (c) some LA walls 
suffering from lateral resolution by which pixels will become lines in the image display. Because the 
objective of our study was to prove a physiological concept rather than to demonstrate the feasibility of 
three-dimensional assessment for LA volumes we only included patients with good image quality in 
our study (representing about one third of routinely referred patients). Because of this selection, we 
cannot make recommendations on the routine clinical value for routine LAV measurements and 
assessment of LAV changes. For such recommendations intra- and interobserver variabilities and the 
accuracy of such measurements (compared to a “gold standard”) should be assessed in the whole 
spectrum of image qualities. 
CONCLUSION 
In this RT3DE study, the presence of a Frank-Starling mechanism was shown by an increase in LA 
contractility in response to an increase in LA preload up to a point, beyond which LA contractility 
decreased. RT3DE assessment of LAV may help in understanding LA physiology and clinical 
assessment.    
 127
Chapter 11 
 
REFERENCES 
1. Fuchs F, Smith SH. Calcium, cross-bridges, and the Frank-Starling relationship. News Physiol Sci 
2001;16:5-10. 
2. Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart 
failure: with emphasis on regional systolic function. Circulation 2006;113:296-304. 
3. Nakatani S, Garcia MJ, Firstenberg MS, Rodriguez L, Grimm RA, Greenberg NL, McCarthy PM, 
Vandervoort PM, Thomas JD. Noninvasive assessment of left atrial maximum dP/dt by a combination 
of transmitral and pulmonary venous flow. J Am Coll Cardiol 1999;34:795-801. 
4. Hoit BD, Shao Y, Gabel M, Walsh RA. In vivo assessment of left atrial contractile performance in 
normal and pathological conditions using a time-varying elastance model. Circulation 1994;89:1829-
38. 
5. Stefanadis C, Dernellis J, Stratos C, Tsiamis E, Tsioufis C, Toutouzas K, Vlachopoulos C, Pitsavos 
C, Toutouzas P. Assessment of left atrial pressure-area relation in humans by means of retrograde left 
atrial catheterization and echocardiographic automatic boundary detection: effects of dobutamine. J Am 
Coll Cardiol 1998;31:426-36. 
6. Dernellis JM, Panaretou MP. Effects of digoxin on left atrial function in heart failure. Heart 
2003;89:1308-15. 
7. Kircher B, Abbott JA, Pau S, Gould RG, Himelman RB, Higgins CB, Lipton MJ, Schiller NB. Left 
atrial volume determination by biplane two-dimensional echocardiography: validation by cine 
computed tomography. Am Heart J 1991;121:864-71. 
8. Marmor A, Frankel A, Blondeheim DS, Satinger A, Front D. Scintigraphic assessment of atrial 
function in patients with longstanding hypertension. Radiology 1984;151:483-6. 
9. Jarvinen V, Kupari M, Hekali P, Poutanen VP. Assessment of left atrial volumes and phasic function 
using cine magnetic resonance imaging in normal subjects. Am J Cardiol 1994;73:1135-8. 
10. Matsuzaki M, Tamitani M, Toma Y, Ogawa H, Katayama K, Matsuda Y, Kusukawa R. Mechanism 
of augmented left atrial pump function in myocardial infarction and essential hypertension evaluated by 
left atrial pressure-dimension relation. Am J Cardiol 1991;67:1121-6. 
11. Dernellis JM, Stefanadis CI, Zacharoulis AA, Toutouzas PK. Left atrial mechanical adaptation to 
long-standing hemodynamic loads based on pressure-volume relations. Am J Cardiol 1998;81:1138-43. 
12. Blondheim DS, Osipov A, Meisel SR, Frimerman A, Shochat M, Shotan A. Relation of left atrial 
size to function as determined by transesophageal echocardiography. Am J Cardiol 2005;96:457-63. 
13. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies 
to determine left atrial size. Am J Cardiol 1999;84:829-32. 
14. Keller AM, Gopal AS, King DL. Left and right atrial volume by freehand three-dimensional 
echocardiography: in vivo validation using magnetic resonance imaging. Eur J Echocardiogr 
2000;1:55-65. 
15. Poutanen T, Ikonen A, Vainio P, Jokinen E, Tikanoja T. Left atrial volume assessed by 
transthoracic three dimensional echocardiography and magnetic resonance imaging: dynamic changes 
during the heart cycle in children. Heart 2000;83:537-42. 
16. Poutanen T, Jokinen E, Sairanen H, Tikanoja T. Left atrial and left ventricular function in healthy 
children and young adults assessed by three dimensional echocardiography. Heart 2003;89:544-9. 
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Lancet 1986;1:307-10. 
18. Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, Pennock GD, Safford 
RE, Rothbart RM, Halperin JL, Hart RG. Left atrial diameter in nonvalvular atrial fibrillation: An 
echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 
1999;137:494-9. 
19. Quinones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC, Shindler DM, Shelton BJ, 
Weiner DH. Echocardiographic predictors of clinical outcome in patients with left ventricular 
dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. 
Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 2000;35:1237-44. 
20. Spencer KT, Mor-Avi V, Gorcsan J, 3rd, DeMaria AN, Kimball TR, Monaghan MJ, Perez JE, 
Weinert L, Bednarz J, Edelman K, Kwan OL, Glascock B, Hancock J, Baumann C, Lang RM. Effects 
of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic 
quantification study. Heart 2001;85:272-7. 
21. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS. 
Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. 
J Am Coll Cardiol 1994;23:1535-40. 
 128
Left atrial Frank-Starling law assessment 
 129
22. Nikitin NP, Witte KK, Thackray SD, Goodge LJ, Clark AL, Cleland JG. Effect of age and sex on 
left atrial morphology and function. Eur J Echocardiogr 2003;4:36-42. 
23. Stefanadis C, Dernellis J, Tsiamis E, Toutouzas P. Effects of pacing-induced and balloon coronary 
occlusion ischemia on left atrial function in patients with coronary artery disease. J Am Coll Cardiol 
1999;33:687-96. 
24. Henein MY, Amadi A, O'Sullivan C, Coats A, Gibson DG. ACE inhibitors unmask incoordinate 
diastolic wall motion in restrictive left ventricular disease. Heart 1996;76:326-31. 
25. Barbier P, Solomon SB, Schiller NB, Glantz SA. Left atrial relaxation and left ventricular systolic 
function determine left atrial reservoir function. Circulation 1999;100:427-36. 
26. Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, Kitagawa T, Kato I, Kitahata H, Oshita S. Role 
of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping 
during cardiac surgery. Am J Cardiol 1998;81:327-32. 
 
 
 
 
CHAPTER 12 
 
 
 
Assessment of Left Atrial Ejection Force in Hypertrophic 
Cardiomyopathy Using Real-Time Three-Dimensional 
Echocardiography 
 
 
Ashraf M. Anwar1,2, Osama I.I. Soliman1,2,  Marcel L. Geleijnse1, Michelle Michels1, Wim B. Vletter1, 
Attila Nemes1,3 and Folkert J. ten Cate1 
 
  
1Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The 
Netherlands 
2Department of Cardiology, Al-Hussein University Hospital, Al-Azhar University, Cairo, Egypt 
3Second Department of Medicine and Cardiology Center, University of Szeged, Szeged, Hungary 
 
 
Journal of American Society of Echocardiography 2007; 20:744-748.  
 
Chapter 12 
 
ABSTRACT 
The study included 30 patients with hypertrophic cardiomyopathy (HCM) (obstructive and non-
obstructive) and 15 control subjects. End-diastolic mitral annulus area (MAA3D) and mitral valve area 
(MVA3D) were measured by real-time 3-dimensional (3D) echocardiography . MVA2D and peak mitral 
inflow A wave velocity (V) were measured by 2-dimensional (2D) echocardiography. Left atrial 
ejection force (LA-EF) was calculated by 2D echocardiography and real-time 3D echocardiography 
using formula: 0.5 x 1.06 x (MAA or MVA) x V2, where (1.06) is blood viscosity. LA-EF2D-MVA, LA-
EF3D-MVA, LA-EF3D-MAA, and V were significantly higher in patients with HCM than control subjects 
(p<0.001). LA-EF2D-MVA and LA-EF3D-MVA were lower than LA-EF3D-MAA in HCM only (p<0.001). In 
obstructive HCM, LA-EF2D-MVA, LA-EF3D-MVA, LA-EF3D-MAA and V were significantly higher than in 
non-obstructive HCM (p<0.05). LV outflow tract gradient contributed independently to high LA-EF in 
obstructive HCM. We concluded that HCM is associated with higher LA-EF than normal, and higher in 
obstructive HCM than non-obstructive indicating a higher atrial workload that is reflected by LA-EF3D-
MAA.  
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INTRODUCTION 
Hypertrophic cardiomyopathy (HCM) is a relatively common form of genetic heart disease affecting 
approximately 1 in 500 people in the general population 1,2. The disease is characterized by asymmetric 
hypertrophy involving primarily the ventricular septum 3-5. The pathophysiologic appearance of HCM 
is complex and includes dynamic left ventricular (LV) outflow tract (LVOT) obstruction, mitral 
regurgitation, diastolic dysfunction, myocardial ischemia and cardiac arrhythmia 6. Diastolic 
dysfunction is more common than systolic dysfunction in HCM. Marked LV hypertrophy, interstitial 
fibrosis and myocardial ischemia all contribute to reduced ventricular compliance and impaired 
relaxation. These factors contribute to elevated left atrial (LA) and pulmonary vascular pressures 5. 
Decreased compliance also affects LA reservoir function and may affect cardiac output 7. The thin-
walled LA is sensitive to volume and pressure changes 8. Assessment of diastolic function through 
measurement of the components of ventricular filling usually does not include LA contractile function 
9. LA ejection force (LA-EF) defined as the force exerted by the LA to accelerate blood into the LV 
during atrial systole provides a physiological assessment of LA systolic function 10. Based on the 
second law of Newton that stated force = mass X acceleration, LA-EF was calculated by the equation: 
0.5 x 1.06 x (MAA or MVA) x V2, and 0.5 is a coefficient factor. We believe that LA function should 
be included in the clinical assessment of HCM. This study aimed to assess LA-EF non-invasively in 
patients with HCM using real-time (RT) 3-dimensional (3D) echocardiography (3DE).   
METHODS 
The study included thirty patients (80% males, mean age 38  15 years) with an established diagnosis 
of HCM11 and good 2-diensional (2D) echocardiography (2DE) image quality. According to the type of 
HCM, patients were classified into two groups. The non-obstructive group included 20 patients with 
LVOT gradient < 50 mmHg, and the obstructive group included 10 patients with LVOT gradient 50 
mmHg or greater. A group of 15 healthy age-matched adults (mean age 35  16 years) without 
evidence of cardiovascular disease served as control subjects. All patients and control subjects were 
examined by 2DE and RT3DE. Because of 2DE and RT3DE are performed routinely in our lab, only 
informed consent was obtained from our patients  
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Transthoracic 2DE 
2DE was undertaken with the patient lying in the left lateral decubitus using both apical and parasternal 
views. The 2DE studies were performed using a 3.5 MHZ transducer and a commercially available 
ultrasound system (Sonos 7500, Philips, Best, The Netherlands). The following measures were 
obtained: (1) site and maximal thickness of asymmetric LV hypertrophy from the 2DE images (septal, 
antero-lateral, apical, or concentric), (2) mitral valve area (2DMVA) measured by planimetry from a 
parasternal short axis view and defined as the narrowest area at maximum valve opening, (3) LV end-
diastolic (LV-EDD) and LV end-systolic dimensions (LV-ESD) by M-mode, (4) LV fractional 
shortening (LV-FS) calculated as (LV-EDD – LV-ESD) / LV-EDD x 100%, (5) V and peak velocity of 
transmitral E wave with pulsed Doppler, (6) E/A ratio calculation, (7) LVOT gradient with continuous 
wave Doppler using Bernoulli equation, (8) LA-EF2D-MVA calculated as 0.5 x 1.06 x MVA x V2, where 
(V) is the peak velocity of A wave, (1.06) is blood viscosity and (0.5) is a coefficient factor12, and 9) 
mitral regurgitation graded as mild (jet area <4 cm2), moderate (jet area 4-8 cm2), and severe (jet area 
>8 cm2) according to maximum jet area by color Doppler 13. 
Transthoracic RT3DE 
RT3DE was performed using the same ultrasound system, and performed with a X-4 matrix transducer 
capable of providing RT B-mode and color Doppler. The 3D images were collected within 5 to 7 
seconds of breath holding in full volume mode. The 3D data were transferred to an offline analysis 
system (Tom Tec, Munich, Germany). Data were stored digitally and subsequently evaluated by two 
echocardiographers. Data analysis of 3D echo imaging was based on a 2D approach relying on the 
echocardiographic images obtained from the apical views and on manual tracing of inner border of the 
mitral annulus (MA). Once this was completed the surface area was automatically delineated and could 
be visualized from different points of views. Manual modification was done to correct any image if 
necessary. The following measures were obtained: (1) 3DMVA measured by planimetry as described in 
the 2DE section, (2) MA area (3DMAA) measured at end-diastole (just before mitral valve closure), (3) 
LA-EF3D-MVA calculated by the same formula used in 2DE, and (4) LA-EF3D-MAA calculated by 
formula10 as 0.5 x 1.06 x MAA x V 2. 
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Statistical Analysis 
All data obtained by 2DE or RT3DE were presented as mean  SD. Data analysis was performed using 
statistical software (SPSS, version 12.1, SPSS Inc, Chicago). Independent sample t-test was performed 
to compare between means of variables of groups to determine the statistical significance of difference. 
The level of significance was set to P less than 0.05. Interobserver agreement for MAA measurements 
by RT3DE was expressed according to Bland and Altman method14.    
 
RESULTS 
All patients were in sinus rhythm (mean heart rate 73  14 beats per minute) and had normal LV 
systolic function and type I diastolic dysfunction (E/A ratio <0.75)15. The clinical and 
echocardiographic data of all HCM patients are displayed in Table 1. Mitral regurgitation was present 
in 22 patients (73%), 15 patients (50%) had mild regurgitation, and 7 patients (23%) had moderate to 
severe regurgitation. There were no significant differences in clinical variables (age, sex) between the 
two patient groups. Obstructive cases had significantly lower LV-ESD (2.3  0.7 vs. 3.1  0.7 cm, P 
<0.01) and significantly higher LV fractional shortening (48.0  6.0 vs. 34.3  8.0 %, P <0.001) than 
non-obstructive cases, whereas LV-EDD was comparable in both patient groups. Mean thickness of LV 
hypertrophy, its distribution, and the prevalence and severity of mitral regurgitation were comparable 
in both patients groups. Obstructive cases had a higher mean transmitral V (74.2  19.7 vs. 50.1  13.8 
cm/sec, P <0.01) and LA-EF2D-MVA (12.2  6.4 vs. 6.7  4.7 kdynes, P <0.001) compared to non-
obstructive patients.  
Table 1: Clinical and echocardiographic data 
 HCM patients (n = 30) 
Non-obstructive 
(n = 20) 
Obstructive 
(n = 10) 
Age (yr) 38  15 37  15 39  14 
Male gender 24 (80%) 16 (80%) 8 (80%) 
LV-EDD (cm) 4.7  0.8 4.8  0.6 4.4  1.0 
LV-ESD (cm) 2.9  0.8 3.1  0.7 2.3  0.7* 
LV-FS (%) 38.9  9.8 34.3  8.0 48.0  6.0$ 
LVOT gradient (mmHg) 24.9  25.5 8.1  8.5 58.9  8.6$ 
LV hypertrophy (cm) 2.2  0.7 2.2  0.7 2.2  0.4 
Site of LV hypertrophy 
Septal 
Septal + Anterolateral 
Apical 
Symmetrical 
 
22 (73%) 
4 (13%) 
2 (7%) 
2 (7%) 
 
13 (65%) 
3 (15%) 
2 (10%) 
2 (10%) 
 
9 (90%) 
1 (10%) 
0 (0%) 
0 (0%) 
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2DMVA (cm2) 4.3  1.4 4.4  1.5 4.0  1.3 
3DMVA (cm2) 4.2  1.3 4.3  1.3 4.0  1.4 
3DMAA (cm2) 10.1  4.7 10.2  4.7 9.8  5.1 
Peak A velocity (cm/s) 61.5  20.3 50.1  13.8 74.2  19.7* 
LA-EF2D-MVA (kdynes) 9.2  6.1 6.7  4.7 12.2  6.4$ 
LA-EF3D-MVA (kdynes) 9.1  5.6 6.8  5.1 11.4  7.1$  
LA-EF3D-MAA (kdynes) 21.5  16.3 14.7  12.0 29.5  17.6* 
Mitral regurgitation 
No 
Mild 
Moderate-severe 
 
 
8 (27%) 
15 (50%) 
7 (23%) 
 
 
5 (25%) 
10 (50%) 
5 (25%) 
 
 
3 (30%) 
5 (50%) 
2 (20%) 
 
HCM: Hypertrophic cardiomyopathy; LA-EF: left atrial ejection force; LV: left ventricular; LV-EDD: 
LV end-diastolic dimension, LV-ESD: LV end-systolic dimension, LV-FS: LV fractional shortening, 
LVOT: LV outflow tract, MAA: mitral annulus area; MVA: mitral valve area, 2D: 2-diensional; 3D:3-
diensional, P value  <0.05*and  <0.001$ 
 
Acquisition and post-processing of RT3DE data were performed successfully with clear 
delineation of the MA in all patients (Figure 1). 3DMAA showed good agreement between two 
independent observers (mean difference = 0.01  0.17 cm2, agreement = - 0.33, 0.35 cm2). No 
significant differences between the obstructive and non-obstructive patient groups were found for 
3DMAA and 3DMVA. In the overall HCM group, LA-EF2D-MVA was well correlated to LA-EF3D-MVA (r = 
0.96, P <0.0001) and LA-EF3D-MAA (r = 0.67, P <0.001). No significant difference was found between 
LA-EF2D-MVA and LA-EF3D-MVA. Both LA-EF3D-MVA (11.4  7.1 vs. 6.8  5.1 kdynes, P <0.05) and 
LA-EF3D-MAA (29.5  17.6 vs. 14.7  12.0 kdynes, P <0.05) were significantly higher in obstructive 
group than in non-obstructive group. In all patients with HCM, LA-EF3D-MAA was significantly higher 
than LA-EF2D-MVA (21.5  16.3 vs. 9.2  6.1 kdynes, P <0.001) and LA-EF3D-MVA (21.5  16.3 vs. 9.1 
± 5.6 kdynes, P <0.001). V was well correlated to LA-EF3D-MVA (r = 0.75, P <0.0001), LA-EF3D-MAA (r 
= 0.85, P <0.0001), and LA-EF2D-MVA (r = 0.85, P <0.0001).  To detect the contributing factors 
associated with higher LA-EF in the obstructive group, multivariate regression analysis was done. 
Among the echocardiographic factors that differed in both studied groups (LV-ESD, LV fractional 
shortening, LVOT gradient), the LVOT gradient was the only contributing factor associated with 
higher LA-EF by 2DE and RT3DE in the obstructive group.  
 
Compared with control subjects, 3DMAA was significantly larger in both HCM groups than in 
control group (P <0.01). V was higher in both HCM groups than control group (P <0.05). Contrary to 
patients with HCM, no significant difference was detected between LA-EF3D-MAA, LA-EF2D-MVA, and 
LA-EF3D-MVA in control subjects. LA-EF3D-MAA, LA-EF2D-MVA, and LA-EF3D-MVA were significantly
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lower than both obstructive and non-obstructive HCM groups (P <0.001). In obstructive HCM group, 
significantly higher values for and LA-EF by 2DE and RT3DE were found (Table 2). 
Table 2: Comparison between patients with hypertrophic cardiomyopathy and normal subjects  
 Normal subjects (n = 15) 
Non-obstructive HCM 
(n = 20) 
Obstructive HCM 
(n = 10) 
MVA2D (cm2) 4.8  0.9 4.4  1.5 4.0  1.3 
MVA3D (cm2) 4.9  0.7 4.3  1.3 4.0  1.4 
MAA3D  (cm2) 6.1  1.7$ 10.2  4.7 9.8  5.1 
Peak A velocity (cm/s) 39.7  9.9$ 50.1  13.8 74.2  19.7* 
LA-EF2D-MVA (kdynes) 4.2  2.9$ 6.7  4.7 12.2  6.4* 
LA-EF3D-MVA (kdynes) 4.3  2.3$ 6.8  5.1 11.4  7.1* 
LA-EF3D-MAA (kdynes) 5.0  2.1$ 14.7  12.0 29.5  17.6* 
HCM: Hypertrophic cardiomyopathy; LA-EF: left atrial ejection force; MAA: mitral annulus area; 
MVA: mitral valve area, 2D: 2-dimensional; 3D:3-dimensional, * P value< 0.05 between obstructive 
group and non-obstructive, $ P value <0.05 between control group and both HCM groups. 
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DISCUSSION 
 
In this study, LA-EF was used as a marker for LA contractile function in HCM. LA-EF by 2DE and 
RT3DE was higher in patients with HCM compared with control subjects, with the highest value found 
in obstructive HCM. LA-EF3D-MAA calculated by the MAA3D-derived formula in HCM patients was 
higher than by the MVA-derived formula either by 2DE or RT3DE. This difference was not present in 
control subjects. As seen in Figure 3, high LA-EF in HCM was correlated with the V, and thus the 
severity of LV diastolic dysfunction. In our opinion, the clinical implication of this study is the concept 
that LA-EF is a sensitive indicator for LA work that reflects the severity of LV diastolic dysfunction.  
 
In this study, RT3DE helped in good visualization of MA in all patients. Tracing of 3DMAA 
was successfully performed with good interobserver agreement. Previous studies describing LA-EF by 
2DE used MVA for calculation12,16,17, whereas in the current study, LA-EF was assessed by RT3DE 
using 3DMVA and 3DMAA. The values of LA-EF by both techniques regardless of the formula used were 
well correlated. However, a higher LA-EF3D-MAA compared to LA-EF3D-MVA and LA-EF2D-MVA was 
found in HCM patients but not in control subjects. This could be explained by overstretching and 
dilatation of MAA in patients with HCM, 18 which increased the difference between MAA and MVA 
compared to control subjects. The high LA-EF3D-MAA value in patients with HCM is concordant with 
the concept that LA work increases significantly with higher LA preload 12,17,19. Our findings are in 
accordance with Nagueh et al 20 who reported high LA-EF2D-MAA in patients with obstructive HCM. 
The higher value of LA-EF in patients with obstructive HCM compared with non-obstructive HCM 
may be explained by augmentation of LA contractility because of higher LV resistance. Therefore, 
successful therapeutic attempts to decrease LVOT gradients such as septal ablation reduced LA-EF 
indicating reduction of LA workload 20.  
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CONCLUSION 
HCM is associated with high LA-EF indicating a high LA workload especially in obstructive type. For 
RT3DE, LA-EF should be determined in patients with HCM by MAA-derived formula instead of 
MVA-derived formula because of MA dilatation. Thus, LA-EF3D-MAA is recommended as a better 
indicator for LA work in HCM and this may help in the clinical assessment and follow up. 
 139
Chapter 12 
 
 140
REFERENCES 
 
1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic 
cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects 
in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 
1995;92:785-9. 
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Bild DE. HCM in the general population. Circulation 
1996;94:588-9. 
3. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy 
in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-
dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708. 
4. Obeid AI, Maron BJ. Apical hypertrophic cardiomyopathy developing at a relatively advanced age. 
Circulation 2001;103:1605. 
5. Braunwald E, Seidman CE, Sigwart U. Contemporary evaluation and management of hypertrophic 
cardiomyopathy. Circulation 2002;106:1312-6. 
6. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. 
N Engl J Med 1997;336:775-85. 
7. Sanada H, Shimizu M, Kita Y, Sugihara N, Shimizu K, Murakami T, Takeda R, Mifune J. [Left 
atrial booster pump function in patients with hypertrophic cardiomyopathy and essential hypertension: 
evaluations based on left atrial pressure-volume relationship]. J Cardiol 1992;22:99-106. 
8. Michalak E, Michalak JM, Chojnowska L, Ruzyllo W, Hoffman P. [Echocardiographic assessment 
of left atrial volume and emptying in hypertrophic cardiomyopathy]. Przegl Lek 2004;61:729-32. 
9. Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J 
2001;22:22-36. 
10. Manning WJ, Silverman DI, Katz SE, Douglas PS. Atrial ejection force: a noninvasive assessment 
of atrial systolic function. J Am Coll Cardiol 1993;22:221-5. 
11. Rakowski H, Sasson Z, Wigle ED. Echocardiographic and Doppler assessment of hypertrophic 
cardiomyopathy. J Am Soc Echocardiogr 1988;1:31-47. 
12. Hesse B, Schuele SU, Thamilasaran M, Thomas J, Rodriguez L. A rapid method to quantify left 
atrial contractile function: Doppler tissue imaging of the mitral annulus during atrial systole. Eur J 
Echocardiogr 2004;5:86-92. 
13. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of 
mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am 
Coll Cardiol 1989;13:585-90. 
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Lancet 1986;1:307-10. 
15. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation 
of diastolic function. J Am Soc Echocardiogr 2004;17:290-7. 
16. Qirko S, Tase M, Lushnjari V, Sinjari T. [Left atrial contractility function in hypertension]. Arch 
Mal Coeur Vaiss 1996;89:1003-7. 
17. Qirko S, Goda T, Rroku LI. [Relationship between the force of left atrial ejection to left ventricular 
function in arterial hypertension]. Arch Mal Coeur Vaiss 1999;92:971-4. 
18. Flachskampf FA, Chandra S, Gaddipatti A, Levine RA, Weyman AE, Ameling W, Hanrath P, 
Thomas JD. Analysis of shape and motion of the mitral annulus in subjects with and without 
cardiomyopathy by echocardiographic 3-dimensional reconstruction. J Am Soc Echocardiogr 
2000;13:277-87. 
19. Stefanadis C, Dernellis J, Lambrou S, Toutouzas P. Left atrial energy in normal subjects, in patients 
with symptomatic mitral stenosis, and in patients with advanced heart failure. Am J Cardiol 
1998;82:1220-3. 
20. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quinones MA, Spencer WH, 3rd. 
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction 
therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999;34:1123-8. 
 
 
CHAPTER 13 
 
 
SUMMARY, CONCLUSION AND FUTURE PERSPECTIVES 
 
 
Ashraf M. Anwar; MD, MSC 
 
  
Department of Cardiology, Thoraxcenter,  
Erasmus University Medical Center, Rotterdam, The Netherlands 
Department of Cardiology, Al-Hussein University Hospital, Al-Azhar University, Cairo, Egypt 
 
 
 
Chapter 13 
 
Summary 
Over the last few years, the introduction of matrix array transducer and advances in computer software 
analysis technology led to enhancement of real-time three-dimensional echocardiography (RT3DE) to be applied 
for clinical utility. By this transducer, the entire heart image could be obtained by a pyramidal full-volume 
acquisition of four cardiac cycles. The development in software made the data off-line analysis faster and easier.  
Application of RT3DE for diagnosis of many cardiovascular abnormalities has been proven and well validated. 
RT3DE assessment of LV volumes, function, mass, and testing dyssynchrony is more accurate and reproducible 
than 2DE and comparable to MRI. RT3DE assessment of valves (especially mitral valve), and congenital septal 
defects has a good advantage for direct visualization in a surgical view. Time now, RT3DE achieved rapid 
transition from academic research field limited to selected patient series to the daily routine clinical practice. 
RT3DE In the course of time RT3DE will be more integrated with 2DE for full and accurate echocardiographic 
examination. The aim of this thesis was to investigate the feasibility and clinical applicability of RT3DE 
anatomical and functional assessment of other important cardiac structures little or not studied before.    
 
RT3DE assessment of tricuspid annulus: (Chapter 2, 3)  
In both chapters, an actual description of the tricuspid valve annulus morphology was obtained by RT3DE. Its 
shape was evident as an oval and not completely circular. RT3DE measurement of tricuspid annulus area and 
diameter is superior to 2DE measurements and comparable to MRI. The ability to study the cyclic changes of the 
annulus area and diameter during systole and diastole helps in calculation of the annular function. RT3DE 
functional assessment of the annulus has an important surgical implication and can be used as a marker of right 
ventricular function.  
 
RT3DE assessment of tricuspid valve: (Chapter 4, 5) 
RT3DE was applied for quantitative and qualitative assessment of the normal tricuspid valve. The qualitative 
assessment included morphologic description of the three leaflets shape, position and their relation to each other 
and to the surrounding structures. By RT3DE description, the identification of the each leaflet seen by variable 
2DE views could be clearly defined. The quantative assessment included measurements of tricuspid valve area, 
commissural width, tricuspid annular area and diameter. Chapter 4 described the value of RT3DE assessment in 
rheumatic tricuspid valve stenosis. Through RT3DE enface view, a detailed morphological assessment of 
mobility, thickness and calcification of all tricuspid valve leaflets was achieved. RT3DE was helpful for 
assessment of stenosis severity through measurement of valve orifice area, and the three commissural widths. All 
these information had an impact on the selection of therapeutic strategy. 
 
RT3DE assessment of mitral annulus: (Chapter 6, 7) 
Chapter 6 explained the feasibility and reliability of RT3DE for assessment of the true mitral annulus area and 
diameter. Its shape was seen as D-shaped and not completely circular. MRI measurements of mitral annulus were 
used as a gold standard to compare between 2DE and RT3DE measurements. It showed underestimation of 2DE 
while RT3DE was superior to it and comparable to MRI. The accuracy of RT3DE measurements was obtained 
with good interobserver and intraobserver agreements. Chapter 7 assessed the morphological and functional 
changes of mitral annulus in both dilated and hypertrophic cardiomyopathy. The annulus increased in size and 
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became flat due to over stretching in both types. Assessment of mitral annulus function by RT3DE calculation of 
fractional area changes and fractional shortening showed augmented function in hypertrophic cardiomyopathy 
and impaired in dilated cardiomyopathy. RT3DE measurements in both types were comparable with MRI 
measurements with good interobserver agreement.  
 
RT3DE assessment of mitral stenosis: (Chapter 8) 
Chapter 8 applied a new proposed RT3DE score for evaluation of mitral valve stenosis before percutaneous 
mitral valvuloplasty. Through RT3DE enface view, the score assessed each part of the two leaflets separately 
including mobility, thickness, and calcification. In addition, chordal thickness, mobility and separation are 
included in the score. The definition of mild, moderate and severe valve affection was settled. Compared to the 
standard 2DE Wilkins' score, the score has many advantages including simple, less subjective and less 
interobserver variability. Its application added more valuable information needed before valvuloplasty and could 
predict the results and complications.   
 
RT3DE assessment of right ventricular outflow tract and pulmonary valve: (Chapter 9) 
Chapter 9 applied RT3DE for morphologic description of right ventricular outflow tract and pulmonary valve. 
Qualitative assessment of outflow tract, pulmonary valve annulus, pulmonary valve, and proximal pulmonary 
artery was achieved in a considerable number of patients. RT3DE measurements of the outflow tract and 
pulmonary valve annulus diameter were higher than that obtained by 2DE. 
 
RT3DE assessment of left atrial volume and function: (Chapter 10, 11, 12) 
Chapter 10 described the feasibility and reliability of RT3DE for assessment of left atrial volume at three phases 
of cardiac cycle (maximum volume, minimum volume, and pre-atrial contraction volume). The advantage of 
RT3DE over 2DE in calculation of left atrial volume is the absence of geometric assumption and thus accuracy 
in both normal and dilated left atrium. Both active and passive left atrial function could be assessed through the 
volumetric changes during the cardiac cycle. The logic understanding of left atrial physiology accepts the 
existence of left atrial Frank-Starling mechanism that evidenced by an increase in left atrial contractility in 
response to an increase in preload up to a certain point, beyond which the left atrial contractility decreased 
(Chapter 11). Chapter 12 described the calculation of left atrial ejection force in normals and in patients with 
hypertrophic cardiomyopathy which provides a physiologic assessment of left atrial systolic function. The 
RT3DE calculation of ejection force by the annulus area-derived formula showed that hypertrophic 
cardiomyopathy is associated with higher ejection force than normal, and higher in obstructive type than non-
obstructive indicating a higher atrial workload which is logic. The study concluded that ejection force should be 
determined by the annulus area-derived formula especially in hypertrophic cardiomyopathy instead of valve 
area-derived formula due to annular dilatation.  
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Conclusion 
1. RT3DE is reliable and feasible technique achieved an accurate assessment (shape, size and function) of 
both mitral and tricuspid annulus irrespective to the annulus size (normal or dilated) comparable to 
MRI. 
2. RT3DE is helpful in morphologic and functional assessment of the tricuspid valve both normal and 
stenotic through the measurement of valve area and commissural width. 
3. The newly proposed RT3DE score for assessment of mitral valve before percutaneous valvuloplasty is 
simple, reliable and clinician can depend on it for better prediction of the procedure outcome. 
4. RT3DE provided detailed qualitative and quantitative information on the right ventricular outflow tract 
and pulmonary valve. 
5. RT3DE became a standard for volume quantification of both ventricles. With the same principle, left 
atrial volume quantification was easily obtained by RT3DE. 
6. RT3DE study of the left atrial volume through cardiac cycle helped in assessment of active and passive 
atrial function and described the existence of Frank-Starling mechanism. 
7. Calculation of left atrial ejection force by RT3DE annulus area-derived formula is superior than valve 
area-derived formula especially in condition of increased atrial load e.g. hypertrophic cardiomyopathy. 
 
Future Perspectives 
Development and advances in probe technology and software analysis are ongoing. This will improve image 
quality and analysis that will be impacted on the diagnostic performance and clinical application. One of the 
major advance is the introduction of broadband monocrystal transducer that will allow high-resolution harmonic 
imaging with improved cavity delineation due to its better penetration and increased signal to noise ratio. 
Transesophageal monocrystal matrix transducer will carry good imaging performance. Real-time tissue tagging 
and tracking for mechanical quantification of the myocardium will help in assessment of myocardial strain in all 
directions (radial, longitudinal, and circumferential). Development of one transducer capable to do 2DE, RT3DE, 
color and tissue Doppler examination will help in full assessment within short time. Advances in software 
analysis can incorporate the 3D data set into digital system.    
 144
Summery, conclusion and future perspectives 
 
SAMENVATTING, CONCLUSIE EN TOEKOMSTPERSPECTIEVEN 
 
 
Folkert J. ten Cate MD, PhD, FESC, FACC1 
Ashraf M. Anwar; MD, MSC, FESC 1,2 
 
  
1 Afdeling Cardiologie, Thoraxcentrum,  
Erasmus Medisch Centrum, Rotterdam, Netherlands 
2 Department of Cardiology, Al-Hussein University Hospital, Al-Azhar University, Cairo, Egypt 
 
 
 
 
 145
Chapter 13 
 
Samenvatting 
Gedurende de laatste paar jaar heeft de introductie van de matrix transducer en vooruitgang in computer 
programmatuur geleid tot verbetering van de real-time drie dimensionale echo (RT3DE) voor klinisch gebruik. 
Met behulp van deze transducer kan het hele hart in beeld worden gebracht door acquisitie van piramidaal 
volumes van vier hart cycli. De nieuwe ontwikkelingen in programmatuur hebben de analyse sneller en 
gemakkelijker gemaakt. Toepassingen van RT3DE voor diagnose van vele cardiovasculaire afwijkingen is 
aangetoond en gevalideerd. RT3DE bepaling van linker kamer volume functie massa en beoordeling van 
dyssynchrony is meer precies en reproduceerbaar geworden dan 2DE en vergelijkbaar met MRI. RT3DE 
bepaling van klepafwijkingen (speciaal de mitraalklep) en congenitale afwijkingen kunnen worden getoond in 
chirurgische doorsneden. Het is dus nu tijd voor RT3DE om een transitie te maken van academische research 
naar dagelijkse routine praktijk. RT3DE moeten worden geïntegreerd met 2DE voor een volledige 
echocardiografische onderzoek.  
Het doel van dit proefschrift is om de mogelijkheden en klinische toepassingen van RT3DE in zijn anatomische 
en functionele bepaling van andere belangrijke cardiale structuren zichtbaar te maken. 
 
RT3DE bepaling van de annulus tricuspidalis (Hoofdstuk 2, 3) 
In beide hoofdstukken wordt een beschrijving gegeven van de morfologie van tricuspidalis klep annulus welke 
bepaald werd met RT3DE. De vorm was ovaal en niet geheel circulair. RT3DE bepaling van tricuspidalis 
annulus oppervlakte en diameter is beter dan de 2DE bepalingen en vergelijkbaar met MRI. De mogelijkheid om 
de cyclische verandering van de oppervlakke van de annulus en de diameter tijdens de systole en diastole te 
bepalen helpt in de bepaling van de annulaire functie. RT3DE functionele bepaling van de annulus heeft 
belangrijke chirurgische implicaties en kan gebruikt worden als onderdeel van rechter kamer functie. 
 
RT3DE bepaling van tricuspidalis klep (Hoofdstuk 4,5) 
RT3DE werd gebruikt voor de kwantitatieve en kwalitatieve bepalingen van de normale tricuspidalis klep. De 
kwalitatieve bepaling hield in een morfologische beschrijving van de drie onderdelen van de klep voor wat 
betreft zijn vorm, positie en de relatie tot elkaar. Met behulp van RT3DE kan elk klepblad goed gedefinieerd 
worden. De kwantitatieve bepaling hielp o.a. in bepaling van de tricuspidalis klep oppervlakte, de wijdte van de 
commissure, de tricuspidalis annulus oppervlakte en diameter. Hoofdstuk 4 beschrijft de waarde van RT3DE in 
de reumatische tricuspidalis klep stenose door een enface bepaling van de klep.  
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RT3DE kan een gedetailleerde morfologische bepaling van de beweeglijkheid, dikte en calcificatie van alle 
klepdeeltjes geven. RT3DE was behulpzaam voor de bepaling van de ernst van de tricuspidalis stenose d.m.v de 
bepaling van het klep oppervlakte en de drie wijdtes van de commissure. Al deze informatie zou een impact 
kunnen hebben voor de selectie van een strategie voor een eventuele therapie.  
 
RT3DE bepaling van de mitraalklep annulus (Hoofdstuk 6,7) 
In hoofdstuk 6 wordt de mogelijkheid en de betrouwbaarheid van RT3DE bepaling van de echte annulus 
oppervlakte van de mitralis en zijn diameter getoond. De vorm van de annulus wordt gezien als een zogenaamde 
D-vorm en is niet compleet circulair. De metingen van de mitraal annulus werden getest met een gouden 
standaard zoals MRI en er werd vergeleken tussen de 2DE en de 3DE bepalingen. 2DE toont een onderschatting 
van de meting terwijl 3DE superieur was aan 2DE en vergelijkbaar met MRI. De nauwkeurigheid van RT3DE 
bepalingen werd bepaald met goede interobserver en intraobserver overeenkomsten. Hoofdstuk 7 bepaalde de 
morfologische en functionele veranderingen van de mitraal annulus in zowel hypertrofische als gedilateerde 
cardiomyopathie. De annulus was toegenomen in grootte en werd overrekt in beide types cardiomyopathie. De 
bepaling van de mitraal klep annulus functie door 3DE voor wat betreft de meting van de veranderingen in 
oppervlakte en verkorting toonde een toegenomen functie in hypertrofische cardiomyopathie en een afgenomen 
functie in gedilateerde cardiomyopathie. De bepaling met RT3DE in beide types waren vergelijkbaar met MRI 
met goede interobserver vergelijking. 
 
RT3DE bepaling mitraal stenose (Hoofdstuk 8) 
In hoofdstuk 8 wordt een nieuwe RT3DE score voor de evaluatie van de mitraal klep stenose voor een percutane 
mitraal klep valvuloplastiek voorgesteld door en enface RT3DE view. De score wordt bepaald door elk van de 
twee klepdelen te meten en te bepalen voor wat betreft mobiliteit, dikte en calcificatie. Verder werd de dikte van 
het chorda beweeglijkheid en stand tussen twee chorda in de score geïncludeerd. De definitie van milde, matige 
en ernstige klepafwijking werd vastgesteld en vergeleken met de standaard 2DE Wilkin’s score. De beschreven 
score had vele voordelen omdat het eenvoudig is, minder subjectief en minder interobserver variabiliteit heeft. 
De toepassing geeft inzicht in een keuze voor een valvuloplastiek en kan eventueel de resultaten en complicaties 
voorspellen. 
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RT3DE bepaling van de rechter ventrikel uitstroombaan en pulmonaal klep (Hoofdstuk 9) 
In hoofdstuk 9 wordt de morfologische beschrijving van de rechter ventrikel uitstroombaan en pulmonaal klep 
met RT3DE beschreven. Er is een een kwalitatieve bepaling van de uitstroombaan, pulmonaal klep annulus, 
pulmonaal klep zelf en de proximale pulmonale arterie te verkrijgen in een aantal patiënten. De bepalingen van 
RT3DE van de uitstroombaan en pulmonale klep annulus diameter waren hoger dan in het verleden bepaald met 
2DE. 
 
RT3DE bepaling van linker atrium volume en functie (hoofdstuk 10, 11, 12) 
In hoofdstuk 10 beschrijven wij de mogelijkheid en betrouwbaarheid van RT3DE voor een bepaling van linker 
atrium volume in drie fasen van de cardiale cyclus (op het maximale volume, op het kleinste volume en vlak 
voor de atrium contractie). Het voordeel van RT3DE boven 2DE in bepaling van linker atrium volume is dat wij 
voor RT3DE echo geen geometrische aannames moeten hebben en dus een grotere betrouwbaarheid van de 
meting als gedilateerd linker atrium. Zowel de actieve en passieve linker atrium functie kon worden vastgesteld 
door volumetrische verandering te bepalen gedurende de hartcyclus. Met behulp van deze metingen kan linker 
atrium fysiologie bepaald worden door gebruik te maken van het Frank-Straling mechanisme voor linker atrium 
waarbij een vergroot linker atrium contractiliteit wordt gezien in response naar een toename in preload 
(hoofdstuk 11). In hoofdstuk 12 wordt de bepaling van het linker atrium ejectie 
kracht bepaald in normale patiënten en patiënten met hypertrofische cardiomyopathie zodat een fysiologische 
bepaling van linker atrium systolische functie kan worden verkregen. De RT3DE bepaling van ejectie kracht 
door de formule afgeleid van de annulus oppervlakte liet zien dat hypertrofische cardiomyopathie is geassocieerd 
met hogere ejectie kracht dan normaal en hoger in obstructieve dan non-obstructieve patiënten die dus een 
hogere atriale workload laten zien. Uit de studie wordt geconcludeerd dat ejectie kracht moet worden bepaald 
door een formule afgeleid van de annulus oppervlakte in hypertrofische cardiomyopathie en niet door een 
formule afgeleid van klepoppervlakte 
 
Conclusie 
1. RT3DE is betrouwbaar en het is goed mogelijk om een accurate bepaling te krijgen van vorm, grootte 
en functie van zowel mitralis en tricuspidalis annulus onafhankelijk van de vraag of de annulus vergroot 
of normaal is. Deze gegevens zijn vergelijkbaar met MRI. 
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2. RT3DE is behulpzaam in de morfologische en functionele bepaling van tricuspidalis klep stenose en 
normale tricuspidalis klep door de bepaling van klepoppervlakte en de wijdte van de commisuren. 
3. De hierbij voorgestelde RT3DE score voor de bepaling van mitraalklep voor een percutane 
valvuloplastiek is relatief eenvoudig, betrouwbaar en de clinicus kan hierop vertrouwen voor een 
waarschijnlijk betere voorspelling van de uitkomst van de procedure. 
4. RT3DE geeft een gedetailleerde kwalitatieve en kwantitatieve informatie van de rechter ventrikel 
uitstroombaan en pulmonale klep. 
5. RT3DE is standaard geworden voor bepaling van volumes van beide kamers. Met hetzelfde principe 
kan linker atrium volume gekwantificeerd worden. 
6. RT3DE van linker atrium volume door de cardiale cyclus is behulpzaam in de bepaling van actieve en 
passieve linker atrium functie d.m.v. een Frank-Starling mechanisme. 
7. Meting van linker atrium kracht door RT3DE afgeleid van een formule waarbij de annulus oppervlakte 
wordt gebruikt, is beter dan een formule waarbij de klepoppervlakte wordt gebruikt, met name in 
hypertrofische cardiomyopathie. 
 
Toekomstperspectieven 
 De ontwikkeling en voordelen van transducer technologie en programmatuur is nog steeds aan de gang. Daarom 
wordt verwacht dat beeldkwaliteit en analyse nog sterker wordt verbeterd welke een invloed kan hebben op de 
diagnostische betrouwbaarheid en klinische applicatie. Op dit ogenblijk wordt gewerkt aan de introductie van 
een breedband monokristal transducer die hoog resolutie harmonic beeldvorming mogelijk maakt d.m.v. betere 
penetratie en toename van een signaal ruis verhouding. 
Transoesophagale monokristal matrix transducer zullen een goede beeldvorming laten zien.  Myocardiale strain 
in alle richtingen (radiaal, longitudinaal en circumferentieel) kan waarschijnlijk in de toekomst bepaald worden 
met RT3DE tissue tracking. De RT3DE transducer kan gebruikt worden voor zowel 2DE, RT3DE, kleur en 
tissue doppler en geeft dus een compleet beeld van hartfunctie in een korte tijd. Deze ontwikkelingen worden 
nog gesteund door betere software die in alle digitale systemen kan worden verwerkt.  
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 2005- Registered as Consultant Cardiologist in the Egyptain Medical Syndicate 
 
Position Held 
 
 1994: House Officer (Rotations in different clinical department) at Al-Azhar University 
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 Annual international meetings of Egyptian Society of Cardiology since 1996 and every 
year after. 
 Annual meetings of Cardiac Intervention Working Group at 2000, 2001, 2002. 
 Annual meetings of Egyptian Society of Atherosclerosis at 1999 and 2000. 
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3.  Attendant in the 15th annual cardiovascular conference held on 2007 at Taif, KSA (18 CME hours). 
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2006- First European Course on 3D Echocardiography (2days) Rotterdam, The Netherlands (12 EBAC 
hours). 
2007- Basic Cardiac Life Support  (BCLS), Saudi Heart association affiliated to the American Heart 
Association, Jeddah, Saudi Arabia (4 CME hours) 
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